id	sid	tid	token	lemma	pos
ajlm-2201	1	1	abstract	abstract	ADJ
ajlm-2201	1	2	introduction	introduction	NOUN
ajlm-2201	1	3	methods	method	NOUN
ajlm-2201	1	4	results	result	VERB
ajlm-2201	1	5	discussion	discussion	NOUN
ajlm-2201	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2201	1	7	references	reference	NOUN
ajlm-2201	1	8	about	about	ADP
ajlm-2201	1	9	the	the	DET
ajlm-2201	1	10	author(s	author(s	NOUN
ajlm-2201	1	11	)	)	PUNCT
ajlm-2201	1	12	razia	razia	PROPN
ajlm-2201	1	13	b.	b.	PROPN
ajlm-2201	1	14	banderker	banderker	PROPN
ajlm-2201	1	15	department	department	PROPN
ajlm-2201	1	16	of	of	ADP
ajlm-2201	1	17	pathology	pathology	PROPN
ajlm-2201	1	18	,	,	PUNCT
ajlm-2201	1	19	division	division	NOUN
ajlm-2201	1	20	of	of	ADP
ajlm-2201	1	21	chemical	chemical	ADJ
ajlm-2201	1	22	pathology	pathology	NOUN
ajlm-2201	1	23	,	,	PUNCT
ajlm-2201	1	24	faculty	faculty	NOUN
ajlm-2201	1	25	of	of	ADP
ajlm-2201	1	26	medicine	medicine	NOUN
ajlm-2201	1	27	and	and	CCONJ
ajlm-2201	1	28	health	health	NOUN
ajlm-2201	1	29	sciences	sciences	PROPN
ajlm-2201	1	30	,	,	PUNCT
ajlm-2201	1	31	stellenbosch	stellenbosch	PROPN
ajlm-2201	1	32	university	university	PROPN
ajlm-2201	1	33	,	,	PUNCT
ajlm-2201	1	34	cape	cape	NOUN
ajlm-2201	1	35	town	town	NOUN
ajlm-2201	1	36	,	,	PUNCT
ajlm-2201	1	37	south	south	PROPN
ajlm-2201	1	38	africa	africa	PROPN
ajlm-2201	1	39	department	department	PROPN
ajlm-2201	1	40	of	of	ADP
ajlm-2201	1	41	pathology	pathology	PROPN
ajlm-2201	1	42	,	,	PUNCT
ajlm-2201	1	43	division	division	NOUN
ajlm-2201	1	44	of	of	ADP
ajlm-2201	1	45	chemical	chemical	ADJ
ajlm-2201	1	46	pathology	pathology	PROPN
ajlm-2201	1	47	,	,	PUNCT
ajlm-2201	1	48	national	national	PROPN
ajlm-2201	1	49	health	health	PROPN
ajlm-2201	1	50	laboratory	laboratory	PROPN
ajlm-2201	1	51	service	service	PROPN
ajlm-2201	1	52	,	,	PUNCT
ajlm-2201	1	53	cape	cape	NOUN
ajlm-2201	1	54	town	town	NOUN
ajlm-2201	1	55	,	,	PUNCT
ajlm-2201	1	56	south	south	PROPN
ajlm-2201	1	57	africa	africa	PROPN
ajlm-2201	1	58	fatima	fatima	PROPN
ajlm-2201	1	59	b.	b.	PROPN
ajlm-2201	1	60	fazel	fazel	PROPN
ajlm-2201	1	61	department	department	PROPN
ajlm-2201	1	62	of	of	ADP
ajlm-2201	1	63	internal	internal	ADJ
ajlm-2201	1	64	medicine	medicine	NOUN
ajlm-2201	1	65	,	,	PUNCT
ajlm-2201	1	66	division	division	NOUN
ajlm-2201	1	67	of	of	ADP
ajlm-2201	1	68	clinical	clinical	ADJ
ajlm-2201	1	69	haematology	haematology	NOUN
ajlm-2201	1	70	,	,	PUNCT
ajlm-2201	1	71	faculty	faculty	NOUN
ajlm-2201	1	72	of	of	ADP
ajlm-2201	1	73	medicine	medicine	NOUN
ajlm-2201	1	74	and	and	CCONJ
ajlm-2201	1	75	health	health	NOUN
ajlm-2201	1	76	sciences	sciences	PROPN
ajlm-2201	1	77	,	,	PUNCT
ajlm-2201	1	78	stellenbosch	stellenbosch	PROPN
ajlm-2201	1	79	university	university	PROPN
ajlm-2201	1	80	,	,	PUNCT
ajlm-2201	1	81	cape	cape	NOUN
ajlm-2201	1	82	town	town	NOUN
ajlm-2201	1	83	,	,	PUNCT
ajlm-2201	1	84	south	south	PROPN
ajlm-2201	1	85	africa	africa	PROPN
ajlm-2201	1	86	annalise	annalise	PROPN
ajlm-2201	1	87	e.	e.	PROPN
ajlm-2201	1	88	zemlin	zemlin	PROPN
ajlm-2201	1	89	department	department	PROPN
ajlm-2201	1	90	of	of	ADP
ajlm-2201	1	91	pathology	pathology	PROPN
ajlm-2201	1	92	,	,	PUNCT
ajlm-2201	1	93	division	division	NOUN
ajlm-2201	1	94	of	of	ADP
ajlm-2201	1	95	chemical	chemical	ADJ
ajlm-2201	1	96	pathology	pathology	NOUN
ajlm-2201	1	97	,	,	PUNCT
ajlm-2201	1	98	faculty	faculty	NOUN
ajlm-2201	1	99	of	of	ADP
ajlm-2201	1	100	medicine	medicine	NOUN
ajlm-2201	1	101	and	and	CCONJ
ajlm-2201	1	102	health	health	NOUN
ajlm-2201	1	103	sciences	sciences	PROPN
ajlm-2201	1	104	,	,	PUNCT
ajlm-2201	1	105	stellenbosch	stellenbosch	PROPN
ajlm-2201	1	106	university	university	PROPN
ajlm-2201	1	107	,	,	PUNCT
ajlm-2201	1	108	cape	cape	NOUN
ajlm-2201	1	109	town	town	NOUN
ajlm-2201	1	110	,	,	PUNCT
ajlm-2201	1	111	south	south	PROPN
ajlm-2201	1	112	africa	africa	PROPN
ajlm-2201	1	113	department	department	PROPN
ajlm-2201	1	114	of	of	ADP
ajlm-2201	1	115	pathology	pathology	PROPN
ajlm-2201	1	116	,	,	PUNCT
ajlm-2201	1	117	division	division	NOUN
ajlm-2201	1	118	of	of	ADP
ajlm-2201	1	119	chemical	chemical	ADJ
ajlm-2201	1	120	pathology	pathology	PROPN
ajlm-2201	1	121	,	,	PUNCT
ajlm-2201	1	122	national	national	PROPN
ajlm-2201	1	123	health	health	PROPN
ajlm-2201	1	124	laboratory	laboratory	PROPN
ajlm-2201	1	125	service	service	PROPN
ajlm-2201	1	126	,	,	PUNCT
ajlm-2201	1	127	cape	cape	NOUN
ajlm-2201	1	128	town	town	NOUN
ajlm-2201	1	129	,	,	PUNCT
ajlm-2201	1	130	south	south	PROPN
ajlm-2201	1	131	africa	africa	PROPN
ajlm-2201	1	132	aye	aye	PROPN
ajlm-2201	1	133	-	-	PUNCT
ajlm-2201	1	134	aye	aye	NOUN
ajlm-2201	1	135	khine	khine	NOUN
ajlm-2201	1	136	division	division	NOUN
ajlm-2201	1	137	of	of	ADP
ajlm-2201	1	138	chemical	chemical	PROPN
ajlm-2201	1	139	pathology	pathology	PROPN
ajlm-2201	1	140	,	,	PUNCT
ajlm-2201	1	141	national	national	PROPN
ajlm-2201	1	142	health	health	PROPN
ajlm-2201	1	143	laboratory	laboratory	PROPN
ajlm-2201	1	144	service	service	PROPN
ajlm-2201	1	145	,	,	PUNCT
ajlm-2201	1	146	green	green	ADJ
ajlm-2201	1	147	point	point	NOUN
ajlm-2201	1	148	,	,	PUNCT
ajlm-2201	1	149	cape	cape	NOUN
ajlm-2201	1	150	town	town	NOUN
ajlm-2201	1	151	,	,	PUNCT
ajlm-2201	1	152	south	south	PROPN
ajlm-2201	1	153	africa	africa	PROPN
ajlm-2201	1	154	thumeka	thumeka	PROPN
ajlm-2201	1	155	p.	p.	PROPN
ajlm-2201	1	156	jalavu	jalavu	PROPN
ajlm-2201	2	1	department	department	PROPN
ajlm-2201	2	2	of	of	ADP
ajlm-2201	2	3	pathology	pathology	PROPN
ajlm-2201	2	4	,	,	PUNCT
ajlm-2201	2	5	division	division	NOUN
ajlm-2201	2	6	of	of	ADP
ajlm-2201	2	7	chemical	chemical	ADJ
ajlm-2201	2	8	pathology	pathology	NOUN
ajlm-2201	2	9	,	,	PUNCT
ajlm-2201	2	10	faculty	faculty	NOUN
ajlm-2201	2	11	of	of	ADP
ajlm-2201	2	12	medicine	medicine	NOUN
ajlm-2201	2	13	and	and	CCONJ
ajlm-2201	2	14	health	health	NOUN
ajlm-2201	2	15	sciences	sciences	PROPN
ajlm-2201	2	16	,	,	PUNCT
ajlm-2201	2	17	stellenbosch	stellenbosch	PROPN
ajlm-2201	2	18	university	university	PROPN
ajlm-2201	2	19	,	,	PUNCT
ajlm-2201	2	20	cape	cape	NOUN
ajlm-2201	2	21	town	town	NOUN
ajlm-2201	2	22	,	,	PUNCT
ajlm-2201	2	23	south	south	PROPN
ajlm-2201	2	24	africa	africa	PROPN
ajlm-2201	2	25	department	department	PROPN
ajlm-2201	2	26	of	of	ADP
ajlm-2201	2	27	pathology	pathology	PROPN
ajlm-2201	2	28	,	,	PUNCT
ajlm-2201	2	29	division	division	NOUN
ajlm-2201	2	30	of	of	ADP
ajlm-2201	2	31	chemical	chemical	ADJ
ajlm-2201	2	32	pathology	pathology	PROPN
ajlm-2201	2	33	,	,	PUNCT
ajlm-2201	2	34	national	national	PROPN
ajlm-2201	2	35	health	health	PROPN
ajlm-2201	2	36	laboratory	laboratory	PROPN
ajlm-2201	2	37	service	service	PROPN
ajlm-2201	2	38	,	,	PUNCT
ajlm-2201	2	39	cape	cape	NOUN
ajlm-2201	2	40	town	town	NOUN
ajlm-2201	2	41	,	,	PUNCT
ajlm-2201	2	42	south	south	PROPN
ajlm-2201	2	43	africa	africa	PROPN
ajlm-2201	2	44	citation	citation	PROPN
ajlm-2201	2	45	banderker	banderker	NOUN
ajlm-2201	2	46	rb	rb	PROPN
ajlm-2201	2	47	,	,	PUNCT
ajlm-2201	2	48	fazel	fazel	ADJ
ajlm-2201	2	49	fb	fb	INTJ
ajlm-2201	2	50	,	,	PUNCT
ajlm-2201	2	51	zemlin	zemlin	PROPN
ajlm-2201	2	52	ae	ae	PROPN
ajlm-2201	2	53	,	,	PUNCT
ajlm-2201	2	54	khine	khine	VERB
ajlm-2201	2	55	a	a	PROPN
ajlm-2201	2	56	-	-	PUNCT
ajlm-2201	2	57	a	a	NOUN
ajlm-2201	2	58	,	,	PUNCT
ajlm-2201	2	59	jalavu	jalavu	PROPN
ajlm-2201	2	60	tp	tp	PROPN
ajlm-2201	2	61	.	.	PUNCT
ajlm-2201	2	62	serum	serum	NOUN
ajlm-2201	2	63	-	-	PUNCT
ajlm-2201	2	64	free	free	ADJ
ajlm-2201	2	65	light	light	NOUN
ajlm-2201	2	66	chain	chain	NOUN
ajlm-2201	2	67	test	test	NOUN
ajlm-2201	2	68	utilisation	utilisation	NOUN
ajlm-2201	2	69	at	at	ADP
ajlm-2201	2	70	a	a	DET
ajlm-2201	2	71	south	south	ADJ
ajlm-2201	2	72	african	african	ADJ
ajlm-2201	2	73	academic	academic	ADJ
ajlm-2201	2	74	laboratory	laboratory	NOUN
ajlm-2201	2	75	and	and	CCONJ
ajlm-2201	2	76	comparison	comparison	NOUN
ajlm-2201	2	77	with	with	ADP
ajlm-2201	2	78	serum	serum	NOUN
ajlm-2201	2	79	protein	protein	NOUN
ajlm-2201	2	80	electrophoresis	electrophoresis	NOUN
ajlm-2201	2	81	results	result	NOUN
ajlm-2201	2	82	.	.	PUNCT
ajlm-2201	3	1	afr	afr	PROPN
ajlm-2201	3	2	j	j	PROPN
ajlm-2201	3	3	lab	lab	PROPN
ajlm-2201	3	4	med	med	PROPN
ajlm-2201	3	5	.	.	PUNCT
ajlm-2201	4	1	2023;12(1	2023;12(1	NUM
ajlm-2201	4	2	)	)	PUNCT
ajlm-2201	4	3	,	,	PUNCT
ajlm-2201	4	4	a2201	a2201	NUM
ajlm-2201	4	5	.	.	NOUN
ajlm-2201	4	6	https://doi.org/10.4102/ajlm.v12i1.2201	https://doi.org/10.4102/ajlm.v12i1.2201	NOUN
ajlm-2201	4	7	original	original	ADJ
ajlm-2201	4	8	research	research	NOUN
ajlm-2201	4	9	serum	serum	NOUN
ajlm-2201	4	10	-	-	PUNCT
ajlm-2201	4	11	free	free	ADJ
ajlm-2201	4	12	light	light	NOUN
ajlm-2201	4	13	chain	chain	NOUN
ajlm-2201	4	14	test	test	NOUN
ajlm-2201	4	15	utilisation	utilisation	NOUN
ajlm-2201	4	16	at	at	ADP
ajlm-2201	4	17	a	a	DET
ajlm-2201	4	18	south	south	ADJ
ajlm-2201	4	19	african	african	ADJ
ajlm-2201	4	20	academic	academic	ADJ
ajlm-2201	4	21	laboratory	laboratory	NOUN
ajlm-2201	4	22	and	and	CCONJ
ajlm-2201	4	23	comparison	comparison	NOUN
ajlm-2201	4	24	with	with	ADP
ajlm-2201	4	25	serum	serum	NOUN
ajlm-2201	4	26	protein	protein	NOUN
ajlm-2201	4	27	electrophoresis	electrophoresis	NOUN
ajlm-2201	4	28	results	result	VERB
ajlm-2201	4	29	razia	razia	PROPN
ajlm-2201	4	30	b.	b.	PROPN
ajlm-2201	4	31	banderker	banderker	PROPN
ajlm-2201	4	32	,	,	PUNCT
ajlm-2201	4	33	fatima	fatima	PROPN
ajlm-2201	4	34	b.	b.	PROPN
ajlm-2201	4	35	fazel	fazel	PROPN
ajlm-2201	4	36	,	,	PUNCT
ajlm-2201	5	1	annalise	annalise	PROPN
ajlm-2201	5	2	e.	e.	PROPN
ajlm-2201	5	3	zemlin	zemlin	PROPN
ajlm-2201	5	4	,	,	PUNCT
ajlm-2201	5	5	aye	aye	ADJ
ajlm-2201	5	6	-	-	PUNCT
ajlm-2201	5	7	aye	aye	NOUN
ajlm-2201	5	8	khine	khine	NOUN
ajlm-2201	5	9	,	,	PUNCT
ajlm-2201	5	10	thumeka	thumeka	PROPN
ajlm-2201	5	11	p.	p.	PROPN
ajlm-2201	5	12	jalavu	jalavu	PROPN
ajlm-2201	5	13	received	receive	VERB
ajlm-2201	5	14	:	:	PUNCT
ajlm-2201	5	15	24	24	NUM
ajlm-2201	5	16	mar	mar	PROPN
ajlm-2201	5	17	.	.	PROPN
ajlm-2201	5	18	2023	2023	NUM
ajlm-2201	5	19	;	;	PUNCT
ajlm-2201	5	20	accepted	accept	VERB
ajlm-2201	5	21	:	:	PUNCT
ajlm-2201	5	22	05	05	NUM
ajlm-2201	5	23	sept	sept	PROPN
ajlm-2201	5	24	.	.	PROPN
ajlm-2201	5	25	2023	2023	NUM
ajlm-2201	5	26	;	;	PUNCT
ajlm-2201	5	27	published	publish	VERB
ajlm-2201	5	28	:	:	PUNCT
ajlm-2201	5	29	24	24	NUM
ajlm-2201	5	30	nov	nov	PROPN
ajlm-2201	5	31	.	.	PROPN
ajlm-2201	5	32	2023	2023	NUM
ajlm-2201	5	33	copyright	copyright	NOUN
ajlm-2201	5	34	:	:	PUNCT
ajlm-2201	6	1	©	©	PROPN
ajlm-2201	6	2	2023	2023	NUM
ajlm-2201	6	3	.	.	PUNCT
ajlm-2201	7	1	the	the	DET
ajlm-2201	7	2	author(s	author(s	NOUN
ajlm-2201	7	3	)	)	PUNCT
ajlm-2201	7	4	.	.	PUNCT
ajlm-2201	8	1	licensee	licensee	NOUN
ajlm-2201	8	2	:	:	PUNCT
ajlm-2201	8	3	aosis	aosis	NOUN
ajlm-2201	8	4	.	.	PUNCT
ajlm-2201	9	1	this	this	PRON
ajlm-2201	9	2	is	be	AUX
ajlm-2201	9	3	an	an	DET
ajlm-2201	9	4	open	open	ADJ
ajlm-2201	9	5	access	access	NOUN
ajlm-2201	9	6	article	article	NOUN
ajlm-2201	9	7	distributed	distribute	VERB
ajlm-2201	9	8	under	under	ADP
ajlm-2201	9	9	the	the	DET
ajlm-2201	9	10	terms	term	NOUN
ajlm-2201	9	11	of	of	ADP
ajlm-2201	9	12	the	the	DET
ajlm-2201	9	13	creative	creative	ADJ
ajlm-2201	9	14	commons	common	NOUN
ajlm-2201	9	15	attribution	attribution	NOUN
ajlm-2201	9	16	license	license	NOUN
ajlm-2201	9	17	,	,	PUNCT
ajlm-2201	9	18	which	which	PRON
ajlm-2201	9	19	permits	permit	VERB
ajlm-2201	9	20	unrestricted	unrestricted	ADJ
ajlm-2201	9	21	use	use	NOUN
ajlm-2201	9	22	,	,	PUNCT
ajlm-2201	9	23	distribution	distribution	NOUN
ajlm-2201	9	24	,	,	PUNCT
ajlm-2201	9	25	and	and	CCONJ
ajlm-2201	9	26	reproduction	reproduction	NOUN
ajlm-2201	9	27	in	in	ADP
ajlm-2201	9	28	any	any	DET
ajlm-2201	9	29	medium	medium	NOUN
ajlm-2201	9	30	,	,	PUNCT
ajlm-2201	9	31	provided	provide	VERB
ajlm-2201	9	32	the	the	DET
ajlm-2201	9	33	original	original	ADJ
ajlm-2201	9	34	work	work	NOUN
ajlm-2201	9	35	is	be	AUX
ajlm-2201	9	36	properly	properly	ADV
ajlm-2201	9	37	cited	cite	VERB
ajlm-2201	9	38	.	.	PUNCT
ajlm-2201	10	1	abstract	abstract	ADJ
ajlm-2201	10	2	background	background	NOUN
ajlm-2201	10	3	:	:	PUNCT
ajlm-2201	10	4	serum	serum	NOUN
ajlm-2201	10	5	protein	protein	NOUN
ajlm-2201	10	6	electrophoresis	electrophoresis	NOUN
ajlm-2201	10	7	(	(	PUNCT
ajlm-2201	10	8	spe	spe	PROPN
ajlm-2201	10	9	)	)	PUNCT
ajlm-2201	10	10	,	,	PUNCT
ajlm-2201	10	11	urine	urine	NOUN
ajlm-2201	10	12	protein	protein	NOUN
ajlm-2201	10	13	electrophoresis	electrophoresis	NOUN
ajlm-2201	10	14	and	and	CCONJ
ajlm-2201	10	15	immunofixation	immunofixation	NOUN
ajlm-2201	10	16	electrophoresis	electrophoresis	NOUN
ajlm-2201	10	17	were	be	AUX
ajlm-2201	10	18	traditionally	traditionally	ADV
ajlm-2201	10	19	utilised	utilise	VERB
ajlm-2201	10	20	for	for	ADP
ajlm-2201	10	21	the	the	DET
ajlm-2201	10	22	diagnosis	diagnosis	NOUN
ajlm-2201	10	23	of	of	ADP
ajlm-2201	10	24	monoclonal	monoclonal	NOUN
ajlm-2201	10	25	gammopathies	gammopathy	NOUN
ajlm-2201	10	26	.	.	PUNCT
ajlm-2201	11	1	the	the	DET
ajlm-2201	11	2	quantitative	quantitative	ADJ
ajlm-2201	11	3	serum	serum	NOUN
ajlm-2201	11	4	-	-	PUNCT
ajlm-2201	11	5	free	free	ADJ
ajlm-2201	11	6	light	light	NOUN
ajlm-2201	11	7	chain	chain	NOUN
ajlm-2201	11	8	(	(	PUNCT
ajlm-2201	11	9	sflc	sflc	PROPN
ajlm-2201	11	10	)	)	PUNCT
ajlm-2201	11	11	assay	assay	NOUN
ajlm-2201	11	12	is	be	AUX
ajlm-2201	11	13	reportedly	reportedly	ADV
ajlm-2201	11	14	more	more	ADV
ajlm-2201	11	15	sensitive	sensitive	ADJ
ajlm-2201	11	16	and	and	CCONJ
ajlm-2201	11	17	has	have	AUX
ajlm-2201	11	18	been	be	AUX
ajlm-2201	11	19	introduced	introduce	VERB
ajlm-2201	11	20	to	to	ADP
ajlm-2201	11	21	recent	recent	ADJ
ajlm-2201	11	22	clinical	clinical	ADJ
ajlm-2201	11	23	guidelines	guideline	NOUN
ajlm-2201	11	24	.	.	PUNCT
ajlm-2201	12	1	objective	objective	NOUN
ajlm-2201	12	2	:	:	PUNCT
ajlm-2201	12	3	this	this	DET
ajlm-2201	12	4	study	study	NOUN
ajlm-2201	12	5	aimed	aim	VERB
ajlm-2201	12	6	to	to	PART
ajlm-2201	12	7	investigate	investigate	VERB
ajlm-2201	12	8	sflc	sflc	ADP
ajlm-2201	12	9	test	test	NOUN
ajlm-2201	12	10	utilisation	utilisation	NOUN
ajlm-2201	12	11	and	and	CCONJ
ajlm-2201	12	12	describe	describe	VERB
ajlm-2201	12	13	spe	spe	PROPN
ajlm-2201	12	14	findings	finding	NOUN
ajlm-2201	12	15	in	in	ADP
ajlm-2201	12	16	patients	patient	NOUN
ajlm-2201	12	17	with	with	ADP
ajlm-2201	12	18	abnormal	abnormal	ADJ
ajlm-2201	12	19	sflc	sflc	VERB
ajlm-2201	12	20	ratios	ratio	NOUN
ajlm-2201	12	21	.	.	PUNCT
ajlm-2201	13	1	methods	method	NOUN
ajlm-2201	13	2	:	:	PUNCT
ajlm-2201	13	3	a	a	DET
ajlm-2201	13	4	retrospective	retrospective	ADJ
ajlm-2201	13	5	audit	audit	NOUN
ajlm-2201	13	6	of	of	ADP
ajlm-2201	13	7	sflc	sflc	VERB
ajlm-2201	13	8	analyses	analysis	NOUN
ajlm-2201	13	9	was	be	AUX
ajlm-2201	13	10	conducted	conduct	VERB
ajlm-2201	13	11	in	in	ADP
ajlm-2201	13	12	cape	cape	NOUN
ajlm-2201	13	13	town	town	NOUN
ajlm-2201	13	14	,	,	PUNCT
ajlm-2201	13	15	south	south	PROPN
ajlm-2201	13	16	africa	africa	PROPN
ajlm-2201	13	17	,	,	PUNCT
ajlm-2201	13	18	from	from	ADP
ajlm-2201	13	19	may	may	PROPN
ajlm-2201	13	20	2018	2018	NUM
ajlm-2201	13	21	to	to	ADP
ajlm-2201	13	22	april	april	PROPN
ajlm-2201	13	23	2020	2020	NUM
ajlm-2201	13	24	.	.	PUNCT
ajlm-2201	14	1	agreement	agreement	NOUN
ajlm-2201	14	2	between	between	ADP
ajlm-2201	14	3	abnormal	abnormal	ADJ
ajlm-2201	14	4	sflc	sflc	VERB
ajlm-2201	14	5	ratios	ratio	NOUN
ajlm-2201	14	6	and	and	CCONJ
ajlm-2201	14	7	spe	spe	PROPN
ajlm-2201	14	8	results	result	NOUN
ajlm-2201	14	9	was	be	AUX
ajlm-2201	14	10	determined	determine	VERB
ajlm-2201	14	11	in	in	ADP
ajlm-2201	14	12	a	a	DET
ajlm-2201	14	13	sub	sub	NOUN
ajlm-2201	14	14	-	-	NOUN
ajlm-2201	14	15	group	group	NOUN
ajlm-2201	14	16	of	of	ADP
ajlm-2201	14	17	patients	patient	NOUN
ajlm-2201	14	18	screened	screen	VERB
ajlm-2201	14	19	for	for	ADP
ajlm-2201	14	20	monoclonal	monoclonal	NOUN
ajlm-2201	14	21	gammopathies	gammopathy	NOUN
ajlm-2201	14	22	.	.	PUNCT
ajlm-2201	15	1	serum	serum	NOUN
ajlm-2201	15	2	-	-	PUNCT
ajlm-2201	15	3	free	free	ADJ
ajlm-2201	15	4	light	light	ADJ
ajlm-2201	15	5	chains	chain	NOUN
ajlm-2201	15	6	were	be	AUX
ajlm-2201	15	7	analysed	analyse	VERB
ajlm-2201	15	8	using	use	VERB
ajlm-2201	15	9	freelite	freelite	PROPN
ajlm-2201	15	10	®	®	PROPN
ajlm-2201	15	11	kappa	kappa	NOUN
ajlm-2201	15	12	and	and	CCONJ
ajlm-2201	15	13	lambda	lambda	ADJ
ajlm-2201	15	14	assays	assay	NOUN
ajlm-2201	15	15	.	.	PUNCT
ajlm-2201	16	1	results	result	NOUN
ajlm-2201	16	2	:	:	PUNCT
ajlm-2201	16	3	of	of	ADP
ajlm-2201	16	4	the	the	DET
ajlm-2201	16	5	1425	1425	NUM
ajlm-2201	16	6	patients	patient	NOUN
ajlm-2201	16	7	included	include	VERB
ajlm-2201	16	8	in	in	ADP
ajlm-2201	16	9	the	the	DET
ajlm-2201	16	10	audit	audit	NOUN
ajlm-2201	16	11	,	,	PUNCT
ajlm-2201	16	12	741	741	NUM
ajlm-2201	16	13	(	(	PUNCT
ajlm-2201	16	14	52	52	NUM
ajlm-2201	16	15	%	%	NOUN
ajlm-2201	16	16	)	)	PUNCT
ajlm-2201	16	17	had	have	VERB
ajlm-2201	16	18	abnormal	abnormal	ADJ
ajlm-2201	16	19	sflc	sflc	VERB
ajlm-2201	16	20	ratios	ratio	NOUN
ajlm-2201	16	21	;	;	PUNCT
ajlm-2201	16	22	636	636	NUM
ajlm-2201	16	23	(	(	PUNCT
ajlm-2201	16	24	45	45	NUM
ajlm-2201	16	25	%	%	NOUN
ajlm-2201	16	26	)	)	PUNCT
ajlm-2201	16	27	had	have	AUX
ajlm-2201	16	28	increased	increase	VERB
ajlm-2201	16	29	and	and	CCONJ
ajlm-2201	16	30	105	105	NUM
ajlm-2201	16	31	(	(	PUNCT
ajlm-2201	16	32	7	7	NUM
ajlm-2201	16	33	%	%	NOUN
ajlm-2201	16	34	)	)	PUNCT
ajlm-2201	16	35	had	have	AUX
ajlm-2201	16	36	decreased	decrease	VERB
ajlm-2201	16	37	sflc	sflc	VERB
ajlm-2201	16	38	ratios	ratio	NOUN
ajlm-2201	16	39	.	.	PUNCT
ajlm-2201	17	1	in	in	ADP
ajlm-2201	17	2	a	a	DET
ajlm-2201	17	3	sub	sub	ADJ
ajlm-2201	17	4	-	-	ADJ
ajlm-2201	17	5	group	group	NOUN
ajlm-2201	17	6	analysis	analysis	NOUN
ajlm-2201	17	7	of	of	ADP
ajlm-2201	17	8	117	117	NUM
ajlm-2201	17	9	new	new	ADJ
ajlm-2201	17	10	patients	patient	NOUN
ajlm-2201	17	11	with	with	ADP
ajlm-2201	17	12	an	an	DET
ajlm-2201	17	13	abnormal	abnormal	ADJ
ajlm-2201	17	14	sflc	sflc	VERB
ajlm-2201	17	15	ratio	ratio	NOUN
ajlm-2201	17	16	,	,	PUNCT
ajlm-2201	17	17	57	57	NUM
ajlm-2201	17	18	had	have	VERB
ajlm-2201	17	19	a	a	DET
ajlm-2201	17	20	monoclonal	monoclonal	NOUN
ajlm-2201	17	21	protein	protein	NOUN
ajlm-2201	17	22	(	(	PUNCT
ajlm-2201	17	23	m	m	NOUN
ajlm-2201	17	24	-	-	NOUN
ajlm-2201	17	25	protein	protein	NOUN
ajlm-2201	17	26	)	)	PUNCT
ajlm-2201	17	27	on	on	ADP
ajlm-2201	17	28	spe	spe	PROPN
ajlm-2201	17	29	(	(	PUNCT
ajlm-2201	17	30	49	49	NUM
ajlm-2201	17	31	%	%	NOUN
ajlm-2201	17	32	)	)	PUNCT
ajlm-2201	17	33	,	,	PUNCT
ajlm-2201	17	34	and	and	CCONJ
ajlm-2201	17	35	60	60	NUM
ajlm-2201	17	36	(	(	PUNCT
ajlm-2201	17	37	51	51	NUM
ajlm-2201	17	38	%	%	NOUN
ajlm-2201	17	39	)	)	PUNCT
ajlm-2201	17	40	did	do	VERB
ajlm-2201	17	41	not	not	PART
ajlm-2201	17	42	.	.	PUNCT
ajlm-2201	18	1	four	four	NUM
ajlm-2201	18	2	out	out	ADP
ajlm-2201	18	3	of	of	ADP
ajlm-2201	18	4	60	60	NUM
ajlm-2201	18	5	patients	patient	NOUN
ajlm-2201	18	6	without	without	ADP
ajlm-2201	18	7	m	m	NOUN
ajlm-2201	18	8	-	-	NOUN
ajlm-2201	18	9	protein	protein	NOUN
ajlm-2201	18	10	had	have	VERB
ajlm-2201	18	11	a	a	DET
ajlm-2201	18	12	plasma	plasma	NOUN
ajlm-2201	18	13	cell	cell	NOUN
ajlm-2201	18	14	dyscrasia	dyscrasia	PROPN
ajlm-2201	18	15	,	,	PUNCT
ajlm-2201	18	16	while	while	SCONJ
ajlm-2201	18	17	renal	renal	ADJ
ajlm-2201	18	18	impairment	impairment	NOUN
ajlm-2201	18	19	or	or	CCONJ
ajlm-2201	18	20	inflammatory	inflammatory	ADJ
ajlm-2201	18	21	response	response	NOUN
ajlm-2201	18	22	accounted	account	VERB
ajlm-2201	18	23	for	for	ADP
ajlm-2201	18	24	the	the	DET
ajlm-2201	18	25	rest	rest	NOUN
ajlm-2201	18	26	.	.	PUNCT
ajlm-2201	19	1	of	of	ADP
ajlm-2201	19	2	the	the	DET
ajlm-2201	19	3	57	57	NUM
ajlm-2201	19	4	patients	patient	NOUN
ajlm-2201	19	5	with	with	ADP
ajlm-2201	19	6	a	a	DET
ajlm-2201	19	7	m	m	NOUN
ajlm-2201	19	8	-	-	ADJ
ajlm-2201	19	9	protein	protein	NOUN
ajlm-2201	19	10	and	and	CCONJ
ajlm-2201	19	11	abnormal	abnormal	ADJ
ajlm-2201	19	12	sflc	sflc	VERB
ajlm-2201	19	13	ratio	ratio	NOUN
ajlm-2201	19	14	,	,	PUNCT
ajlm-2201	19	15	41	41	NUM
ajlm-2201	19	16	(	(	PUNCT
ajlm-2201	19	17	72	72	NUM
ajlm-2201	19	18	%	%	NOUN
ajlm-2201	19	19	)	)	PUNCT
ajlm-2201	19	20	had	have	VERB
ajlm-2201	19	21	a	a	DET
ajlm-2201	19	22	plasma	plasma	NOUN
ajlm-2201	19	23	cell	cell	NOUN
ajlm-2201	19	24	dyscrasia	dyscrasia	PROPN
ajlm-2201	19	25	,	,	PUNCT
ajlm-2201	19	26	seven	seven	NUM
ajlm-2201	19	27	(	(	PUNCT
ajlm-2201	19	28	12	12	NUM
ajlm-2201	19	29	%	%	NOUN
ajlm-2201	19	30	)	)	PUNCT
ajlm-2201	19	31	had	have	VERB
ajlm-2201	20	1	lymphomas	lymphoma	NOUN
ajlm-2201	20	2	and	and	CCONJ
ajlm-2201	20	3	nine	nine	NUM
ajlm-2201	20	4	patients	patient	NOUN
ajlm-2201	20	5	(	(	PUNCT
ajlm-2201	20	6	16	16	NUM
ajlm-2201	20	7	%	%	NOUN
ajlm-2201	20	8	)	)	PUNCT
ajlm-2201	20	9	were	be	AUX
ajlm-2201	20	10	unclassifiable	unclassifiable	ADJ
ajlm-2201	20	11	.	.	PUNCT
ajlm-2201	21	1	conclusion	conclusion	NOUN
ajlm-2201	21	2	:	:	PUNCT
ajlm-2201	21	3	serum	serum	NOUN
ajlm-2201	21	4	-	-	PUNCT
ajlm-2201	21	5	free	free	ADJ
ajlm-2201	21	6	light	light	ADJ
ajlm-2201	21	7	chains	chain	NOUN
ajlm-2201	21	8	should	should	AUX
ajlm-2201	21	9	be	be	AUX
ajlm-2201	21	10	requested	request	VERB
ajlm-2201	21	11	when	when	SCONJ
ajlm-2201	21	12	there	there	PRON
ajlm-2201	21	13	is	be	VERB
ajlm-2201	21	14	a	a	DET
ajlm-2201	21	15	high	high	ADJ
ajlm-2201	21	16	index	index	NOUN
ajlm-2201	21	17	of	of	ADP
ajlm-2201	21	18	clinical	clinical	ADJ
ajlm-2201	21	19	suspicion	suspicion	NOUN
ajlm-2201	21	20	.	.	PUNCT
ajlm-2201	22	1	neither	neither	CCONJ
ajlm-2201	22	2	sflc	sflc	PROPN
ajlm-2201	22	3	nor	nor	CCONJ
ajlm-2201	22	4	spe	spe	PROPN
ajlm-2201	22	5	should	should	AUX
ajlm-2201	22	6	be	be	AUX
ajlm-2201	22	7	performed	perform	VERB
ajlm-2201	22	8	in	in	ADP
ajlm-2201	22	9	isolation	isolation	NOUN
ajlm-2201	22	10	when	when	SCONJ
ajlm-2201	22	11	screening	screen	VERB
ajlm-2201	22	12	patients	patient	NOUN
ajlm-2201	22	13	for	for	ADP
ajlm-2201	22	14	monoclonal	monoclonal	NOUN
ajlm-2201	22	15	gammopathy	gammopathy	ADJ
ajlm-2201	22	16	,	,	PUNCT
ajlm-2201	22	17	to	to	PART
ajlm-2201	22	18	ensure	ensure	VERB
ajlm-2201	22	19	that	that	SCONJ
ajlm-2201	22	20	no	no	DET
ajlm-2201	22	21	patient	patient	NOUN
ajlm-2201	22	22	is	be	AUX
ajlm-2201	22	23	missed	miss	VERB
ajlm-2201	22	24	.	.	PUNCT
ajlm-2201	23	1	what	what	PRON
ajlm-2201	23	2	this	this	DET
ajlm-2201	23	3	study	study	NOUN
ajlm-2201	23	4	adds	add	VERB
ajlm-2201	23	5	:	:	PUNCT
ajlm-2201	23	6	the	the	DET
ajlm-2201	23	7	study	study	NOUN
ajlm-2201	23	8	adds	add	VERB
ajlm-2201	23	9	to	to	ADP
ajlm-2201	23	10	the	the	DET
ajlm-2201	23	11	evidence	evidence	NOUN
ajlm-2201	23	12	on	on	ADP
ajlm-2201	23	13	sflc	sflc	ADP
ajlm-2201	23	14	test	test	NOUN
ajlm-2201	23	15	utilisation	utilisation	NOUN
ajlm-2201	23	16	.	.	PUNCT
ajlm-2201	24	1	serum	serum	NOUN
ajlm-2201	24	2	protein	protein	NOUN
ajlm-2201	24	3	electrophoresis	electrophoresis	NOUN
ajlm-2201	24	4	alone	alone	ADV
ajlm-2201	24	5	may	may	AUX
ajlm-2201	24	6	miss	miss	VERB
ajlm-2201	24	7	cases	case	NOUN
ajlm-2201	24	8	of	of	ADP
ajlm-2201	24	9	light	light	ADJ
ajlm-2201	24	10	chain	chain	NOUN
ajlm-2201	24	11	myeloma	myeloma	NOUN
ajlm-2201	24	12	,	,	PUNCT
ajlm-2201	24	13	while	while	SCONJ
ajlm-2201	24	14	sflc	sflc	NOUN
ajlm-2201	24	15	performed	perform	VERB
ajlm-2201	24	16	in	in	ADP
ajlm-2201	24	17	isolation	isolation	NOUN
ajlm-2201	24	18	may	may	AUX
ajlm-2201	24	19	produce	produce	VERB
ajlm-2201	24	20	false	false	ADJ
ajlm-2201	24	21	positive	positive	ADJ
ajlm-2201	24	22	results	result	NOUN
ajlm-2201	24	23	in	in	ADP
ajlm-2201	24	24	the	the	DET
ajlm-2201	24	25	setting	setting	NOUN
ajlm-2201	24	26	of	of	ADP
ajlm-2201	24	27	inflammatory	inflammatory	ADJ
ajlm-2201	24	28	disorders	disorder	NOUN
ajlm-2201	24	29	or	or	CCONJ
ajlm-2201	24	30	renal	renal	ADJ
ajlm-2201	24	31	impairment	impairment	NOUN
ajlm-2201	24	32	,	,	PUNCT
ajlm-2201	24	33	leading	lead	VERB
ajlm-2201	24	34	to	to	ADP
ajlm-2201	24	35	unnecessary	unnecessary	ADJ
ajlm-2201	24	36	further	further	ADJ
ajlm-2201	24	37	investigation	investigation	NOUN
ajlm-2201	24	38	.	.	PUNCT
ajlm-2201	25	1	keywords	keyword	NOUN
ajlm-2201	25	2	:	:	PUNCT
ajlm-2201	25	3	monoclonal	monoclonal	NOUN
ajlm-2201	25	4	gammopathy	gammopathy	ADJ
ajlm-2201	25	5	;	;	PUNCT
ajlm-2201	25	6	multiple	multiple	ADJ
ajlm-2201	25	7	myeloma	myeloma	NOUN
ajlm-2201	25	8	;	;	PUNCT
ajlm-2201	25	9	m	m	NOUN
ajlm-2201	25	10	-	-	NOUN
ajlm-2201	25	11	protein	protein	NOUN
ajlm-2201	25	12	;	;	PUNCT
ajlm-2201	25	13	paraprotein	paraprotein	ADJ
ajlm-2201	25	14	;	;	PUNCT
ajlm-2201	25	15	plasma	plasma	NOUN
ajlm-2201	25	16	cell	cell	NOUN
ajlm-2201	25	17	dyscrasia	dyscrasia	PROPN
ajlm-2201	25	18	;	;	PUNCT
ajlm-2201	25	19	polyclonal	polyclonal	ADJ
ajlm-2201	25	20	gammopathy	gammopathy	ADJ
ajlm-2201	25	21	;	;	PUNCT
ajlm-2201	25	22	free	free	ADJ
ajlm-2201	25	23	light	light	ADJ
ajlm-2201	25	24	chains	chain	NOUN
ajlm-2201	25	25	.	.	PUNCT
ajlm-2201	26	1	introduction	introduction	NOUN
ajlm-2201	26	2	monoclonal	monoclonal	NOUN
ajlm-2201	26	3	gammopathies	gammopathy	NOUN
ajlm-2201	26	4	(	(	PUNCT
ajlm-2201	26	5	mg	mg	X
ajlm-2201	26	6	)	)	PUNCT
ajlm-2201	26	7	comprise	comprise	VERB
ajlm-2201	26	8	a	a	DET
ajlm-2201	26	9	spectrum	spectrum	NOUN
ajlm-2201	26	10	of	of	ADP
ajlm-2201	26	11	disorders	disorder	NOUN
ajlm-2201	26	12	,	,	PUNCT
ajlm-2201	26	13	from	from	ADP
ajlm-2201	26	14	the	the	DET
ajlm-2201	26	15	pre	pre	ADJ
ajlm-2201	26	16	-	-	ADJ
ajlm-2201	26	17	malignant	malignant	ADJ
ajlm-2201	26	18	monoclonal	monoclonal	NOUN
ajlm-2201	26	19	gammopathy	gammopathy	ADJ
ajlm-2201	26	20	of	of	ADP
ajlm-2201	26	21	undetermined	undetermined	ADJ
ajlm-2201	26	22	significance	significance	NOUN
ajlm-2201	26	23	(	(	PUNCT
ajlm-2201	26	24	mgus	mgus	ADJ
ajlm-2201	26	25	)	)	PUNCT
ajlm-2201	26	26	to	to	ADP
ajlm-2201	26	27	multiple	multiple	ADJ
ajlm-2201	26	28	myeloma	myeloma	NOUN
ajlm-2201	26	29	(	(	PUNCT
ajlm-2201	26	30	mm	mm	PROPN
ajlm-2201	26	31	)	)	PUNCT
ajlm-2201	26	32	,	,	PUNCT
ajlm-2201	26	33	which	which	PRON
ajlm-2201	26	34	is	be	AUX
ajlm-2201	26	35	associated	associate	VERB
ajlm-2201	26	36	with	with	ADP
ajlm-2201	26	37	significant	significant	ADJ
ajlm-2201	26	38	morbidity	morbidity	NOUN
ajlm-2201	26	39	and	and	CCONJ
ajlm-2201	26	40	mortality.1	mortality.1	VERB
ajlm-2201	26	41	a	a	DET
ajlm-2201	26	42	hallmark	hallmark	NOUN
ajlm-2201	26	43	of	of	ADP
ajlm-2201	26	44	mg	mg	PROPN
ajlm-2201	26	45	is	be	AUX
ajlm-2201	26	46	the	the	DET
ajlm-2201	26	47	production	production	NOUN
ajlm-2201	26	48	of	of	ADP
ajlm-2201	26	49	a	a	DET
ajlm-2201	26	50	monoclonal	monoclonal	NOUN
ajlm-2201	26	51	protein	protein	NOUN
ajlm-2201	26	52	(	(	PUNCT
ajlm-2201	26	53	m	m	NOUN
ajlm-2201	26	54	-	-	NOUN
ajlm-2201	26	55	protein	protein	NOUN
ajlm-2201	26	56	)	)	PUNCT
ajlm-2201	26	57	(	(	PUNCT
ajlm-2201	26	58	except	except	SCONJ
ajlm-2201	26	59	in	in	ADP
ajlm-2201	26	60	cases	case	NOUN
ajlm-2201	26	61	of	of	ADP
ajlm-2201	26	62	non	non	ADJ
ajlm-2201	26	63	-	-	ADJ
ajlm-2201	26	64	secretory	secretory	ADJ
ajlm-2201	26	65	mm).2	mm).2	NOUN
ajlm-2201	26	66	some	some	DET
ajlm-2201	26	67	synonyms	synonym	NOUN
ajlm-2201	26	68	include	include	VERB
ajlm-2201	26	69	‘	'	PUNCT
ajlm-2201	26	70	paraprotein	paraprotein	ADJ
ajlm-2201	26	71	’	'	PUNCT
ajlm-2201	26	72	,	,	PUNCT
ajlm-2201	26	73	‘	'	PUNCT
ajlm-2201	26	74	m	m	NOUN
ajlm-2201	26	75	-	-	NOUN
ajlm-2201	26	76	component	component	NOUN
ajlm-2201	26	77	’	'	PUNCT
ajlm-2201	26	78	,	,	PUNCT
ajlm-2201	26	79	and	and	CCONJ
ajlm-2201	26	80	‘	'	PUNCT
ajlm-2201	26	81	monoclonal	monoclonal	NOUN
ajlm-2201	26	82	immunoglobulin	immunoglobulin	NOUN
ajlm-2201	26	83	’	'	PUNCT
ajlm-2201	26	84	.	.	PUNCT
ajlm-2201	27	1	the	the	DET
ajlm-2201	27	2	m	m	NOUN
ajlm-2201	27	3	-	-	ADJ
ajlm-2201	27	4	protein	protein	NOUN
ajlm-2201	27	5	may	may	AUX
ajlm-2201	27	6	consist	consist	VERB
ajlm-2201	27	7	of	of	ADP
ajlm-2201	27	8	intact	intact	ADJ
ajlm-2201	27	9	immunoglobulins	immunoglobulin	NOUN
ajlm-2201	27	10	(	(	PUNCT
ajlm-2201	27	11	heavy	heavy	ADJ
ajlm-2201	27	12	and	and	CCONJ
ajlm-2201	27	13	light	light	ADJ
ajlm-2201	27	14	chains	chain	NOUN
ajlm-2201	27	15	bound	bind	VERB
ajlm-2201	27	16	together	together	ADV
ajlm-2201	27	17	)	)	PUNCT
ajlm-2201	27	18	,	,	PUNCT
ajlm-2201	27	19	free	free	ADJ
ajlm-2201	27	20	light	light	ADJ
ajlm-2201	27	21	chains	chain	NOUN
ajlm-2201	27	22	(	(	PUNCT
ajlm-2201	27	23	not	not	PART
ajlm-2201	27	24	bound	bind	VERB
ajlm-2201	27	25	to	to	ADP
ajlm-2201	27	26	a	a	DET
ajlm-2201	27	27	heavy	heavy	ADJ
ajlm-2201	27	28	chain	chain	NOUN
ajlm-2201	27	29	)	)	PUNCT
ajlm-2201	27	30	or	or	CCONJ
ajlm-2201	27	31	fragments	fragment	NOUN
ajlm-2201	27	32	of	of	ADP
ajlm-2201	27	33	either	either	DET
ajlm-2201	27	34	one	one	NUM
ajlm-2201	27	35	.	.	PUNCT
ajlm-2201	28	1	the	the	PRON
ajlm-2201	28	2	m	m	NOUN
ajlm-2201	28	3	-	-	ADJ
ajlm-2201	28	4	protein	protein	NOUN
ajlm-2201	28	5	is	be	AUX
ajlm-2201	28	6	produced	produce	VERB
ajlm-2201	28	7	more	more	ADV
ajlm-2201	28	8	commonly	commonly	ADV
ajlm-2201	28	9	by	by	ADP
ajlm-2201	28	10	a	a	DET
ajlm-2201	28	11	malignant	malignant	ADJ
ajlm-2201	28	12	clone	clone	NOUN
ajlm-2201	28	13	of	of	ADP
ajlm-2201	28	14	plasma	plasma	NOUN
ajlm-2201	28	15	cells	cell	NOUN
ajlm-2201	28	16	but	but	CCONJ
ajlm-2201	28	17	may	may	AUX
ajlm-2201	28	18	also	also	ADV
ajlm-2201	28	19	be	be	AUX
ajlm-2201	28	20	produced	produce	VERB
ajlm-2201	28	21	by	by	ADP
ajlm-2201	28	22	clonal	clonal	ADJ
ajlm-2201	28	23	lymphoplasmacytic	lymphoplasmacytic	ADJ
ajlm-2201	28	24	cells	cell	NOUN
ajlm-2201	28	25	(	(	PUNCT
ajlm-2201	28	26	as	as	SCONJ
ajlm-2201	28	27	seen	see	VERB
ajlm-2201	28	28	in	in	ADP
ajlm-2201	28	29	waldenström	waldenström	PROPN
ajlm-2201	28	30	’s	’s	PART
ajlm-2201	28	31	macroglobulinaemia).3	macroglobulinaemia).3	NOUN
ajlm-2201	28	32	according	accord	VERB
ajlm-2201	28	33	to	to	ADP
ajlm-2201	28	34	the	the	DET
ajlm-2201	28	35	2019	2019	NUM
ajlm-2201	28	36	cancer	cancer	NOUN
ajlm-2201	28	37	association	association	NOUN
ajlm-2201	28	38	of	of	ADP
ajlm-2201	28	39	south	south	PROPN
ajlm-2201	28	40	africa	africa	PROPN
ajlm-2201	28	41	cancer	cancer	PROPN
ajlm-2201	28	42	registry	registry	PROPN
ajlm-2201	28	43	statistics	statistic	NOUN
ajlm-2201	28	44	,	,	PUNCT
ajlm-2201	28	45	mm	mm	PROPN
ajlm-2201	28	46	accounted	account	VERB
ajlm-2201	28	47	for	for	ADP
ajlm-2201	28	48	0.5	0.5	NUM
ajlm-2201	28	49	%	%	NOUN
ajlm-2201	28	50	of	of	ADP
ajlm-2201	28	51	all	all	DET
ajlm-2201	28	52	histologically	histologically	ADV
ajlm-2201	28	53	diagnosed	diagnose	VERB
ajlm-2201	28	54	cancers	cancer	NOUN
ajlm-2201	28	55	.	.	PUNCT
ajlm-2201	29	1	the	the	DET
ajlm-2201	29	2	most	most	ADV
ajlm-2201	29	3	common	common	ADJ
ajlm-2201	29	4	age	age	NOUN
ajlm-2201	29	5	group	group	NOUN
ajlm-2201	29	6	at	at	ADP
ajlm-2201	29	7	diagnosis	diagnosis	NOUN
ajlm-2201	29	8	was	be	AUX
ajlm-2201	29	9	60–64	60–64	NUM
ajlm-2201	29	10	years	year	NOUN
ajlm-2201	29	11	among	among	ADP
ajlm-2201	29	12	both	both	CCONJ
ajlm-2201	29	13	male	male	ADJ
ajlm-2201	29	14	and	and	CCONJ
ajlm-2201	29	15	female	female	ADJ
ajlm-2201	29	16	patients.4	patients.4	NOUN
ajlm-2201	29	17	for	for	ADP
ajlm-2201	29	18	decades	decade	NOUN
ajlm-2201	29	19	,	,	PUNCT
ajlm-2201	29	20	serum	serum	NOUN
ajlm-2201	29	21	protein	protein	NOUN
ajlm-2201	29	22	electrophoresis	electrophoresis	NOUN
ajlm-2201	29	23	(	(	PUNCT
ajlm-2201	29	24	spe	spe	X
ajlm-2201	29	25	)	)	PUNCT
ajlm-2201	29	26	and	and	CCONJ
ajlm-2201	29	27	urine	urine	NOUN
ajlm-2201	29	28	protein	protein	NOUN
ajlm-2201	29	29	electrophoresis	electrophoresis	NOUN
ajlm-2201	29	30	(	(	PUNCT
ajlm-2201	29	31	upe	upe	NOUN
ajlm-2201	29	32	)	)	PUNCT
ajlm-2201	29	33	and	and	CCONJ
ajlm-2201	29	34	immunofixation	immunofixation	NOUN
ajlm-2201	29	35	electrophoresis	electrophoresis	NOUN
ajlm-2201	29	36	(	(	PUNCT
ajlm-2201	29	37	ife	ife	PROPN
ajlm-2201	29	38	)	)	PUNCT
ajlm-2201	29	39	were	be	AUX
ajlm-2201	29	40	the	the	DET
ajlm-2201	29	41	initial	initial	ADJ
ajlm-2201	29	42	tests	test	NOUN
ajlm-2201	29	43	for	for	ADP
ajlm-2201	29	44	diagnosing	diagnose	VERB
ajlm-2201	29	45	mg	mg	PROPN
ajlm-2201	29	46	.	.	PUNCT
ajlm-2201	30	1	a	a	DET
ajlm-2201	30	2	limitation	limitation	NOUN
ajlm-2201	30	3	of	of	ADP
ajlm-2201	30	4	spe	spe	X
ajlm-2201	30	5	is	be	AUX
ajlm-2201	30	6	that	that	SCONJ
ajlm-2201	30	7	it	it	PRON
ajlm-2201	30	8	can	can	AUX
ajlm-2201	30	9	only	only	ADV
ajlm-2201	30	10	identify	identify	VERB
ajlm-2201	30	11	m	m	NOUN
ajlm-2201	30	12	-	-	NOUN
ajlm-2201	30	13	proteins	protein	NOUN
ajlm-2201	30	14	with	with	ADP
ajlm-2201	30	15	a	a	DET
ajlm-2201	30	16	concentration	concentration	NOUN
ajlm-2201	30	17	greater	great	ADJ
ajlm-2201	30	18	than	than	ADP
ajlm-2201	30	19	500	500	NUM
ajlm-2201	30	20	mg	mg	NUM
ajlm-2201	30	21	/	/	SYM
ajlm-2201	30	22	l	l	NOUN
ajlm-2201	30	23	–	–	PUNCT
ajlm-2201	30	24	2000	2000	NUM
ajlm-2201	30	25	mg	mg	PROPN
ajlm-2201	30	26	/	/	SYM
ajlm-2201	30	27	l	l	NOUN
ajlm-2201	30	28	,	,	PUNCT
ajlm-2201	30	29	and	and	CCONJ
ajlm-2201	30	30	patients	patient	NOUN
ajlm-2201	30	31	with	with	ADP
ajlm-2201	30	32	lower	low	ADJ
ajlm-2201	30	33	concentrations	concentration	NOUN
ajlm-2201	30	34	of	of	ADP
ajlm-2201	30	35	m	m	NOUN
ajlm-2201	30	36	-	-	NOUN
ajlm-2201	30	37	protein	protein	NOUN
ajlm-2201	30	38	,	,	PUNCT
ajlm-2201	30	39	such	such	ADJ
ajlm-2201	30	40	as	as	ADP
ajlm-2201	30	41	those	those	PRON
ajlm-2201	30	42	with	with	ADP
ajlm-2201	30	43	oligosecretory	oligosecretory	ADJ
ajlm-2201	30	44	myeloma	myeloma	PROPN
ajlm-2201	30	45	,	,	PUNCT
ajlm-2201	30	46	may	may	AUX
ajlm-2201	30	47	be	be	AUX
ajlm-2201	30	48	missed	miss	VERB
ajlm-2201	30	49	,	,	PUNCT
ajlm-2201	30	50	especially	especially	ADV
ajlm-2201	30	51	if	if	SCONJ
ajlm-2201	30	52	the	the	DET
ajlm-2201	30	53	m	m	NOUN
ajlm-2201	30	54	-	-	NOUN
ajlm-2201	30	55	protein	protein	NOUN
ajlm-2201	30	56	is	be	AUX
ajlm-2201	30	57	a	a	DET
ajlm-2201	30	58	free	free	ADJ
ajlm-2201	30	59	light	light	NOUN
ajlm-2201	30	60	chain.5,6	chain.5,6	PROPN
ajlm-2201	30	61	also	also	ADV
ajlm-2201	30	62	,	,	PUNCT
ajlm-2201	30	63	for	for	ADP
ajlm-2201	30	64	accurate	accurate	ADJ
ajlm-2201	30	65	quantification	quantification	NOUN
ajlm-2201	30	66	of	of	ADP
ajlm-2201	30	67	the	the	DET
ajlm-2201	30	68	m	m	NOUN
ajlm-2201	30	69	-	-	NOUN
ajlm-2201	30	70	protein	protein	NOUN
ajlm-2201	30	71	in	in	ADP
ajlm-2201	30	72	urine	urine	NOUN
ajlm-2201	30	73	,	,	PUNCT
ajlm-2201	30	74	a	a	DET
ajlm-2201	30	75	24	24	NUM
ajlm-2201	30	76	-	-	PUNCT
ajlm-2201	30	77	h	h	NOUN
ajlm-2201	30	78	urine	urine	NOUN
ajlm-2201	30	79	collection	collection	NOUN
ajlm-2201	30	80	is	be	AUX
ajlm-2201	30	81	preferred	prefer	VERB
ajlm-2201	30	82	over	over	ADP
ajlm-2201	30	83	a	a	DET
ajlm-2201	30	84	random	random	ADJ
ajlm-2201	30	85	specimen	speciman	NOUN
ajlm-2201	30	86	.	.	PUNCT
ajlm-2201	31	1	collection	collection	NOUN
ajlm-2201	31	2	of	of	ADP
ajlm-2201	31	3	urine	urine	NOUN
ajlm-2201	31	4	for	for	ADP
ajlm-2201	31	5	24	24	NUM
ajlm-2201	31	6	h	h	NOUN
ajlm-2201	31	7	is	be	AUX
ajlm-2201	31	8	inconvenient	inconvenient	ADJ
ajlm-2201	31	9	for	for	ADP
ajlm-2201	31	10	patients	patient	NOUN
ajlm-2201	31	11	and	and	CCONJ
ajlm-2201	31	12	often	often	ADV
ajlm-2201	31	13	incorrectly	incorrectly	ADV
ajlm-2201	31	14	collected	collect	VERB
ajlm-2201	31	15	.	.	PUNCT
ajlm-2201	32	1	however	however	ADV
ajlm-2201	32	2	,	,	PUNCT
ajlm-2201	32	3	a	a	DET
ajlm-2201	32	4	recent	recent	ADJ
ajlm-2201	32	5	local	local	ADJ
ajlm-2201	32	6	study	study	NOUN
ajlm-2201	32	7	suggested	suggest	VERB
ajlm-2201	32	8	random	random	ADJ
ajlm-2201	32	9	urine	urine	NOUN
ajlm-2201	32	10	specimens	specimen	NOUN
ajlm-2201	32	11	may	may	AUX
ajlm-2201	32	12	be	be	AUX
ajlm-2201	32	13	used	use	VERB
ajlm-2201	32	14	to	to	PART
ajlm-2201	32	15	estimate	estimate	VERB
ajlm-2201	32	16	the	the	DET
ajlm-2201	32	17	24	24	NUM
ajlm-2201	32	18	-	-	PUNCT
ajlm-2201	32	19	h	h	NOUN
ajlm-2201	32	20	urine	urine	NOUN
ajlm-2201	32	21	m	m	ADJ
ajlm-2201	32	22	-	-	ADJ
ajlm-2201	32	23	protein	protein	ADJ
ajlm-2201	32	24	concentration	concentration	NOUN
ajlm-2201	32	25	with	with	ADP
ajlm-2201	32	26	equations	equation	NOUN
ajlm-2201	32	27	in	in	ADP
ajlm-2201	32	28	patients	patient	NOUN
ajlm-2201	32	29	previously	previously	ADV
ajlm-2201	32	30	diagnosed	diagnose	VERB
ajlm-2201	32	31	with	with	ADP
ajlm-2201	32	32	mm.7	mm.7	PROPN
ajlm-2201	32	33	the	the	DET
ajlm-2201	32	34	quantitative	quantitative	ADJ
ajlm-2201	32	35	serum	serum	NOUN
ajlm-2201	32	36	-	-	PUNCT
ajlm-2201	32	37	free	free	ADJ
ajlm-2201	32	38	light	light	NOUN
ajlm-2201	32	39	chain	chain	NOUN
ajlm-2201	32	40	(	(	PUNCT
ajlm-2201	32	41	sflc	sflc	PROPN
ajlm-2201	32	42	)	)	PUNCT
ajlm-2201	32	43	assay	assay	NOUN
ajlm-2201	32	44	was	be	AUX
ajlm-2201	32	45	developed	develop	VERB
ajlm-2201	32	46	in	in	ADP
ajlm-2201	32	47	2001	2001	NUM
ajlm-2201	32	48	by	by	ADP
ajlm-2201	32	49	the	the	DET
ajlm-2201	32	50	binding	bind	VERB
ajlm-2201	32	51	site	site	NOUN
ajlm-2201	32	52	group5	group5	NOUN
ajlm-2201	32	53	and	and	CCONJ
ajlm-2201	32	54	can	can	AUX
ajlm-2201	32	55	detect	detect	VERB
ajlm-2201	32	56	light	light	ADJ
ajlm-2201	32	57	chains	chain	NOUN
ajlm-2201	32	58	at	at	ADP
ajlm-2201	32	59	concentrations	concentration	NOUN
ajlm-2201	32	60	less	less	ADJ
ajlm-2201	32	61	than	than	ADP
ajlm-2201	32	62	1	1	NUM
ajlm-2201	32	63	mg	mg	NUM
ajlm-2201	32	64	/	/	SYM
ajlm-2201	32	65	l	l	NOUN
ajlm-2201	32	66	,	,	PUNCT
ajlm-2201	32	67	making	make	VERB
ajlm-2201	32	68	it	it	PRON
ajlm-2201	32	69	a	a	DET
ajlm-2201	32	70	more	more	ADV
ajlm-2201	32	71	sensitive	sensitive	ADJ
ajlm-2201	32	72	method	method	NOUN
ajlm-2201	32	73	than	than	ADP
ajlm-2201	32	74	spe	spe	ADV
ajlm-2201	32	75	and	and	CCONJ
ajlm-2201	32	76	upe.8	upe.8	PROPN
ajlm-2201	32	77	the	the	DET
ajlm-2201	32	78	international	international	ADJ
ajlm-2201	32	79	myeloma	myeloma	PROPN
ajlm-2201	32	80	working	working	PROPN
ajlm-2201	32	81	group	group	NOUN
ajlm-2201	32	82	released	release	VERB
ajlm-2201	32	83	a	a	DET
ajlm-2201	32	84	consensus	consensus	NOUN
ajlm-2201	32	85	guideline	guideline	NOUN
ajlm-2201	32	86	for	for	ADP
ajlm-2201	32	87	investigating	investigate	VERB
ajlm-2201	32	88	patients	patient	NOUN
ajlm-2201	32	89	suspected	suspect	VERB
ajlm-2201	32	90	of	of	ADP
ajlm-2201	32	91	having	have	VERB
ajlm-2201	32	92	mm	mm	PROPN
ajlm-2201	32	93	in	in	ADP
ajlm-2201	32	94	20119	20119	NUM
ajlm-2201	32	95	and	and	CCONJ
ajlm-2201	32	96	guidelines	guideline	NOUN
ajlm-2201	32	97	on	on	ADP
ajlm-2201	32	98	the	the	DET
ajlm-2201	32	99	use	use	NOUN
ajlm-2201	32	100	of	of	ADP
ajlm-2201	32	101	the	the	DET
ajlm-2201	32	102	binding	bind	VERB
ajlm-2201	32	103	site	site	NOUN
ajlm-2201	32	104	sflc	sflc	NOUN
ajlm-2201	32	105	assay	assay	NOUN
ajlm-2201	32	106	in	in	ADP
ajlm-2201	32	107	screening	screening	NOUN
ajlm-2201	32	108	,	,	PUNCT
ajlm-2201	32	109	diagnosis	diagnosis	NOUN
ajlm-2201	32	110	and	and	CCONJ
ajlm-2201	32	111	monitoring	monitoring	NOUN
ajlm-2201	32	112	of	of	ADP
ajlm-2201	32	113	mg	mg	PROPN
ajlm-2201	32	114	in	in	ADP
ajlm-2201	32	115	2009.10	2009.10	NUM
ajlm-2201	32	116	the	the	DET
ajlm-2201	32	117	two	two	NUM
ajlm-2201	32	118	recommended	recommend	VERB
ajlm-2201	32	119	screening	screening	NOUN
ajlm-2201	32	120	profiles	profile	NOUN
ajlm-2201	32	121	are	be	AUX
ajlm-2201	32	122	either	either	CCONJ
ajlm-2201	32	123	spe	spe	X
ajlm-2201	32	124	with	with	ADP
ajlm-2201	32	125	ife	ife	PROPN
ajlm-2201	32	126	and	and	CCONJ
ajlm-2201	32	127	the	the	DET
ajlm-2201	32	128	sflc	sflc	NOUN
ajlm-2201	32	129	assay	assay	NOUN
ajlm-2201	32	130	,	,	PUNCT
ajlm-2201	32	131	or	or	CCONJ
ajlm-2201	32	132	spe	spe	X
ajlm-2201	32	133	with	with	ADP
ajlm-2201	32	134	ife	ife	PROPN
ajlm-2201	32	135	and	and	CCONJ
ajlm-2201	32	136	upe	upe	ADJ
ajlm-2201	32	137	with	with	ADP
ajlm-2201	32	138	urine	urine	NOUN
ajlm-2201	32	139	immunofixation	immunofixation	NOUN
ajlm-2201	32	140	electrophoresis	electrophoresis	NOUN
ajlm-2201	32	141	(	(	PUNCT
ajlm-2201	32	142	uife).11	uife).11	ADP
ajlm-2201	32	143	the	the	DET
ajlm-2201	32	144	sflc	sflc	ADJ
ajlm-2201	32	145	assay	assay	NOUN
ajlm-2201	32	146	was	be	AUX
ajlm-2201	32	147	added	add	VERB
ajlm-2201	32	148	to	to	ADP
ajlm-2201	32	149	our	our	PRON
ajlm-2201	32	150	laboratory	laboratory	NOUN
ajlm-2201	32	151	test	test	NOUN
ajlm-2201	32	152	repertoire	repertoire	NOUN
ajlm-2201	32	153	in	in	ADP
ajlm-2201	32	154	2018	2018	NUM
ajlm-2201	32	155	.	.	PUNCT
ajlm-2201	33	1	although	although	SCONJ
ajlm-2201	33	2	spe	spe	PROPN
ajlm-2201	33	3	and	and	CCONJ
ajlm-2201	33	4	sflc	sflc	NOUN
ajlm-2201	33	5	have	have	AUX
ajlm-2201	33	6	been	be	AUX
ajlm-2201	33	7	recommended	recommend	VERB
ajlm-2201	33	8	,	,	PUNCT
ajlm-2201	33	9	we	we	PRON
ajlm-2201	33	10	have	have	AUX
ajlm-2201	33	11	subjectively	subjectively	ADV
ajlm-2201	33	12	noted	note	VERB
ajlm-2201	33	13	that	that	SCONJ
ajlm-2201	33	14	clinicians	clinician	NOUN
ajlm-2201	33	15	at	at	ADP
ajlm-2201	33	16	our	our	PRON
ajlm-2201	33	17	centre	centre	NOUN
ajlm-2201	33	18	frequently	frequently	ADV
ajlm-2201	33	19	request	request	VERB
ajlm-2201	33	20	a	a	DET
ajlm-2201	33	21	single	single	ADJ
ajlm-2201	33	22	test	test	NOUN
ajlm-2201	33	23	(	(	PUNCT
ajlm-2201	33	24	either	either	CCONJ
ajlm-2201	33	25	spe	spe	PROPN
ajlm-2201	33	26	or	or	CCONJ
ajlm-2201	33	27	sflc	sflc	VERB
ajlm-2201	33	28	)	)	PUNCT
ajlm-2201	33	29	when	when	SCONJ
ajlm-2201	33	30	screening	screen	VERB
ajlm-2201	33	31	patients	patient	NOUN
ajlm-2201	33	32	for	for	ADP
ajlm-2201	33	33	mg	mg	PROPN
ajlm-2201	33	34	.	.	PUNCT
ajlm-2201	34	1	this	this	DET
ajlm-2201	34	2	practice	practice	NOUN
ajlm-2201	34	3	may	may	AUX
ajlm-2201	34	4	be	be	AUX
ajlm-2201	34	5	an	an	DET
ajlm-2201	34	6	attempt	attempt	NOUN
ajlm-2201	34	7	to	to	PART
ajlm-2201	34	8	reduce	reduce	VERB
ajlm-2201	34	9	hospital	hospital	NOUN
ajlm-2201	34	10	expenditure	expenditure	NOUN
ajlm-2201	34	11	;	;	PUNCT
ajlm-2201	34	12	however	however	ADV
ajlm-2201	34	13	,	,	PUNCT
ajlm-2201	34	14	it	it	PRON
ajlm-2201	34	15	may	may	AUX
ajlm-2201	34	16	lead	lead	VERB
ajlm-2201	34	17	to	to	ADP
ajlm-2201	34	18	false	false	ADJ
ajlm-2201	34	19	-	-	PUNCT
ajlm-2201	34	20	negative	negative	ADJ
ajlm-2201	34	21	screening	screening	NOUN
ajlm-2201	34	22	results	result	NOUN
ajlm-2201	34	23	and	and	CCONJ
ajlm-2201	34	24	poorer	poor	ADJ
ajlm-2201	34	25	patient	patient	ADJ
ajlm-2201	34	26	outcomes	outcome	NOUN
ajlm-2201	34	27	.	.	PUNCT
ajlm-2201	35	1	this	this	DET
ajlm-2201	35	2	study	study	NOUN
ajlm-2201	35	3	aimed	aim	VERB
ajlm-2201	35	4	to	to	PART
ajlm-2201	35	5	investigate	investigate	VERB
ajlm-2201	35	6	sflc	sflc	ADP
ajlm-2201	35	7	test	test	NOUN
ajlm-2201	35	8	utilisation	utilisation	NOUN
ajlm-2201	35	9	and	and	CCONJ
ajlm-2201	35	10	to	to	PART
ajlm-2201	35	11	describe	describe	VERB
ajlm-2201	35	12	the	the	DET
ajlm-2201	35	13	spe	spe	PROPN
ajlm-2201	35	14	findings	finding	NOUN
ajlm-2201	35	15	in	in	ADP
ajlm-2201	35	16	those	those	PRON
ajlm-2201	35	17	with	with	ADP
ajlm-2201	35	18	abnormal	abnormal	ADJ
ajlm-2201	35	19	sflc	sflc	VERB
ajlm-2201	35	20	ratios	ratio	NOUN
ajlm-2201	35	21	in	in	ADP
ajlm-2201	35	22	the	the	DET
ajlm-2201	35	23	screening	screening	NOUN
ajlm-2201	35	24	of	of	ADP
ajlm-2201	35	25	patients	patient	NOUN
ajlm-2201	35	26	for	for	ADP
ajlm-2201	35	27	mg	mg	PROPN
ajlm-2201	35	28	at	at	ADP
ajlm-2201	35	29	tygerberg	tygerberg	PROPN
ajlm-2201	35	30	hospital	hospital	NOUN
ajlm-2201	35	31	(	(	PUNCT
ajlm-2201	35	32	tbh	tbh	NOUN
ajlm-2201	35	33	)	)	PUNCT
ajlm-2201	35	34	national	national	PROPN
ajlm-2201	35	35	health	health	PROPN
ajlm-2201	35	36	laboratory	laboratory	PROPN
ajlm-2201	35	37	service	service	NOUN
ajlm-2201	35	38	(	(	PUNCT
ajlm-2201	35	39	nhls	nhls	PROPN
ajlm-2201	35	40	)	)	PUNCT
ajlm-2201	35	41	.	.	PUNCT
ajlm-2201	36	1	methods	method	NOUN
ajlm-2201	36	2	ethical	ethical	ADJ
ajlm-2201	36	3	considerations	consideration	NOUN
ajlm-2201	36	4	this	this	DET
ajlm-2201	36	5	study	study	NOUN
ajlm-2201	36	6	was	be	AUX
ajlm-2201	36	7	approved	approve	VERB
ajlm-2201	36	8	by	by	ADP
ajlm-2201	36	9	the	the	DET
ajlm-2201	36	10	health	health	NOUN
ajlm-2201	36	11	research	research	PROPN
ajlm-2201	36	12	ethics	ethic	NOUN
ajlm-2201	36	13	committee	committee	PROPN
ajlm-2201	36	14	of	of	ADP
ajlm-2201	36	15	stellenbosch	stellenbosch	PROPN
ajlm-2201	36	16	university	university	PROPN
ajlm-2201	36	17	(	(	PUNCT
ajlm-2201	36	18	s19/10/270	s19/10/270	PROPN
ajlm-2201	36	19	,	,	PUNCT
ajlm-2201	36	20	05	05	NUM
ajlm-2201	36	21	december	december	PROPN
ajlm-2201	36	22	2019	2019	NUM
ajlm-2201	36	23	)	)	PUNCT
ajlm-2201	36	24	and	and	CCONJ
ajlm-2201	36	25	was	be	AUX
ajlm-2201	36	26	performed	perform	VERB
ajlm-2201	36	27	according	accord	VERB
ajlm-2201	36	28	to	to	ADP
ajlm-2201	36	29	the	the	DET
ajlm-2201	36	30	declaration	declaration	NOUN
ajlm-2201	36	31	of	of	ADP
ajlm-2201	36	32	helsinki	helsinki	PROPN
ajlm-2201	36	33	.	.	PUNCT
ajlm-2201	37	1	informed	inform	VERB
ajlm-2201	37	2	consent	consent	NOUN
ajlm-2201	37	3	was	be	AUX
ajlm-2201	37	4	not	not	PART
ajlm-2201	37	5	required	require	VERB
ajlm-2201	37	6	as	as	SCONJ
ajlm-2201	37	7	the	the	DET
ajlm-2201	37	8	study	study	NOUN
ajlm-2201	37	9	was	be	AUX
ajlm-2201	37	10	a	a	DET
ajlm-2201	37	11	laboratory	laboratory	NOUN
ajlm-2201	37	12	-	-	PUNCT
ajlm-2201	37	13	based	base	VERB
ajlm-2201	37	14	,	,	PUNCT
ajlm-2201	37	15	retrospective	retrospective	ADJ
ajlm-2201	37	16	audit	audit	NOUN
ajlm-2201	37	17	.	.	PUNCT
ajlm-2201	38	1	all	all	DET
ajlm-2201	38	2	results	result	NOUN
ajlm-2201	38	3	were	be	AUX
ajlm-2201	38	4	de	de	ADJ
ajlm-2201	38	5	-	-	VERB
ajlm-2201	38	6	identified	identify	VERB
ajlm-2201	38	7	to	to	PART
ajlm-2201	38	8	maintain	maintain	VERB
ajlm-2201	38	9	patient	patient	ADJ
ajlm-2201	38	10	confidentiality	confidentiality	NOUN
ajlm-2201	38	11	and	and	CCONJ
ajlm-2201	38	12	only	only	ADV
ajlm-2201	38	13	shared	share	VERB
ajlm-2201	38	14	with	with	ADP
ajlm-2201	38	15	members	member	NOUN
ajlm-2201	38	16	of	of	ADP
ajlm-2201	38	17	the	the	DET
ajlm-2201	38	18	study	study	NOUN
ajlm-2201	38	19	team	team	NOUN
ajlm-2201	38	20	when	when	SCONJ
ajlm-2201	38	21	deemed	deem	VERB
ajlm-2201	38	22	necessary	necessary	ADJ
ajlm-2201	38	23	.	.	PUNCT
ajlm-2201	39	1	data	datum	NOUN
ajlm-2201	39	2	were	be	AUX
ajlm-2201	39	3	stored	store	VERB
ajlm-2201	39	4	on	on	ADP
ajlm-2201	39	5	password	password	NOUN
ajlm-2201	39	6	-	-	PUNCT
ajlm-2201	39	7	protected	protect	VERB
ajlm-2201	39	8	devices	device	NOUN
ajlm-2201	39	9	.	.	PUNCT
ajlm-2201	40	1	study	study	NOUN
ajlm-2201	40	2	design	design	VERB
ajlm-2201	40	3	the	the	DET
ajlm-2201	40	4	study	study	NOUN
ajlm-2201	40	5	was	be	AUX
ajlm-2201	40	6	a	a	DET
ajlm-2201	40	7	retrospective	retrospective	ADJ
ajlm-2201	40	8	audit	audit	NOUN
ajlm-2201	40	9	of	of	ADP
ajlm-2201	40	10	laboratory	laboratory	NOUN
ajlm-2201	40	11	data	datum	NOUN
ajlm-2201	40	12	and	and	CCONJ
ajlm-2201	40	13	clinical	clinical	ADJ
ajlm-2201	40	14	folders	folder	NOUN
ajlm-2201	40	15	of	of	ADP
ajlm-2201	40	16	select	select	ADJ
ajlm-2201	40	17	adult	adult	NOUN
ajlm-2201	40	18	patients	patient	NOUN
ajlm-2201	40	19	on	on	ADP
ajlm-2201	40	20	whom	whom	PRON
ajlm-2201	40	21	sflc	sflc	ADJ
ajlm-2201	40	22	assays	assay	NOUN
ajlm-2201	40	23	were	be	AUX
ajlm-2201	40	24	requested	request	VERB
ajlm-2201	40	25	at	at	ADP
ajlm-2201	40	26	tbh	tbh	PROPN
ajlm-2201	40	27	nhls	nhls	PROPN
ajlm-2201	40	28	for	for	ADP
ajlm-2201	40	29	2	2	NUM
ajlm-2201	40	30	years	year	NOUN
ajlm-2201	40	31	,	,	PUNCT
ajlm-2201	40	32	from	from	ADP
ajlm-2201	40	33	may	may	PROPN
ajlm-2201	40	34	2018	2018	NUM
ajlm-2201	40	35	to	to	ADP
ajlm-2201	40	36	april	april	PROPN
ajlm-2201	40	37	2020	2020	NUM
ajlm-2201	40	38	.	.	PUNCT
ajlm-2201	41	1	setting	set	VERB
ajlm-2201	41	2	tygerberg	tygerberg	PROPN
ajlm-2201	41	3	hospital	hospital	NOUN
ajlm-2201	41	4	is	be	AUX
ajlm-2201	41	5	a	a	DET
ajlm-2201	41	6	1380	1380	NUM
ajlm-2201	41	7	-	-	PUNCT
ajlm-2201	41	8	bed	bed	NOUN
ajlm-2201	41	9	tertiary	tertiary	ADJ
ajlm-2201	41	10	academic	academic	ADJ
ajlm-2201	41	11	hospital	hospital	NOUN
ajlm-2201	41	12	in	in	ADP
ajlm-2201	41	13	cape	cape	NOUN
ajlm-2201	41	14	town	town	NOUN
ajlm-2201	41	15	,	,	PUNCT
ajlm-2201	41	16	western	western	ADJ
ajlm-2201	41	17	cape	cape	NOUN
ajlm-2201	41	18	,	,	PUNCT
ajlm-2201	41	19	south	south	PROPN
ajlm-2201	41	20	africa	africa	PROPN
ajlm-2201	41	21	,	,	PUNCT
ajlm-2201	41	22	affiliated	affiliate	VERB
ajlm-2201	41	23	with	with	ADP
ajlm-2201	41	24	stellenbosch	stellenbosch	PROPN
ajlm-2201	41	25	university	university	PROPN
ajlm-2201	41	26	’s	’s	PART
ajlm-2201	41	27	faculty	faculty	NOUN
ajlm-2201	41	28	of	of	ADP
ajlm-2201	41	29	medicine	medicine	NOUN
ajlm-2201	41	30	and	and	CCONJ
ajlm-2201	41	31	health	health	NOUN
ajlm-2201	41	32	sciences	science	NOUN
ajlm-2201	41	33	.	.	PUNCT
ajlm-2201	42	1	the	the	DET
ajlm-2201	42	2	nhls	nhls	PROPN
ajlm-2201	42	3	is	be	AUX
ajlm-2201	42	4	the	the	DET
ajlm-2201	42	5	sole	sole	ADJ
ajlm-2201	42	6	laboratory	laboratory	NOUN
ajlm-2201	42	7	service	service	NOUN
ajlm-2201	42	8	provider	provider	NOUN
ajlm-2201	42	9	for	for	ADP
ajlm-2201	42	10	public	public	ADJ
ajlm-2201	42	11	healthcare	healthcare	NOUN
ajlm-2201	42	12	in	in	ADP
ajlm-2201	42	13	south	south	PROPN
ajlm-2201	42	14	africa	africa	PROPN
ajlm-2201	42	15	.	.	PUNCT
ajlm-2201	43	1	the	the	DET
ajlm-2201	43	2	nhls	nhls	PROPN
ajlm-2201	43	3	laboratory	laboratory	NOUN
ajlm-2201	43	4	at	at	ADP
ajlm-2201	43	5	tbh	tbh	NOUN
ajlm-2201	43	6	participates	participate	VERB
ajlm-2201	43	7	in	in	ADP
ajlm-2201	43	8	internal	internal	ADJ
ajlm-2201	43	9	and	and	CCONJ
ajlm-2201	43	10	external	external	ADJ
ajlm-2201	43	11	quality	quality	NOUN
ajlm-2201	43	12	control	control	NOUN
ajlm-2201	43	13	programmes	programme	NOUN
ajlm-2201	43	14	and	and	CCONJ
ajlm-2201	43	15	is	be	AUX
ajlm-2201	43	16	an	an	DET
ajlm-2201	43	17	international	international	ADJ
ajlm-2201	43	18	organization	organization	NOUN
ajlm-2201	43	19	for	for	ADP
ajlm-2201	43	20	standardization	standardization	NOUN
ajlm-2201	43	21	15189	15189	NUM
ajlm-2201	43	22	accredited	accredit	VERB
ajlm-2201	43	23	laboratory	laboratory	NOUN
ajlm-2201	43	24	.	.	PUNCT
ajlm-2201	44	1	serum	serum	NOUN
ajlm-2201	44	2	-	-	PUNCT
ajlm-2201	44	3	free	free	ADJ
ajlm-2201	44	4	light	light	NOUN
ajlm-2201	44	5	chain	chain	NOUN
ajlm-2201	44	6	samples	sample	NOUN
ajlm-2201	44	7	are	be	AUX
ajlm-2201	44	8	referred	refer	VERB
ajlm-2201	44	9	for	for	ADP
ajlm-2201	44	10	analysis	analysis	NOUN
ajlm-2201	44	11	from	from	ADP
ajlm-2201	44	12	regional	regional	ADJ
ajlm-2201	44	13	hospitals	hospital	NOUN
ajlm-2201	44	14	and	and	CCONJ
ajlm-2201	44	15	clinics	clinic	NOUN
ajlm-2201	44	16	surrounding	surround	VERB
ajlm-2201	44	17	tbh	tbh	NOUN
ajlm-2201	44	18	.	.	PUNCT
ajlm-2201	45	1	data	datum	NOUN
ajlm-2201	45	2	collection	collection	NOUN
ajlm-2201	45	3	data	datum	NOUN
ajlm-2201	45	4	of	of	ADP
ajlm-2201	45	5	all	all	DET
ajlm-2201	45	6	sflc	sflc	NOUN
ajlm-2201	45	7	performed	perform	VERB
ajlm-2201	45	8	in	in	ADP
ajlm-2201	45	9	the	the	DET
ajlm-2201	45	10	above	above	ADJ
ajlm-2201	45	11	period	period	NOUN
ajlm-2201	45	12	were	be	AUX
ajlm-2201	45	13	extracted	extract	VERB
ajlm-2201	45	14	and	and	CCONJ
ajlm-2201	45	15	anonymised	anonymise	VERB
ajlm-2201	45	16	from	from	ADP
ajlm-2201	45	17	the	the	DET
ajlm-2201	45	18	nhls	nhls	PROPN
ajlm-2201	45	19	laboratory	laboratory	NOUN
ajlm-2201	45	20	information	information	NOUN
ajlm-2201	45	21	system	system	NOUN
ajlm-2201	45	22	(	(	PUNCT
ajlm-2201	45	23	trakcare	trakcare	NOUN
ajlm-2201	45	24	lab	lab	NOUN
ajlm-2201	45	25	enterprise	enterprise	NOUN
ajlm-2201	45	26	,	,	PUNCT
ajlm-2201	45	27	intersystems	intersystem	VERB
ajlm-2201	45	28	corporation	corporation	NOUN
ajlm-2201	45	29	,	,	PUNCT
ajlm-2201	45	30	cambridge	cambridge	PROPN
ajlm-2201	45	31	,	,	PUNCT
ajlm-2201	45	32	massachusetts	massachusetts	PROPN
ajlm-2201	45	33	,	,	PUNCT
ajlm-2201	45	34	united	united	PROPN
ajlm-2201	45	35	states	states	PROPN
ajlm-2201	45	36	)	)	PUNCT
ajlm-2201	45	37	by	by	ADP
ajlm-2201	45	38	the	the	DET
ajlm-2201	45	39	corporate	corporate	ADJ
ajlm-2201	45	40	data	datum	NOUN
ajlm-2201	45	41	warehouse	warehouse	NOUN
ajlm-2201	45	42	.	.	PUNCT
ajlm-2201	46	1	serum	serum	NOUN
ajlm-2201	46	2	-	-	PUNCT
ajlm-2201	46	3	free	free	ADJ
ajlm-2201	46	4	light	light	NOUN
ajlm-2201	46	5	chain	chain	NOUN
ajlm-2201	46	6	results	result	NOUN
ajlm-2201	46	7	were	be	AUX
ajlm-2201	46	8	classified	classify	VERB
ajlm-2201	46	9	into	into	ADP
ajlm-2201	46	10	five	five	NUM
ajlm-2201	46	11	groups	group	NOUN
ajlm-2201	46	12	:	:	PUNCT
ajlm-2201	46	13	1	1	NUM
ajlm-2201	46	14	–	–	PUNCT
ajlm-2201	46	15	normal	normal	ADJ
ajlm-2201	46	16	kappa	kappa	NOUN
ajlm-2201	46	17	(	(	PUNCT
ajlm-2201	46	18	κ	κ	NOUN
ajlm-2201	46	19	)	)	PUNCT
ajlm-2201	46	20	and	and	CCONJ
ajlm-2201	46	21	lambda	lambda	NOUN
ajlm-2201	46	22	(	(	PUNCT
ajlm-2201	46	23	λ	λ	NOUN
ajlm-2201	46	24	)	)	PUNCT
ajlm-2201	46	25	free	free	ADJ
ajlm-2201	46	26	light	light	ADJ
ajlm-2201	46	27	chains	chain	NOUN
ajlm-2201	46	28	with	with	ADP
ajlm-2201	46	29	normal	normal	ADJ
ajlm-2201	46	30	κ	κ	NOUN
ajlm-2201	46	31	/	/	SYM
ajlm-2201	46	32	λ	λ	NOUN
ajlm-2201	46	33	ratio	ratio	NOUN
ajlm-2201	46	34	,	,	PUNCT
ajlm-2201	46	35	2	2	NUM
ajlm-2201	46	36	–	–	PUNCT
ajlm-2201	46	37	raised	raise	VERB
ajlm-2201	46	38	κ	κ	NOUN
ajlm-2201	46	39	/	/	SYM
ajlm-2201	46	40	λ	λ	NOUN
ajlm-2201	46	41	ratio	ratio	NOUN
ajlm-2201	46	42	,	,	PUNCT
ajlm-2201	46	43	3	3	NUM
ajlm-2201	46	44	–	–	PUNCT
ajlm-2201	46	45	decreased	decrease	VERB
ajlm-2201	46	46	κ	κ	NOUN
ajlm-2201	46	47	/	/	SYM
ajlm-2201	46	48	λ	λ	NOUN
ajlm-2201	46	49	ratio	ratio	NOUN
ajlm-2201	46	50	,	,	PUNCT
ajlm-2201	46	51	4	4	NUM
ajlm-2201	46	52	–	–	PUNCT
ajlm-2201	46	53	raised	raise	VERB
ajlm-2201	46	54	κ	κ	NOUN
ajlm-2201	46	55	and	and	CCONJ
ajlm-2201	46	56	λ	λ	X
ajlm-2201	46	57	with	with	ADP
ajlm-2201	46	58	normal	normal	ADJ
ajlm-2201	46	59	κ	κ	NOUN
ajlm-2201	46	60	/	/	SYM
ajlm-2201	46	61	λ	λ	NOUN
ajlm-2201	46	62	ratio	ratio	NOUN
ajlm-2201	46	63	(	(	PUNCT
ajlm-2201	46	64	inflammatory	inflammatory	ADJ
ajlm-2201	46	65	pattern	pattern	NOUN
ajlm-2201	46	66	)	)	PUNCT
ajlm-2201	46	67	,	,	PUNCT
ajlm-2201	46	68	and	and	CCONJ
ajlm-2201	46	69	5	5	NUM
ajlm-2201	46	70	–	–	PUNCT
ajlm-2201	46	71	other	other	ADJ
ajlm-2201	46	72	(	(	PUNCT
ajlm-2201	46	73	normal	normal	ADJ
ajlm-2201	46	74	κ	κ	NOUN
ajlm-2201	46	75	/	/	SYM
ajlm-2201	46	76	λ	λ	NOUN
ajlm-2201	46	77	ratio	ratio	NOUN
ajlm-2201	46	78	with	with	ADP
ajlm-2201	46	79	raised	raise	VERB
ajlm-2201	46	80	or	or	CCONJ
ajlm-2201	46	81	decreased	decrease	VERB
ajlm-2201	46	82	κ	κ	NOUN
ajlm-2201	46	83	or	or	CCONJ
ajlm-2201	46	84	λ	λ	X
ajlm-2201	46	85	free	free	ADJ
ajlm-2201	46	86	light	light	ADJ
ajlm-2201	46	87	chains	chain	NOUN
ajlm-2201	46	88	)	)	PUNCT
ajlm-2201	46	89	.	.	PUNCT
ajlm-2201	47	1	stepwise	stepwise	PROPN
ajlm-2201	47	2	exclusions	exclusion	NOUN
ajlm-2201	47	3	were	be	AUX
ajlm-2201	47	4	performed	perform	VERB
ajlm-2201	47	5	(	(	PUNCT
ajlm-2201	47	6	figure	figure	NOUN
ajlm-2201	47	7	1	1	NUM
ajlm-2201	47	8	)	)	PUNCT
ajlm-2201	47	9	.	.	PUNCT
ajlm-2201	48	1	repeat	repeat	VERB
ajlm-2201	48	2	sflc	sflc	VERB
ajlm-2201	48	3	requests	request	NOUN
ajlm-2201	48	4	in	in	ADP
ajlm-2201	48	5	individual	individual	ADJ
ajlm-2201	48	6	patients	patient	NOUN
ajlm-2201	48	7	were	be	AUX
ajlm-2201	48	8	excluded	exclude	VERB
ajlm-2201	48	9	as	as	ADP
ajlm-2201	48	10	patients	patient	NOUN
ajlm-2201	48	11	with	with	ADP
ajlm-2201	48	12	a	a	DET
ajlm-2201	48	13	mg	mg	PROPN
ajlm-2201	48	14	would	would	AUX
ajlm-2201	48	15	have	have	VERB
ajlm-2201	48	16	multiple	multiple	ADJ
ajlm-2201	48	17	requests	request	NOUN
ajlm-2201	48	18	over	over	ADP
ajlm-2201	48	19	time	time	NOUN
ajlm-2201	48	20	,	,	PUNCT
ajlm-2201	48	21	skewing	skew	VERB
ajlm-2201	48	22	demographic	demographic	ADJ
ajlm-2201	48	23	statistics	statistic	NOUN
ajlm-2201	48	24	.	.	PUNCT
ajlm-2201	49	1	after	after	ADP
ajlm-2201	49	2	the	the	DET
ajlm-2201	49	3	initial	initial	ADJ
ajlm-2201	49	4	demographic	demographic	ADJ
ajlm-2201	49	5	analysis	analysis	NOUN
ajlm-2201	49	6	,	,	PUNCT
ajlm-2201	49	7	groups	group	NOUN
ajlm-2201	49	8	1	1	NUM
ajlm-2201	49	9	,	,	PUNCT
ajlm-2201	49	10	4	4	NUM
ajlm-2201	49	11	and	and	CCONJ
ajlm-2201	49	12	5	5	NUM
ajlm-2201	49	13	,	,	PUNCT
ajlm-2201	49	14	and	and	CCONJ
ajlm-2201	49	15	all	all	DET
ajlm-2201	49	16	results	result	NOUN
ajlm-2201	49	17	from	from	ADP
ajlm-2201	49	18	sites	site	NOUN
ajlm-2201	49	19	other	other	ADJ
ajlm-2201	49	20	than	than	ADP
ajlm-2201	49	21	tbh	tbh	NOUN
ajlm-2201	49	22	,	,	PUNCT
ajlm-2201	49	23	were	be	AUX
ajlm-2201	49	24	excluded	exclude	VERB
ajlm-2201	49	25	to	to	PART
ajlm-2201	49	26	allow	allow	VERB
ajlm-2201	49	27	comparison	comparison	NOUN
ajlm-2201	49	28	of	of	ADP
ajlm-2201	49	29	abnormal	abnormal	ADJ
ajlm-2201	49	30	sflc	sflc	VERB
ajlm-2201	49	31	ratio	ratio	NOUN
ajlm-2201	49	32	with	with	ADP
ajlm-2201	49	33	electrophoresis	electrophoresis	NOUN
ajlm-2201	49	34	results	result	NOUN
ajlm-2201	49	35	.	.	PUNCT
ajlm-2201	50	1	results	result	NOUN
ajlm-2201	50	2	of	of	ADP
ajlm-2201	50	3	tbh	tbh	NOUN
ajlm-2201	50	4	patients	patient	NOUN
ajlm-2201	50	5	were	be	AUX
ajlm-2201	50	6	selected	select	VERB
ajlm-2201	50	7	as	as	SCONJ
ajlm-2201	50	8	the	the	DET
ajlm-2201	50	9	electronic	electronic	ADJ
ajlm-2201	50	10	medical	medical	ADJ
ajlm-2201	50	11	records	record	NOUN
ajlm-2201	50	12	were	be	AUX
ajlm-2201	50	13	accessible	accessible	ADJ
ajlm-2201	50	14	for	for	ADP
ajlm-2201	50	15	these	these	DET
ajlm-2201	50	16	patients	patient	NOUN
ajlm-2201	50	17	.	.	PUNCT
ajlm-2201	51	1	medical	medical	ADJ
ajlm-2201	51	2	records	record	NOUN
ajlm-2201	51	3	of	of	ADP
ajlm-2201	51	4	patients	patient	NOUN
ajlm-2201	51	5	seen	see	VERB
ajlm-2201	51	6	at	at	ADP
ajlm-2201	51	7	other	other	ADJ
ajlm-2201	51	8	facilities	facility	NOUN
ajlm-2201	51	9	were	be	AUX
ajlm-2201	51	10	not	not	PART
ajlm-2201	51	11	readily	readily	ADV
ajlm-2201	51	12	available	available	ADJ
ajlm-2201	51	13	.	.	PUNCT
ajlm-2201	52	1	in	in	ADP
ajlm-2201	52	2	the	the	DET
ajlm-2201	52	3	final	final	ADJ
ajlm-2201	52	4	step	step	NOUN
ajlm-2201	52	5	,	,	PUNCT
ajlm-2201	52	6	patients	patient	NOUN
ajlm-2201	52	7	known	know	VERB
ajlm-2201	52	8	with	with	ADP
ajlm-2201	52	9	mg	mg	PROPN
ajlm-2201	52	10	and	and	CCONJ
ajlm-2201	52	11	those	those	PRON
ajlm-2201	52	12	without	without	ADP
ajlm-2201	52	13	an	an	DET
ajlm-2201	52	14	spe	spe	PROPN
ajlm-2201	52	15	performed	perform	VERB
ajlm-2201	52	16	within	within	ADP
ajlm-2201	52	17	3	3	NUM
ajlm-2201	52	18	months	month	NOUN
ajlm-2201	52	19	(	(	PUNCT
ajlm-2201	52	20	90	90	NUM
ajlm-2201	52	21	days	day	NOUN
ajlm-2201	52	22	)	)	PUNCT
ajlm-2201	52	23	of	of	ADP
ajlm-2201	52	24	sflc	sflc	VERB
ajlm-2201	52	25	testing	testing	NOUN
ajlm-2201	52	26	were	be	AUX
ajlm-2201	52	27	excluded	exclude	VERB
ajlm-2201	52	28	.	.	PUNCT
ajlm-2201	53	1	the	the	DET
ajlm-2201	53	2	relationship	relationship	NOUN
ajlm-2201	53	3	between	between	ADP
ajlm-2201	53	4	abnormal	abnormal	ADJ
ajlm-2201	53	5	κ	κ	NOUN
ajlm-2201	53	6	/	/	SYM
ajlm-2201	53	7	λ	λ	NOUN
ajlm-2201	53	8	ratio	ratio	NOUN
ajlm-2201	53	9	and	and	CCONJ
ajlm-2201	53	10	spe	spe	PROPN
ajlm-2201	53	11	was	be	AUX
ajlm-2201	53	12	investigated	investigate	VERB
ajlm-2201	53	13	in	in	ADP
ajlm-2201	53	14	tbh	tbh	NOUN
ajlm-2201	53	15	patients	patient	NOUN
ajlm-2201	53	16	.	.	PUNCT
ajlm-2201	54	1	figure	figure	VERB
ajlm-2201	54	2	1	1	NUM
ajlm-2201	54	3	:	:	PUNCT
ajlm-2201	54	4	stepwise	stepwise	ADJ
ajlm-2201	54	5	exclusion	exclusion	NOUN
ajlm-2201	54	6	of	of	ADP
ajlm-2201	54	7	laboratory	laboratory	NOUN
ajlm-2201	54	8	data	datum	NOUN
ajlm-2201	54	9	in	in	ADP
ajlm-2201	54	10	the	the	DET
ajlm-2201	54	11	study	study	NOUN
ajlm-2201	54	12	conducted	conduct	VERB
ajlm-2201	54	13	at	at	ADP
ajlm-2201	54	14	tygerberg	tygerberg	PROPN
ajlm-2201	54	15	hospital	hospital	PROPN
ajlm-2201	54	16	national	national	PROPN
ajlm-2201	54	17	health	health	PROPN
ajlm-2201	54	18	laboratory	laboratory	PROPN
ajlm-2201	54	19	service	service	PROPN
ajlm-2201	54	20	,	,	PUNCT
ajlm-2201	54	21	south	south	PROPN
ajlm-2201	54	22	africa	africa	PROPN
ajlm-2201	54	23	,	,	PUNCT
ajlm-2201	54	24	from	from	ADP
ajlm-2201	54	25	may	may	PROPN
ajlm-2201	54	26	2018	2018	NUM
ajlm-2201	54	27	to	to	ADP
ajlm-2201	54	28	april	april	PROPN
ajlm-2201	54	29	2020	2020	NUM
ajlm-2201	54	30	.	.	PUNCT
ajlm-2201	55	1	laboratory	laboratory	NOUN
ajlm-2201	55	2	analyses	analyse	VERB
ajlm-2201	55	3	serum	serum	NOUN
ajlm-2201	55	4	-	-	PUNCT
ajlm-2201	55	5	free	free	ADJ
ajlm-2201	55	6	light	light	NOUN
ajlm-2201	55	7	chain	chain	NOUN
ajlm-2201	55	8	serum	serum	NOUN
ajlm-2201	55	9	samples	sample	NOUN
ajlm-2201	55	10	were	be	AUX
ajlm-2201	55	11	analysed	analyse	VERB
ajlm-2201	55	12	using	use	VERB
ajlm-2201	55	13	the	the	DET
ajlm-2201	55	14	immunoturbidimetric	immunoturbidimetric	ADJ
ajlm-2201	55	15	freelite	freelite	PROPN
ajlm-2201	55	16	®	®	PROPN
ajlm-2201	55	17	kappa	kappa	NOUN
ajlm-2201	55	18	and	and	CCONJ
ajlm-2201	55	19	lambda	lambda	ADJ
ajlm-2201	55	20	assays	assay	NOUN
ajlm-2201	55	21	(	(	PUNCT
ajlm-2201	55	22	the	the	DET
ajlm-2201	55	23	binding	bind	VERB
ajlm-2201	55	24	site	site	NOUN
ajlm-2201	55	25	group	group	PROPN
ajlm-2201	55	26	ltd	ltd	PROPN
ajlm-2201	55	27	,	,	PUNCT
ajlm-2201	55	28	birmingham	birmingham	PROPN
ajlm-2201	55	29	,	,	PUNCT
ajlm-2201	55	30	united	united	ADJ
ajlm-2201	55	31	kingdom	kingdom	PROPN
ajlm-2201	55	32	)	)	PUNCT
ajlm-2201	55	33	on	on	ADP
ajlm-2201	55	34	the	the	DET
ajlm-2201	55	35	roche	roche	PROPN
ajlm-2201	55	36	cobas	cobas	PROPN
ajlm-2201	55	37	®	®	PROPN
ajlm-2201	55	38	6000	6000	NUM
ajlm-2201	56	1	c601	c601	PROPN
ajlm-2201	56	2	instrument	instrument	NOUN
ajlm-2201	56	3	(	(	PUNCT
ajlm-2201	56	4	roche	roche	PROPN
ajlm-2201	56	5	diagnostics	diagnostic	NOUN
ajlm-2201	56	6	gmbh	gmbh	PROPN
ajlm-2201	56	7	,	,	PUNCT
ajlm-2201	56	8	mannheim	mannheim	PROPN
ajlm-2201	56	9	,	,	PUNCT
ajlm-2201	56	10	germany	germany	PROPN
ajlm-2201	56	11	)	)	PUNCT
ajlm-2201	56	12	.	.	PUNCT
ajlm-2201	57	1	the	the	DET
ajlm-2201	57	2	coefficient	coefficient	NOUN
ajlm-2201	57	3	of	of	ADP
ajlm-2201	57	4	variation	variation	NOUN
ajlm-2201	57	5	for	for	ADP
ajlm-2201	57	6	the	the	DET
ajlm-2201	57	7	freelite	freelite	ADJ
ajlm-2201	57	8	®	®	NOUN
ajlm-2201	57	9	normal	normal	ADJ
ajlm-2201	57	10	internal	internal	ADJ
ajlm-2201	57	11	quality	quality	NOUN
ajlm-2201	57	12	controls	control	NOUN
ajlm-2201	57	13	was	be	AUX
ajlm-2201	57	14	κ	κ	PROPN
ajlm-2201	57	15	3.98	3.98	NUM
ajlm-2201	57	16	%	%	NOUN
ajlm-2201	57	17	and	and	CCONJ
ajlm-2201	57	18	λ	λ	PROPN
ajlm-2201	57	19	3.79	3.79	NUM
ajlm-2201	57	20	%	%	NOUN
ajlm-2201	57	21	,	,	PUNCT
ajlm-2201	57	22	and	and	CCONJ
ajlm-2201	57	23	κ	κ	VERB
ajlm-2201	57	24	2.52	2.52	NUM
ajlm-2201	57	25	%	%	NOUN
ajlm-2201	57	26	and	and	CCONJ
ajlm-2201	57	27	λ	λ	PROPN
ajlm-2201	57	28	4.14	4.14	NUM
ajlm-2201	57	29	%	%	NOUN
ajlm-2201	57	30	for	for	ADP
ajlm-2201	57	31	the	the	DET
ajlm-2201	57	32	high	high	ADJ
ajlm-2201	57	33	internal	internal	ADJ
ajlm-2201	57	34	quality	quality	NOUN
ajlm-2201	57	35	controls	control	NOUN
ajlm-2201	57	36	(	(	PUNCT
ajlm-2201	57	37	may	may	PROPN
ajlm-2201	57	38	2019	2019	NUM
ajlm-2201	57	39	)	)	PUNCT
ajlm-2201	57	40	.	.	PUNCT
ajlm-2201	58	1	the	the	DET
ajlm-2201	58	2	manufacturer	manufacturer	NOUN
ajlm-2201	58	3	’s	’s	PART
ajlm-2201	58	4	reference	reference	NOUN
ajlm-2201	58	5	intervals	interval	NOUN
ajlm-2201	58	6	were	be	AUX
ajlm-2201	58	7	previously	previously	ADV
ajlm-2201	58	8	verified	verify	VERB
ajlm-2201	58	9	in	in	ADP
ajlm-2201	58	10	a	a	DET
ajlm-2201	58	11	local	local	ADJ
ajlm-2201	58	12	study12	study12	NOUN
ajlm-2201	58	13	and	and	CCONJ
ajlm-2201	58	14	applied	apply	VERB
ajlm-2201	58	15	as	as	SCONJ
ajlm-2201	58	16	follows	follow	VERB
ajlm-2201	58	17	:	:	PUNCT
ajlm-2201	58	18	κ	κ	NOUN
ajlm-2201	58	19	free	free	ADJ
ajlm-2201	58	20	light	light	NOUN
ajlm-2201	58	21	chain	chain	NOUN
ajlm-2201	58	22	(	(	PUNCT
ajlm-2201	58	23	flc	flc	PROPN
ajlm-2201	58	24	):	):	PUNCT
ajlm-2201	58	25	3.3	3.3	NUM
ajlm-2201	58	26	mg	mg	PROPN
ajlm-2201	58	27	/	/	SYM
ajlm-2201	58	28	l	l	NOUN
ajlm-2201	58	29	–	–	PUNCT
ajlm-2201	58	30	19.4	19.4	NUM
ajlm-2201	58	31	mg	mg	NUM
ajlm-2201	58	32	/	/	SYM
ajlm-2201	58	33	l	l	NOUN
ajlm-2201	58	34	,	,	PUNCT
ajlm-2201	58	35	λ	λ	PROPN
ajlm-2201	58	36	flc	flc	PROPN
ajlm-2201	58	37	:	:	PUNCT
ajlm-2201	58	38	5.7	5.7	NUM
ajlm-2201	58	39	mg	mg	PROPN
ajlm-2201	58	40	/	/	SYM
ajlm-2201	58	41	l	l	NOUN
ajlm-2201	58	42	‒	‒	X
ajlm-2201	58	43	26.3	26.3	NUM
ajlm-2201	58	44	mg	mg	PROPN
ajlm-2201	58	45	/	/	SYM
ajlm-2201	58	46	l	l	NOUN
ajlm-2201	58	47	,	,	PUNCT
ajlm-2201	58	48	and	and	CCONJ
ajlm-2201	58	49	κ	κ	NOUN
ajlm-2201	58	50	/	/	SYM
ajlm-2201	58	51	λ	λ	NOUN
ajlm-2201	58	52	ratio	ratio	NOUN
ajlm-2201	58	53	:	:	PUNCT
ajlm-2201	58	54	0.26‒1.65	0.26‒1.65	X
ajlm-2201	58	55	.	.	PUNCT
ajlm-2201	59	1	both	both	PRON
ajlm-2201	59	2	increased	increase	VERB
ajlm-2201	59	3	and	and	CCONJ
ajlm-2201	59	4	decreased	decrease	VERB
ajlm-2201	59	5	ratios	ratio	NOUN
ajlm-2201	59	6	were	be	AUX
ajlm-2201	59	7	considered	consider	VERB
ajlm-2201	59	8	abnormal.5	abnormal.5	ADV
ajlm-2201	59	9	the	the	DET
ajlm-2201	59	10	reference	reference	NOUN
ajlm-2201	59	11	interval	interval	NOUN
ajlm-2201	59	12	of	of	ADP
ajlm-2201	59	13	0.37‒3.1	0.37‒3.1	NOUN
ajlm-2201	59	14	for	for	ADP
ajlm-2201	59	15	κ	κ	NOUN
ajlm-2201	59	16	/	/	SYM
ajlm-2201	59	17	λ	λ	NOUN
ajlm-2201	59	18	ratio	ratio	NOUN
ajlm-2201	59	19	in	in	ADP
ajlm-2201	59	20	renal	renal	ADJ
ajlm-2201	59	21	impairment	impairment	NOUN
ajlm-2201	59	22	was	be	AUX
ajlm-2201	59	23	applied	apply	VERB
ajlm-2201	59	24	in	in	ADP
ajlm-2201	59	25	a	a	DET
ajlm-2201	59	26	select	select	ADJ
ajlm-2201	59	27	group	group	NOUN
ajlm-2201	59	28	of	of	ADP
ajlm-2201	59	29	patients	patient	NOUN
ajlm-2201	59	30	with	with	ADP
ajlm-2201	59	31	abnormal	abnormal	ADJ
ajlm-2201	59	32	ratio	ratio	NOUN
ajlm-2201	59	33	and	and	CCONJ
ajlm-2201	59	34	undetectable	undetectable	ADJ
ajlm-2201	59	35	m	m	NOUN
ajlm-2201	59	36	-	-	NOUN
ajlm-2201	59	37	protein	protein	NOUN
ajlm-2201	59	38	on	on	ADP
ajlm-2201	59	39	spe.13	spe.13	PROPN
ajlm-2201	59	40	serum	serum	NOUN
ajlm-2201	59	41	protein	protein	NOUN
ajlm-2201	59	42	electrophoresis	electrophoresis	NOUN
ajlm-2201	59	43	and	and	CCONJ
ajlm-2201	59	44	ife	ife	PROPN
ajlm-2201	59	45	were	be	AUX
ajlm-2201	59	46	performed	perform	VERB
ajlm-2201	59	47	on	on	ADP
ajlm-2201	59	48	the	the	DET
ajlm-2201	59	49	sebia	sebia	ADJ
ajlm-2201	59	50	hydrasys	hydrasys	NOUN
ajlm-2201	59	51	2	2	NUM
ajlm-2201	59	52	(	(	PUNCT
ajlm-2201	59	53	sebia	sebia	ADJ
ajlm-2201	59	54	,	,	PUNCT
ajlm-2201	59	55	lisses	lisse	NOUN
ajlm-2201	59	56	,	,	PUNCT
ajlm-2201	59	57	france	france	PROPN
ajlm-2201	59	58	)	)	PUNCT
ajlm-2201	59	59	semi	semi	ADV
ajlm-2201	59	60	-	-	ADJ
ajlm-2201	59	61	automated	automated	ADJ
ajlm-2201	59	62	agarose	agarose	NOUN
ajlm-2201	59	63	gel	gel	NOUN
ajlm-2201	59	64	electrophoresis	electrophoresis	NOUN
ajlm-2201	59	65	system	system	NOUN
ajlm-2201	59	66	.	.	PUNCT
ajlm-2201	60	1	clinicians	clinician	NOUN
ajlm-2201	60	2	at	at	ADP
ajlm-2201	60	3	our	our	PRON
ajlm-2201	60	4	centre	centre	NOUN
ajlm-2201	60	5	requested	request	VERB
ajlm-2201	60	6	spe	spe	NOUN
ajlm-2201	60	7	,	,	PUNCT
ajlm-2201	60	8	while	while	SCONJ
ajlm-2201	60	9	ife	ife	PROPN
ajlm-2201	60	10	was	be	AUX
ajlm-2201	60	11	reflexively	reflexively	ADV
ajlm-2201	60	12	added	add	VERB
ajlm-2201	60	13	by	by	ADP
ajlm-2201	60	14	the	the	DET
ajlm-2201	60	15	reporting	reporting	NOUN
ajlm-2201	60	16	pathologist	pathologist	NOUN
ajlm-2201	60	17	if	if	SCONJ
ajlm-2201	60	18	necessary	necessary	ADJ
ajlm-2201	60	19	,	,	PUNCT
ajlm-2201	60	20	based	base	VERB
ajlm-2201	60	21	on	on	ADP
ajlm-2201	60	22	the	the	DET
ajlm-2201	60	23	clinical	clinical	ADJ
ajlm-2201	60	24	context	context	NOUN
ajlm-2201	60	25	or	or	CCONJ
ajlm-2201	60	26	spe	spe	ADJ
ajlm-2201	60	27	appearance	appearance	NOUN
ajlm-2201	60	28	(	(	PUNCT
ajlm-2201	60	29	presence	presence	NOUN
ajlm-2201	60	30	of	of	ADP
ajlm-2201	60	31	suspected	suspect	VERB
ajlm-2201	60	32	m	m	NOUN
ajlm-2201	60	33	-	-	ADJ
ajlm-2201	60	34	protein	protein	NOUN
ajlm-2201	60	35	or	or	CCONJ
ajlm-2201	60	36	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2201	60	37	)	)	PUNCT
ajlm-2201	60	38	.	.	PUNCT
ajlm-2201	61	1	data	datum	NOUN
ajlm-2201	61	2	analysis	analysis	NOUN
ajlm-2201	61	3	laboratory	laboratory	NOUN
ajlm-2201	61	4	data	datum	NOUN
ajlm-2201	61	5	were	be	AUX
ajlm-2201	61	6	captured	capture	VERB
ajlm-2201	61	7	in	in	ADP
ajlm-2201	61	8	microsoft	microsoft	PROPN
ajlm-2201	61	9	excel	excel	NOUN
ajlm-2201	61	10	spreadsheets	spreadsheet	NOUN
ajlm-2201	61	11	(	(	PUNCT
ajlm-2201	61	12	microsoft	microsoft	PROPN
ajlm-2201	61	13	corporation	corporation	PROPN
ajlm-2201	61	14	,	,	PUNCT
ajlm-2201	61	15	redmond	redmond	PROPN
ajlm-2201	61	16	,	,	PUNCT
ajlm-2201	61	17	washington	washington	PROPN
ajlm-2201	61	18	,	,	PUNCT
ajlm-2201	61	19	united	united	PROPN
ajlm-2201	61	20	states	states	PROPN
ajlm-2201	61	21	)	)	PUNCT
ajlm-2201	61	22	.	.	PUNCT
ajlm-2201	62	1	demographic	demographic	ADJ
ajlm-2201	62	2	statistics	statistic	NOUN
ajlm-2201	62	3	of	of	ADP
ajlm-2201	62	4	sflc	sflc	VERB
ajlm-2201	62	5	requests	request	NOUN
ajlm-2201	62	6	and	and	CCONJ
ajlm-2201	62	7	the	the	DET
ajlm-2201	62	8	frequency	frequency	NOUN
ajlm-2201	62	9	of	of	ADP
ajlm-2201	62	10	abnormal	abnormal	ADJ
ajlm-2201	62	11	sflc	sflc	NOUN
ajlm-2201	62	12	results	result	NOUN
ajlm-2201	62	13	were	be	AUX
ajlm-2201	62	14	determined	determine	VERB
ajlm-2201	62	15	using	use	VERB
ajlm-2201	62	16	statistical	statistical	ADJ
ajlm-2201	62	17	package	package	NOUN
ajlm-2201	62	18	for	for	ADP
ajlm-2201	62	19	social	social	ADJ
ajlm-2201	62	20	scieces	sciece	NOUN
ajlm-2201	62	21	,	,	PUNCT
ajlm-2201	62	22	version	version	NOUN
ajlm-2201	62	23	27	27	NUM
ajlm-2201	62	24	(	(	PUNCT
ajlm-2201	62	25	ibm	ibm	PROPN
ajlm-2201	62	26	corp	corp	PROPN
ajlm-2201	62	27	.	.	PROPN
ajlm-2201	62	28	,	,	PUNCT
ajlm-2201	62	29	armonk	armonk	PROPN
ajlm-2201	62	30	,	,	PUNCT
ajlm-2201	62	31	new	new	PROPN
ajlm-2201	62	32	york	york	PROPN
ajlm-2201	62	33	,	,	PUNCT
ajlm-2201	62	34	united	united	PROPN
ajlm-2201	62	35	states	states	PROPN
ajlm-2201	62	36	)	)	PUNCT
ajlm-2201	62	37	.	.	PUNCT
ajlm-2201	63	1	descriptive	descriptive	ADJ
ajlm-2201	63	2	statistics	statistic	NOUN
ajlm-2201	63	3	were	be	AUX
ajlm-2201	63	4	determined	determine	VERB
ajlm-2201	63	5	,	,	PUNCT
ajlm-2201	63	6	where	where	SCONJ
ajlm-2201	63	7	appropriate	appropriate	ADJ
ajlm-2201	63	8	.	.	PUNCT
ajlm-2201	64	1	results	result	NOUN
ajlm-2201	64	2	after	after	SCONJ
ajlm-2201	64	3	the	the	DET
ajlm-2201	64	4	data	data	NOUN
ajlm-2201	64	5	extraction	extraction	NOUN
ajlm-2201	64	6	was	be	AUX
ajlm-2201	64	7	performed	perform	VERB
ajlm-2201	64	8	,	,	PUNCT
ajlm-2201	64	9	1425	1425	NUM
ajlm-2201	64	10	individual	individual	ADJ
ajlm-2201	64	11	test	test	NOUN
ajlm-2201	64	12	results	result	NOUN
ajlm-2201	64	13	were	be	AUX
ajlm-2201	64	14	identified	identify	VERB
ajlm-2201	64	15	(	(	PUNCT
ajlm-2201	64	16	figure	figure	NOUN
ajlm-2201	64	17	1	1	NUM
ajlm-2201	64	18	)	)	PUNCT
ajlm-2201	64	19	and	and	CCONJ
ajlm-2201	64	20	included	include	VERB
ajlm-2201	64	21	in	in	ADP
ajlm-2201	64	22	the	the	DET
ajlm-2201	64	23	retrospective	retrospective	ADJ
ajlm-2201	64	24	audit	audit	NOUN
ajlm-2201	64	25	.	.	PUNCT
ajlm-2201	65	1	sixty	sixty	NUM
ajlm-2201	65	2	percent	percent	NOUN
ajlm-2201	65	3	(	(	PUNCT
ajlm-2201	65	4	n	n	NOUN
ajlm-2201	65	5	=	=	SYM
ajlm-2201	65	6	860/1425	860/1425	NUM
ajlm-2201	65	7	)	)	PUNCT
ajlm-2201	65	8	of	of	ADP
ajlm-2201	65	9	patients	patient	NOUN
ajlm-2201	65	10	were	be	AUX
ajlm-2201	65	11	female	female	ADJ
ajlm-2201	65	12	,	,	PUNCT
ajlm-2201	65	13	with	with	ADP
ajlm-2201	65	14	a	a	DET
ajlm-2201	65	15	mean	mean	ADJ
ajlm-2201	65	16	age	age	NOUN
ajlm-2201	65	17	of	of	ADP
ajlm-2201	65	18	59	59	NUM
ajlm-2201	65	19	years	year	NOUN
ajlm-2201	65	20	(	(	PUNCT
ajlm-2201	65	21	standard	standard	ADJ
ajlm-2201	65	22	deviation	deviation	NOUN
ajlm-2201	65	23	±	±	NUM
ajlm-2201	65	24	13	13	NUM
ajlm-2201	65	25	)	)	PUNCT
ajlm-2201	65	26	(	(	PUNCT
ajlm-2201	65	27	table	table	NOUN
ajlm-2201	65	28	1	1	NUM
ajlm-2201	65	29	)	)	PUNCT
ajlm-2201	65	30	.	.	PUNCT
ajlm-2201	66	1	the	the	DET
ajlm-2201	66	2	most	most	ADJ
ajlm-2201	66	3	requests	request	NOUN
ajlm-2201	66	4	were	be	AUX
ajlm-2201	66	5	received	receive	VERB
ajlm-2201	66	6	for	for	ADP
ajlm-2201	66	7	patients	patient	NOUN
ajlm-2201	66	8	in	in	ADP
ajlm-2201	66	9	the	the	DET
ajlm-2201	66	10	51–70	51–70	NUM
ajlm-2201	66	11	-	-	PUNCT
ajlm-2201	66	12	year	year	NOUN
ajlm-2201	66	13	age	age	NOUN
ajlm-2201	66	14	group	group	NOUN
ajlm-2201	66	15	(	(	PUNCT
ajlm-2201	66	16	figure	figure	NOUN
ajlm-2201	66	17	2	2	NUM
ajlm-2201	66	18	)	)	PUNCT
ajlm-2201	66	19	.	.	PUNCT
ajlm-2201	67	1	a	a	DET
ajlm-2201	67	2	minority	minority	NOUN
ajlm-2201	67	3	of	of	ADP
ajlm-2201	67	4	requests	request	NOUN
ajlm-2201	67	5	were	be	AUX
ajlm-2201	67	6	received	receive	VERB
ajlm-2201	67	7	from	from	ADP
ajlm-2201	67	8	primary	primary	ADJ
ajlm-2201	67	9	(	(	PUNCT
ajlm-2201	67	10	n	n	NOUN
ajlm-2201	67	11	=	=	SYM
ajlm-2201	67	12	19	19	NUM
ajlm-2201	67	13	,	,	PUNCT
ajlm-2201	67	14	1.3	1.3	NUM
ajlm-2201	67	15	%	%	NOUN
ajlm-2201	67	16	)	)	PUNCT
ajlm-2201	67	17	and	and	CCONJ
ajlm-2201	67	18	secondary	secondary	ADJ
ajlm-2201	67	19	healthcare	healthcare	NOUN
ajlm-2201	67	20	institutions	institution	NOUN
ajlm-2201	67	21	(	(	PUNCT
ajlm-2201	67	22	n	n	NOUN
ajlm-2201	67	23	=	=	SYM
ajlm-2201	67	24	228	228	NUM
ajlm-2201	67	25	,	,	PUNCT
ajlm-2201	67	26	16	16	NUM
ajlm-2201	67	27	%	%	NOUN
ajlm-2201	67	28	)	)	PUNCT
ajlm-2201	67	29	.	.	PUNCT
ajlm-2201	68	1	most	most	ADJ
ajlm-2201	68	2	requests	request	NOUN
ajlm-2201	68	3	were	be	AUX
ajlm-2201	68	4	received	receive	VERB
ajlm-2201	68	5	from	from	ADP
ajlm-2201	68	6	tertiary	tertiary	ADJ
ajlm-2201	68	7	healthcare	healthcare	NOUN
ajlm-2201	68	8	institutions	institution	NOUN
ajlm-2201	68	9	(	(	PUNCT
ajlm-2201	68	10	n	n	NOUN
ajlm-2201	68	11	=	=	SYM
ajlm-2201	68	12	1178	1178	NUM
ajlm-2201	68	13	;	;	PUNCT
ajlm-2201	68	14	82.7	82.7	NUM
ajlm-2201	68	15	%	%	NOUN
ajlm-2201	68	16	)	)	PUNCT
ajlm-2201	68	17	.	.	PUNCT
ajlm-2201	69	1	just	just	ADV
ajlm-2201	69	2	over	over	ADP
ajlm-2201	69	3	half	half	NOUN
ajlm-2201	69	4	(	(	PUNCT
ajlm-2201	69	5	n	n	NOUN
ajlm-2201	69	6	=	=	SYM
ajlm-2201	69	7	741	741	NUM
ajlm-2201	69	8	,	,	PUNCT
ajlm-2201	69	9	52	52	NUM
ajlm-2201	69	10	%	%	NOUN
ajlm-2201	69	11	)	)	PUNCT
ajlm-2201	69	12	of	of	ADP
ajlm-2201	69	13	κ	κ	PROPN
ajlm-2201	69	14	/	/	SYM
ajlm-2201	69	15	λ	λ	NOUN
ajlm-2201	69	16	ratios	ratio	NOUN
ajlm-2201	69	17	were	be	AUX
ajlm-2201	69	18	abnormal	abnormal	ADJ
ajlm-2201	69	19	;	;	PUNCT
ajlm-2201	69	20	44.6	44.6	NUM
ajlm-2201	69	21	%	%	NOUN
ajlm-2201	69	22	(	(	PUNCT
ajlm-2201	69	23	n	n	NOUN
ajlm-2201	69	24	=	=	SYM
ajlm-2201	69	25	636	636	NUM
ajlm-2201	69	26	)	)	PUNCT
ajlm-2201	69	27	had	have	VERB
ajlm-2201	69	28	an	an	DET
ajlm-2201	69	29	increased	increase	VERB
ajlm-2201	69	30	ratio	ratio	NOUN
ajlm-2201	69	31	,	,	PUNCT
ajlm-2201	69	32	and	and	CCONJ
ajlm-2201	69	33	7.4	7.4	NUM
ajlm-2201	69	34	%	%	NOUN
ajlm-2201	69	35	(	(	PUNCT
ajlm-2201	69	36	n	n	NOUN
ajlm-2201	69	37	=	=	SYM
ajlm-2201	69	38	105	105	NUM
ajlm-2201	69	39	)	)	PUNCT
ajlm-2201	69	40	had	have	VERB
ajlm-2201	69	41	a	a	DET
ajlm-2201	69	42	decreased	decrease	VERB
ajlm-2201	69	43	ratio	ratio	NOUN
ajlm-2201	69	44	.	.	PUNCT
ajlm-2201	70	1	figure	figure	NOUN
ajlm-2201	70	2	2	2	NUM
ajlm-2201	70	3	:	:	PUNCT
ajlm-2201	70	4	age	age	NOUN
ajlm-2201	70	5	distribution	distribution	NOUN
ajlm-2201	70	6	of	of	ADP
ajlm-2201	70	7	patients	patient	NOUN
ajlm-2201	70	8	for	for	ADP
ajlm-2201	70	9	whom	whom	PRON
ajlm-2201	70	10	serum	serum	NOUN
ajlm-2201	70	11	-	-	PUNCT
ajlm-2201	70	12	free	free	ADJ
ajlm-2201	70	13	light	light	NOUN
ajlm-2201	70	14	chain	chain	NOUN
ajlm-2201	70	15	assays	assay	NOUN
ajlm-2201	70	16	were	be	AUX
ajlm-2201	70	17	requested	request	VERB
ajlm-2201	70	18	at	at	ADP
ajlm-2201	70	19	tygerberg	tygerberg	PROPN
ajlm-2201	70	20	hospital	hospital	PROPN
ajlm-2201	70	21	national	national	PROPN
ajlm-2201	70	22	health	health	PROPN
ajlm-2201	70	23	laboratory	laboratory	PROPN
ajlm-2201	70	24	services	services	PROPN
ajlm-2201	70	25	,	,	PUNCT
ajlm-2201	70	26	south	south	PROPN
ajlm-2201	70	27	africa	africa	PROPN
ajlm-2201	70	28	,	,	PUNCT
ajlm-2201	70	29	from	from	ADP
ajlm-2201	70	30	may	may	PROPN
ajlm-2201	70	31	2018	2018	NUM
ajlm-2201	70	32	to	to	ADP
ajlm-2201	70	33	april	april	PROPN
ajlm-2201	70	34	2020	2020	NUM
ajlm-2201	70	35	.	.	PUNCT
ajlm-2201	71	1	table	table	NOUN
ajlm-2201	71	2	1	1	NUM
ajlm-2201	71	3	:	:	PUNCT
ajlm-2201	71	4	 	 	SPACE
ajlm-2201	71	5	demographics	demographic	NOUN
ajlm-2201	71	6	of	of	ADP
ajlm-2201	71	7	1425	1425	NUM
ajlm-2201	71	8	patients	patient	NOUN
ajlm-2201	71	9	with	with	ADP
ajlm-2201	71	10	serum	serum	NOUN
ajlm-2201	71	11	-	-	PUNCT
ajlm-2201	71	12	free	free	ADJ
ajlm-2201	71	13	light	light	NOUN
ajlm-2201	71	14	chain	chain	NOUN
ajlm-2201	71	15	requests	request	NOUN
ajlm-2201	71	16	received	receive	VERB
ajlm-2201	71	17	at	at	ADP
ajlm-2201	71	18	tygerberg	tygerberg	PROPN
ajlm-2201	71	19	hospital	hospital	PROPN
ajlm-2201	71	20	national	national	PROPN
ajlm-2201	71	21	health	health	PROPN
ajlm-2201	71	22	laboratory	laboratory	PROPN
ajlm-2201	71	23	services	services	PROPN
ajlm-2201	71	24	,	,	PUNCT
ajlm-2201	71	25	south	south	PROPN
ajlm-2201	71	26	africa	africa	PROPN
ajlm-2201	71	27	,	,	PUNCT
ajlm-2201	71	28	from	from	ADP
ajlm-2201	71	29	may	may	PROPN
ajlm-2201	71	30	2018	2018	NUM
ajlm-2201	71	31	to	to	ADP
ajlm-2201	71	32	april	april	PROPN
ajlm-2201	71	33	2020	2020	NUM
ajlm-2201	71	34	.	.	PUNCT
ajlm-2201	72	1	six	six	NUM
ajlm-2201	72	2	patients	patient	NOUN
ajlm-2201	72	3	out	out	ADP
ajlm-2201	72	4	of	of	ADP
ajlm-2201	72	5	199	199	NUM
ajlm-2201	72	6	(	(	PUNCT
ajlm-2201	72	7	3	3	NUM
ajlm-2201	72	8	%	%	NOUN
ajlm-2201	72	9	)	)	PUNCT
ajlm-2201	72	10	were	be	AUX
ajlm-2201	72	11	excluded	exclude	VERB
ajlm-2201	72	12	due	due	ADP
ajlm-2201	72	13	to	to	ADP
ajlm-2201	72	14	the	the	DET
ajlm-2201	72	15	absence	absence	NOUN
ajlm-2201	72	16	of	of	ADP
ajlm-2201	72	17	an	an	DET
ajlm-2201	72	18	spe	spe	NOUN
ajlm-2201	72	19	within	within	ADP
ajlm-2201	72	20	3	3	NUM
ajlm-2201	72	21	months	month	NOUN
ajlm-2201	72	22	of	of	ADP
ajlm-2201	72	23	the	the	DET
ajlm-2201	72	24	sflc	sflc	ADJ
ajlm-2201	72	25	request	request	NOUN
ajlm-2201	72	26	.	.	PUNCT
ajlm-2201	73	1	after	after	SCONJ
ajlm-2201	73	2	stepwise	stepwise	ADJ
ajlm-2201	73	3	exclusion	exclusion	NOUN
ajlm-2201	73	4	was	be	AUX
ajlm-2201	73	5	performed	perform	VERB
ajlm-2201	73	6	(	(	PUNCT
ajlm-2201	73	7	figure	figure	NOUN
ajlm-2201	73	8	1	1	NUM
ajlm-2201	73	9	)	)	PUNCT
ajlm-2201	73	10	,	,	PUNCT
ajlm-2201	73	11	117	117	NUM
ajlm-2201	73	12	new	new	ADJ
ajlm-2201	73	13	patients	patient	NOUN
ajlm-2201	73	14	from	from	ADP
ajlm-2201	73	15	tbh	tbh	NOUN
ajlm-2201	73	16	with	with	ADP
ajlm-2201	73	17	sflc	sflc	ADJ
ajlm-2201	73	18	patterns	pattern	NOUN
ajlm-2201	73	19	2	2	NUM
ajlm-2201	73	20	and	and	CCONJ
ajlm-2201	73	21	3	3	NUM
ajlm-2201	73	22	(	(	PUNCT
ajlm-2201	73	23	abnormal	abnormal	ADJ
ajlm-2201	73	24	κ	κ	NOUN
ajlm-2201	73	25	/	/	SYM
ajlm-2201	73	26	λ	λ	NOUN
ajlm-2201	73	27	ratio	ratio	NOUN
ajlm-2201	73	28	)	)	PUNCT
ajlm-2201	73	29	were	be	AUX
ajlm-2201	73	30	identified	identify	VERB
ajlm-2201	73	31	and	and	CCONJ
ajlm-2201	73	32	had	have	AUX
ajlm-2201	73	33	sflc	sflc	VERB
ajlm-2201	73	34	findings	finding	NOUN
ajlm-2201	73	35	compared	compare	VERB
ajlm-2201	73	36	with	with	ADP
ajlm-2201	73	37	spe	spe	PROPN
ajlm-2201	73	38	/	/	SYM
ajlm-2201	73	39	ife	ife	PROPN
ajlm-2201	73	40	.	.	PUNCT
ajlm-2201	74	1	of	of	ADP
ajlm-2201	74	2	those	those	PRON
ajlm-2201	74	3	,	,	PUNCT
ajlm-2201	74	4	57	57	NUM
ajlm-2201	74	5	(	(	PUNCT
ajlm-2201	74	6	49	49	NUM
ajlm-2201	74	7	%	%	NOUN
ajlm-2201	74	8	)	)	PUNCT
ajlm-2201	74	9	had	have	VERB
ajlm-2201	74	10	an	an	DET
ajlm-2201	74	11	m	m	NOUN
ajlm-2201	74	12	-	-	ADJ
ajlm-2201	74	13	protein	protein	NOUN
ajlm-2201	74	14	present	present	NOUN
ajlm-2201	74	15	on	on	ADP
ajlm-2201	74	16	spe	spe	PROPN
ajlm-2201	74	17	/	/	SYM
ajlm-2201	74	18	ife	ife	PROPN
ajlm-2201	74	19	,	,	PUNCT
ajlm-2201	74	20	and	and	CCONJ
ajlm-2201	74	21	60	60	NUM
ajlm-2201	74	22	(	(	PUNCT
ajlm-2201	74	23	51	51	NUM
ajlm-2201	74	24	%	%	NOUN
ajlm-2201	74	25	)	)	PUNCT
ajlm-2201	74	26	did	do	VERB
ajlm-2201	74	27	not	not	PART
ajlm-2201	74	28	.	.	PUNCT
ajlm-2201	75	1	forty	forty	NUM
ajlm-2201	75	2	-	-	PUNCT
ajlm-2201	75	3	one	one	NUM
ajlm-2201	75	4	patients	patient	NOUN
ajlm-2201	75	5	were	be	AUX
ajlm-2201	75	6	diagnosed	diagnose	VERB
ajlm-2201	75	7	with	with	ADP
ajlm-2201	75	8	a	a	DET
ajlm-2201	75	9	plasma	plasma	NOUN
ajlm-2201	75	10	cell	cell	NOUN
ajlm-2201	75	11	dyscrasia	dyscrasia	NOUN
ajlm-2201	75	12	(	(	PUNCT
ajlm-2201	75	13	72	72	NUM
ajlm-2201	75	14	%	%	NOUN
ajlm-2201	75	15	)	)	PUNCT
ajlm-2201	75	16	,	,	PUNCT
ajlm-2201	75	17	seven	seven	NUM
ajlm-2201	75	18	patients	patient	NOUN
ajlm-2201	75	19	had	have	VERB
ajlm-2201	75	20	lymphoma	lymphoma	NOUN
ajlm-2201	75	21	(	(	PUNCT
ajlm-2201	75	22	12	12	NUM
ajlm-2201	75	23	%	%	NOUN
ajlm-2201	75	24	)	)	PUNCT
ajlm-2201	75	25	,	,	PUNCT
ajlm-2201	75	26	and	and	CCONJ
ajlm-2201	75	27	nine	nine	NUM
ajlm-2201	75	28	patients	patient	NOUN
ajlm-2201	75	29	were	be	AUX
ajlm-2201	75	30	unable	unable	ADJ
ajlm-2201	75	31	to	to	PART
ajlm-2201	75	32	be	be	AUX
ajlm-2201	75	33	classified	classify	VERB
ajlm-2201	75	34	due	due	ADP
ajlm-2201	75	35	to	to	ADP
ajlm-2201	75	36	the	the	DET
ajlm-2201	75	37	absence	absence	NOUN
ajlm-2201	75	38	of	of	ADP
ajlm-2201	75	39	a	a	DET
ajlm-2201	75	40	bone	bone	NOUN
ajlm-2201	75	41	marrow	marrow	NOUN
ajlm-2201	75	42	biopsy	biopsy	NOUN
ajlm-2201	75	43	and	and	CCONJ
ajlm-2201	75	44	incomplete	incomplete	ADJ
ajlm-2201	75	45	investigation	investigation	NOUN
ajlm-2201	75	46	(	(	PUNCT
ajlm-2201	75	47	16	16	NUM
ajlm-2201	75	48	%	%	NOUN
ajlm-2201	75	49	)	)	PUNCT
ajlm-2201	75	50	(	(	PUNCT
ajlm-2201	75	51	table	table	NOUN
ajlm-2201	75	52	2	2	NUM
ajlm-2201	75	53	)	)	PUNCT
ajlm-2201	75	54	.	.	PUNCT
ajlm-2201	76	1	out	out	ADP
ajlm-2201	76	2	of	of	ADP
ajlm-2201	76	3	28	28	NUM
ajlm-2201	76	4	patients	patient	NOUN
ajlm-2201	76	5	diagnosed	diagnose	VERB
ajlm-2201	76	6	with	with	ADP
ajlm-2201	76	7	mm	mm	PROPN
ajlm-2201	76	8	,	,	PUNCT
ajlm-2201	76	9	15	15	NUM
ajlm-2201	76	10	were	be	AUX
ajlm-2201	76	11	female	female	ADJ
ajlm-2201	76	12	,	,	PUNCT
ajlm-2201	76	13	with	with	ADP
ajlm-2201	76	14	a	a	DET
ajlm-2201	76	15	female	female	NOUN
ajlm-2201	76	16	-	-	PUNCT
ajlm-2201	76	17	to	to	ADP
ajlm-2201	76	18	-	-	PUNCT
ajlm-2201	76	19	male	male	NOUN
ajlm-2201	76	20	ratio	ratio	NOUN
ajlm-2201	76	21	of	of	ADP
ajlm-2201	76	22	1.2:1	1.2:1	NUM
ajlm-2201	76	23	.	.	PUNCT
ajlm-2201	77	1	of	of	ADP
ajlm-2201	77	2	the	the	DET
ajlm-2201	77	3	four	four	NUM
ajlm-2201	77	4	patients	patient	NOUN
ajlm-2201	77	5	who	who	PRON
ajlm-2201	77	6	were	be	AUX
ajlm-2201	77	7	hiv	hiv	NOUN
ajlm-2201	77	8	-	-	PUNCT
ajlm-2201	77	9	positive	positive	ADJ
ajlm-2201	77	10	,	,	PUNCT
ajlm-2201	77	11	two	two	NUM
ajlm-2201	77	12	had	have	VERB
ajlm-2201	77	13	mm	mm	PROPN
ajlm-2201	77	14	,	,	PUNCT
ajlm-2201	77	15	one	one	NUM
ajlm-2201	77	16	had	have	VERB
ajlm-2201	77	17	mgus	mgus	ADJ
ajlm-2201	77	18	,	,	PUNCT
ajlm-2201	77	19	and	and	CCONJ
ajlm-2201	77	20	one	one	NUM
ajlm-2201	77	21	had	have	VERB
ajlm-2201	77	22	plasmablastic	plasmablastic	ADJ
ajlm-2201	77	23	lymphoma	lymphoma	NOUN
ajlm-2201	77	24	.	.	PUNCT
ajlm-2201	78	1	table	table	NOUN
ajlm-2201	78	2	2	2	NUM
ajlm-2201	78	3	:	:	PUNCT
ajlm-2201	78	4	 	 	SPACE
ajlm-2201	78	5	clinical	clinical	ADJ
ajlm-2201	78	6	features	feature	NOUN
ajlm-2201	78	7	of	of	ADP
ajlm-2201	78	8	57	57	NUM
ajlm-2201	78	9	patients	patient	NOUN
ajlm-2201	78	10	identified	identify	VERB
ajlm-2201	78	11	with	with	ADP
ajlm-2201	78	12	monoclonal	monoclonal	NOUN
ajlm-2201	78	13	gammopathy	gammopathy	ADJ
ajlm-2201	78	14	at	at	ADP
ajlm-2201	78	15	tygerberg	tygerberg	PROPN
ajlm-2201	78	16	hospital	hospital	PROPN
ajlm-2201	78	17	,	,	PUNCT
ajlm-2201	78	18	south	south	PROPN
ajlm-2201	78	19	africa	africa	PROPN
ajlm-2201	78	20	,	,	PUNCT
ajlm-2201	78	21	between	between	ADP
ajlm-2201	78	22	may	may	PROPN
ajlm-2201	78	23	2018	2018	NUM
ajlm-2201	78	24	and	and	CCONJ
ajlm-2201	78	25	april	april	PROPN
ajlm-2201	78	26	2020	2020	NUM
ajlm-2201	78	27	.	.	PUNCT
ajlm-2201	79	1	of	of	ADP
ajlm-2201	79	2	the	the	DET
ajlm-2201	79	3	57	57	NUM
ajlm-2201	79	4	patients	patient	NOUN
ajlm-2201	79	5	with	with	ADP
ajlm-2201	79	6	mg	mg	PROPN
ajlm-2201	79	7	,	,	PUNCT
ajlm-2201	79	8	two	two	NUM
ajlm-2201	79	9	had	have	VERB
ajlm-2201	79	10	an	an	DET
ajlm-2201	79	11	immunoglobulin	immunoglobulin	NOUN
ajlm-2201	79	12	g	g	PROPN
ajlm-2201	79	13	λ	λ	PROPN
ajlm-2201	79	14	m	m	NOUN
ajlm-2201	79	15	-	-	NOUN
ajlm-2201	79	16	protein	protein	NOUN
ajlm-2201	79	17	with	with	ADP
ajlm-2201	79	18	an	an	DET
ajlm-2201	79	19	unexpectedly	unexpectedly	ADV
ajlm-2201	79	20	raised	raise	VERB
ajlm-2201	79	21	κ	κ	NOUN
ajlm-2201	79	22	/	/	SYM
ajlm-2201	79	23	λ	λ	NOUN
ajlm-2201	79	24	ratio	ratio	NOUN
ajlm-2201	79	25	(	(	PUNCT
ajlm-2201	79	26	figure	figure	NOUN
ajlm-2201	79	27	3	3	NUM
ajlm-2201	79	28	)	)	PUNCT
ajlm-2201	79	29	.	.	PUNCT
ajlm-2201	80	1	both	both	DET
ajlm-2201	80	2	cases	case	NOUN
ajlm-2201	80	3	had	have	VERB
ajlm-2201	80	4	mildly	mildly	ADV
ajlm-2201	80	5	increased	increase	VERB
ajlm-2201	80	6	ratios	ratio	NOUN
ajlm-2201	80	7	of	of	ADP
ajlm-2201	80	8	1.99	1.99	NUM
ajlm-2201	80	9	(	(	PUNCT
ajlm-2201	80	10	patient	patient	NOUN
ajlm-2201	80	11	1	1	NUM
ajlm-2201	80	12	,	,	PUNCT
ajlm-2201	80	13	figure	figure	NOUN
ajlm-2201	80	14	3a	3a	NUM
ajlm-2201	80	15	)	)	PUNCT
ajlm-2201	80	16	and	and	CCONJ
ajlm-2201	80	17	2.09	2.09	NUM
ajlm-2201	80	18	(	(	PUNCT
ajlm-2201	80	19	patient	patient	ADJ
ajlm-2201	80	20	2	2	NUM
ajlm-2201	80	21	,	,	PUNCT
ajlm-2201	80	22	figure	figure	NOUN
ajlm-2201	80	23	3b	3b	NUM
ajlm-2201	80	24	)	)	PUNCT
ajlm-2201	80	25	,	,	PUNCT
ajlm-2201	80	26	respectively	respectively	ADV
ajlm-2201	80	27	(	(	PUNCT
ajlm-2201	80	28	reference	reference	NOUN
ajlm-2201	80	29	interval	interval	NOUN
ajlm-2201	80	30	:	:	PUNCT
ajlm-2201	80	31	0.26–1.65	0.26–1.65	NUM
ajlm-2201	80	32	)	)	PUNCT
ajlm-2201	80	33	.	.	PUNCT
ajlm-2201	81	1	renal	renal	ADJ
ajlm-2201	81	2	impairment	impairment	NOUN
ajlm-2201	81	3	could	could	AUX
ajlm-2201	81	4	not	not	PART
ajlm-2201	81	5	account	account	VERB
ajlm-2201	81	6	for	for	ADP
ajlm-2201	81	7	the	the	DET
ajlm-2201	81	8	mildly	mildly	ADV
ajlm-2201	81	9	raised	raise	VERB
ajlm-2201	81	10	ratios	ratio	NOUN
ajlm-2201	81	11	as	as	SCONJ
ajlm-2201	81	12	both	both	DET
ajlm-2201	81	13	patients	patient	NOUN
ajlm-2201	81	14	had	have	VERB
ajlm-2201	81	15	normal	normal	ADJ
ajlm-2201	81	16	renal	renal	ADJ
ajlm-2201	81	17	function	function	NOUN
ajlm-2201	81	18	.	.	PUNCT
ajlm-2201	82	1	bone	bone	NOUN
ajlm-2201	82	2	marrow	marrow	PROPN
ajlm-2201	82	3	biopsy	biopsy	NOUN
ajlm-2201	82	4	revealed	reveal	VERB
ajlm-2201	82	5	a	a	DET
ajlm-2201	82	6	diagnosis	diagnosis	NOUN
ajlm-2201	82	7	of	of	ADP
ajlm-2201	82	8	mm	mm	PROPN
ajlm-2201	82	9	with	with	ADP
ajlm-2201	82	10	λ	λ	PROPN
ajlm-2201	82	11	restriction	restriction	NOUN
ajlm-2201	82	12	in	in	ADP
ajlm-2201	82	13	patient	patient	NOUN
ajlm-2201	82	14	2	2	NUM
ajlm-2201	82	15	,	,	PUNCT
ajlm-2201	82	16	while	while	SCONJ
ajlm-2201	82	17	bone	bone	NOUN
ajlm-2201	82	18	marrow	marrow	PROPN
ajlm-2201	82	19	findings	finding	NOUN
ajlm-2201	82	20	were	be	AUX
ajlm-2201	82	21	normal	normal	ADJ
ajlm-2201	82	22	in	in	ADP
ajlm-2201	82	23	patient	patient	ADJ
ajlm-2201	82	24	1	1	NUM
ajlm-2201	82	25	,	,	PUNCT
ajlm-2201	82	26	suggestive	suggestive	ADJ
ajlm-2201	82	27	of	of	ADP
ajlm-2201	82	28	mgus	mgus	ADJ
ajlm-2201	82	29	.	.	PUNCT
ajlm-2201	83	1	sixty	sixty	NUM
ajlm-2201	83	2	patients	patient	NOUN
ajlm-2201	83	3	had	have	VERB
ajlm-2201	83	4	an	an	DET
ajlm-2201	83	5	abnormal	abnormal	ADJ
ajlm-2201	83	6	κ	κ	NOUN
ajlm-2201	83	7	/	/	SYM
ajlm-2201	83	8	λ	λ	NOUN
ajlm-2201	83	9	ratio	ratio	NOUN
ajlm-2201	83	10	without	without	ADP
ajlm-2201	83	11	detectable	detectable	ADJ
ajlm-2201	83	12	m	m	NOUN
ajlm-2201	83	13	-	-	NOUN
ajlm-2201	83	14	protein	protein	NOUN
ajlm-2201	83	15	on	on	ADP
ajlm-2201	83	16	spe	spe	NOUN
ajlm-2201	83	17	and	and	CCONJ
ajlm-2201	83	18	their	their	PRON
ajlm-2201	83	19	diagnoses	diagnosis	NOUN
ajlm-2201	83	20	were	be	AUX
ajlm-2201	83	21	investigated	investigate	VERB
ajlm-2201	83	22	(	(	PUNCT
ajlm-2201	83	23	figure	figure	NOUN
ajlm-2201	83	24	4	4	NUM
ajlm-2201	83	25	)	)	PUNCT
ajlm-2201	83	26	.	.	PUNCT
ajlm-2201	84	1	in	in	ADP
ajlm-2201	84	2	38	38	NUM
ajlm-2201	84	3	patients	patient	NOUN
ajlm-2201	84	4	with	with	ADP
ajlm-2201	84	5	renal	renal	ADJ
ajlm-2201	84	6	impairment	impairment	NOUN
ajlm-2201	84	7	,	,	PUNCT
ajlm-2201	84	8	2	2	NUM
ajlm-2201	84	9	patients	patient	NOUN
ajlm-2201	84	10	(	(	PUNCT
ajlm-2201	84	11	5.3	5.3	NUM
ajlm-2201	84	12	%	%	NOUN
ajlm-2201	84	13	)	)	PUNCT
ajlm-2201	84	14	had	have	VERB
ajlm-2201	84	15	κ	κ	NOUN
ajlm-2201	84	16	/	/	SYM
ajlm-2201	84	17	λ	λ	NOUN
ajlm-2201	84	18	ratios	ratio	NOUN
ajlm-2201	84	19	outside	outside	ADP
ajlm-2201	84	20	of	of	ADP
ajlm-2201	84	21	the	the	DET
ajlm-2201	84	22	renal	renal	ADJ
ajlm-2201	84	23	κ	κ	NOUN
ajlm-2201	84	24	/	/	SYM
ajlm-2201	84	25	λ	λ	PROPN
ajlm-2201	84	26	ratio	ratio	NOUN
ajlm-2201	84	27	reference	reference	NOUN
ajlm-2201	84	28	interval	interval	NOUN
ajlm-2201	84	29	(	(	PUNCT
ajlm-2201	84	30	0.37‒3.1	0.37‒3.1	NOUN
ajlm-2201	84	31	)	)	PUNCT
ajlm-2201	84	32	.	.	PUNCT
ajlm-2201	85	1	one	one	NUM
ajlm-2201	85	2	patient	patient	NOUN
ajlm-2201	85	3	had	have	VERB
ajlm-2201	85	4	a	a	DET
ajlm-2201	85	5	κ	κ	NOUN
ajlm-2201	85	6	/	/	SYM
ajlm-2201	85	7	λ	λ	NOUN
ajlm-2201	85	8	ratio	ratio	NOUN
ajlm-2201	85	9	of	of	ADP
ajlm-2201	85	10	0.13	0.13	NUM
ajlm-2201	85	11	and	and	CCONJ
ajlm-2201	85	12	was	be	AUX
ajlm-2201	85	13	diagnosed	diagnose	VERB
ajlm-2201	85	14	with	with	ADP
ajlm-2201	85	15	a	a	DET
ajlm-2201	85	16	mg	mg	PROPN
ajlm-2201	85	17	,	,	PUNCT
ajlm-2201	85	18	while	while	SCONJ
ajlm-2201	85	19	the	the	DET
ajlm-2201	85	20	other	other	ADJ
ajlm-2201	85	21	had	have	VERB
ajlm-2201	85	22	a	a	DET
ajlm-2201	85	23	κ	κ	NOUN
ajlm-2201	85	24	/	/	SYM
ajlm-2201	85	25	λ	λ	NOUN
ajlm-2201	85	26	ratio	ratio	NOUN
ajlm-2201	85	27	of	of	ADP
ajlm-2201	85	28	4.3	4.3	NUM
ajlm-2201	85	29	but	but	CCONJ
ajlm-2201	85	30	the	the	DET
ajlm-2201	85	31	diagnosis	diagnosis	NOUN
ajlm-2201	85	32	could	could	AUX
ajlm-2201	85	33	not	not	PART
ajlm-2201	85	34	be	be	AUX
ajlm-2201	85	35	determined	determine	VERB
ajlm-2201	85	36	as	as	SCONJ
ajlm-2201	85	37	bone	bone	NOUN
ajlm-2201	85	38	marrow	marrow	NOUN
ajlm-2201	85	39	biopsy	biopsy	NOUN
ajlm-2201	85	40	had	have	AUX
ajlm-2201	85	41	not	not	PART
ajlm-2201	85	42	been	be	AUX
ajlm-2201	85	43	performed	perform	VERB
ajlm-2201	85	44	.	.	PUNCT
ajlm-2201	86	1	four	four	NUM
ajlm-2201	86	2	patients	patient	NOUN
ajlm-2201	86	3	out	out	ADP
ajlm-2201	86	4	of	of	ADP
ajlm-2201	86	5	60	60	NUM
ajlm-2201	86	6	had	have	AUX
ajlm-2201	86	7	been	be	AUX
ajlm-2201	86	8	diagnosed	diagnose	VERB
ajlm-2201	86	9	with	with	ADP
ajlm-2201	86	10	a	a	DET
ajlm-2201	86	11	mg	mg	PROPN
ajlm-2201	86	12	(	(	PUNCT
ajlm-2201	86	13	6.7	6.7	NUM
ajlm-2201	86	14	%	%	NOUN
ajlm-2201	86	15	)	)	PUNCT
ajlm-2201	86	16	based	base	VERB
ajlm-2201	86	17	on	on	ADP
ajlm-2201	86	18	bone	bone	NOUN
ajlm-2201	86	19	marrow	marrow	NOUN
ajlm-2201	86	20	or	or	CCONJ
ajlm-2201	86	21	tissue	tissue	NOUN
ajlm-2201	86	22	biopsy	biopsy	NOUN
ajlm-2201	86	23	findings	finding	NOUN
ajlm-2201	86	24	(	(	PUNCT
ajlm-2201	86	25	table	table	NOUN
ajlm-2201	86	26	3	3	NUM
ajlm-2201	86	27	)	)	PUNCT
ajlm-2201	86	28	.	.	PUNCT
ajlm-2201	87	1	of	of	ADP
ajlm-2201	87	2	the	the	DET
ajlm-2201	87	3	19	19	NUM
ajlm-2201	87	4	patients	patient	NOUN
ajlm-2201	87	5	with	with	ADP
ajlm-2201	87	6	a	a	DET
ajlm-2201	87	7	presumed	presume	VERB
ajlm-2201	87	8	inflammatory	inflammatory	ADJ
ajlm-2201	87	9	response	response	NOUN
ajlm-2201	87	10	,	,	PUNCT
ajlm-2201	87	11	17	17	NUM
ajlm-2201	87	12	had	have	VERB
ajlm-2201	87	13	polyclonal	polyclonal	ADJ
ajlm-2201	87	14	hypergammaglobulinaemia	hypergammaglobulinaemia	NOUN
ajlm-2201	87	15	on	on	ADP
ajlm-2201	87	16	spe	spe	PROPN
ajlm-2201	87	17	(	(	PUNCT
ajlm-2201	87	18	89.5	89.5	NUM
ajlm-2201	87	19	%	%	NOUN
ajlm-2201	87	20	)	)	PUNCT
ajlm-2201	87	21	.	.	PUNCT
ajlm-2201	88	1	most	most	ADJ
ajlm-2201	88	2	of	of	ADP
ajlm-2201	88	3	these	these	PRON
ajlm-2201	88	4	were	be	AUX
ajlm-2201	88	5	from	from	ADP
ajlm-2201	88	6	specialities	speciality	NOUN
ajlm-2201	88	7	within	within	ADP
ajlm-2201	88	8	internal	internal	ADJ
ajlm-2201	88	9	medicine	medicine	NOUN
ajlm-2201	88	10	,	,	PUNCT
ajlm-2201	88	11	namely	namely	ADV
ajlm-2201	88	12	pulmonology	pulmonology	NOUN
ajlm-2201	88	13	(	(	PUNCT
ajlm-2201	88	14	n	n	NOUN
ajlm-2201	88	15	=	=	SYM
ajlm-2201	88	16	4	4	NUM
ajlm-2201	88	17	)	)	PUNCT
ajlm-2201	88	18	,	,	PUNCT
ajlm-2201	88	19	neurology	neurology	NOUN
ajlm-2201	88	20	(	(	PUNCT
ajlm-2201	88	21	n	n	NOUN
ajlm-2201	88	22	=	=	SYM
ajlm-2201	88	23	4	4	NUM
ajlm-2201	88	24	)	)	PUNCT
ajlm-2201	88	25	,	,	PUNCT
ajlm-2201	88	26	rheumatology	rheumatology	NOUN
ajlm-2201	88	27	(	(	PUNCT
ajlm-2201	88	28	n	n	NOUN
ajlm-2201	88	29	=	=	SYM
ajlm-2201	88	30	2	2	NUM
ajlm-2201	88	31	)	)	PUNCT
ajlm-2201	88	32	and	and	CCONJ
ajlm-2201	88	33	gastroenterology	gastroenterology	NOUN
ajlm-2201	88	34	(	(	PUNCT
ajlm-2201	88	35	n	n	NOUN
ajlm-2201	88	36	=	=	SYM
ajlm-2201	88	37	2	2	NUM
ajlm-2201	88	38	)	)	PUNCT
ajlm-2201	88	39	.	.	PUNCT
ajlm-2201	89	1	figure	figure	VERB
ajlm-2201	89	2	3	3	NUM
ajlm-2201	89	3	:	:	PUNCT
ajlm-2201	89	4	serum	serum	NOUN
ajlm-2201	89	5	immunofixation	immunofixation	NOUN
ajlm-2201	89	6	gels	gel	NOUN
ajlm-2201	89	7	in	in	ADP
ajlm-2201	89	8	two	two	NUM
ajlm-2201	89	9	patients	patient	NOUN
ajlm-2201	89	10	with	with	ADP
ajlm-2201	89	11	raised	raise	VERB
ajlm-2201	89	12	κ	κ	NOUN
ajlm-2201	89	13	/	/	SYM
ajlm-2201	89	14	λ	λ	NOUN
ajlm-2201	89	15	ratios	ratio	NOUN
ajlm-2201	89	16	and	and	CCONJ
ajlm-2201	89	17	λ	λ	VERB
ajlm-2201	89	18	monoclonal	monoclonal	NOUN
ajlm-2201	89	19	proteins	protein	NOUN
ajlm-2201	89	20	at	at	ADP
ajlm-2201	89	21	tygerberg	tygerberg	PROPN
ajlm-2201	89	22	hospital	hospital	PROPN
ajlm-2201	89	23	,	,	PUNCT
ajlm-2201	89	24	south	south	PROPN
ajlm-2201	89	25	africa	africa	PROPN
ajlm-2201	89	26	,	,	PUNCT
ajlm-2201	89	27	between	between	ADP
ajlm-2201	89	28	may	may	PROPN
ajlm-2201	89	29	2018	2018	NUM
ajlm-2201	89	30	and	and	CCONJ
ajlm-2201	89	31	april	april	PROPN
ajlm-2201	89	32	2020	2020	NUM
ajlm-2201	89	33	.	.	PUNCT
ajlm-2201	90	1	a	a	DET
ajlm-2201	90	2	,	,	PUNCT
ajlm-2201	90	3	patient	patient	ADJ
ajlm-2201	90	4	1	1	NUM
ajlm-2201	90	5	.	.	PUNCT
ajlm-2201	91	1	b	b	X
ajlm-2201	91	2	,	,	PUNCT
ajlm-2201	91	3	patient	patient	ADJ
ajlm-2201	91	4	2	2	NUM
ajlm-2201	91	5	.	.	PUNCT
ajlm-2201	92	1	the	the	DET
ajlm-2201	92	2	black	black	ADJ
ajlm-2201	92	3	arrows	arrow	NOUN
ajlm-2201	92	4	indicate	indicate	VERB
ajlm-2201	92	5	positions	position	NOUN
ajlm-2201	92	6	of	of	ADP
ajlm-2201	92	7	the	the	DET
ajlm-2201	92	8	monoclonal	monoclonal	NOUN
ajlm-2201	92	9	proteins	protein	NOUN
ajlm-2201	92	10	in	in	ADP
ajlm-2201	92	11	each	each	DET
ajlm-2201	92	12	immunofixation	immunofixation	NOUN
ajlm-2201	92	13	gel	gel	NOUN
ajlm-2201	92	14	.	.	PUNCT
ajlm-2201	93	1	figure	figure	NOUN
ajlm-2201	93	2	4	4	NUM
ajlm-2201	93	3	:	:	PUNCT
ajlm-2201	93	4	classification	classification	NOUN
ajlm-2201	93	5	of	of	ADP
ajlm-2201	93	6	patients	patient	NOUN
ajlm-2201	93	7	with	with	ADP
ajlm-2201	93	8	abnormal	abnormal	ADJ
ajlm-2201	93	9	ratio	ratio	NOUN
ajlm-2201	93	10	and	and	CCONJ
ajlm-2201	93	11	absent	absent	ADJ
ajlm-2201	93	12	m	m	NOUN
ajlm-2201	93	13	-	-	NOUN
ajlm-2201	93	14	protein	protein	NOUN
ajlm-2201	93	15	on	on	ADP
ajlm-2201	93	16	serum	serum	NOUN
ajlm-2201	93	17	protein	protein	NOUN
ajlm-2201	93	18	electrophoresis	electrophoresis	NOUN
ajlm-2201	93	19	at	at	ADP
ajlm-2201	93	20	tygerberg	tygerberg	PROPN
ajlm-2201	93	21	hospital	hospital	NOUN
ajlm-2201	93	22	,	,	PUNCT
ajlm-2201	93	23	south	south	PROPN
ajlm-2201	93	24	africa	africa	PROPN
ajlm-2201	93	25	,	,	PUNCT
ajlm-2201	93	26	from	from	ADP
ajlm-2201	93	27	may	may	PROPN
ajlm-2201	93	28	2018	2018	NUM
ajlm-2201	93	29	to	to	ADP
ajlm-2201	93	30	april	april	PROPN
ajlm-2201	93	31	2020	2020	NUM
ajlm-2201	93	32	.	.	PUNCT
ajlm-2201	94	1	table	table	NOUN
ajlm-2201	94	2	3	3	NUM
ajlm-2201	94	3	:	:	PUNCT
ajlm-2201	94	4	 	 	SPACE
ajlm-2201	94	5	findings	finding	NOUN
ajlm-2201	94	6	in	in	ADP
ajlm-2201	94	7	four	four	NUM
ajlm-2201	94	8	patients	patient	NOUN
ajlm-2201	94	9	diagnosed	diagnose	VERB
ajlm-2201	94	10	with	with	ADP
ajlm-2201	94	11	monoclonal	monoclonal	NOUN
ajlm-2201	94	12	gammopathies	gammopathy	NOUN
ajlm-2201	94	13	,	,	PUNCT
ajlm-2201	94	14	without	without	ADP
ajlm-2201	94	15	detectable	detectable	ADJ
ajlm-2201	94	16	m	m	NOUN
ajlm-2201	94	17	-	-	NOUN
ajlm-2201	94	18	protein	protein	NOUN
ajlm-2201	94	19	on	on	ADP
ajlm-2201	94	20	immunofixation	immunofixation	NOUN
ajlm-2201	94	21	electrophoresis	electrophoresis	NOUN
ajlm-2201	94	22	at	at	ADP
ajlm-2201	94	23	tygerberg	tygerberg	PROPN
ajlm-2201	94	24	hospital	hospital	NOUN
ajlm-2201	94	25	,	,	PUNCT
ajlm-2201	94	26	south	south	PROPN
ajlm-2201	94	27	africa	africa	PROPN
ajlm-2201	94	28	,	,	PUNCT
ajlm-2201	94	29	from	from	ADP
ajlm-2201	94	30	may	may	PROPN
ajlm-2201	94	31	2018	2018	NUM
ajlm-2201	94	32	to	to	ADP
ajlm-2201	94	33	april	april	PROPN
ajlm-2201	94	34	2020	2020	NUM
ajlm-2201	94	35	.	.	PUNCT
ajlm-2201	95	1	discussion	discussion	NOUN
ajlm-2201	95	2	the	the	DET
ajlm-2201	95	3	study	study	NOUN
ajlm-2201	95	4	is	be	AUX
ajlm-2201	95	5	one	one	NUM
ajlm-2201	95	6	of	of	ADP
ajlm-2201	95	7	the	the	DET
ajlm-2201	95	8	first	first	ADJ
ajlm-2201	95	9	african	african	ADJ
ajlm-2201	95	10	studies	study	NOUN
ajlm-2201	95	11	investigating	investigate	VERB
ajlm-2201	95	12	sflc	sflc	ADP
ajlm-2201	95	13	test	test	NOUN
ajlm-2201	95	14	utilisation	utilisation	NOUN
ajlm-2201	95	15	and	and	CCONJ
ajlm-2201	95	16	correlating	correlate	VERB
ajlm-2201	95	17	abnormal	abnormal	ADJ
ajlm-2201	95	18	sflc	sflc	ADP
ajlm-2201	95	19	ratios	ratio	NOUN
ajlm-2201	95	20	with	with	ADP
ajlm-2201	95	21	spe	spe	PROPN
ajlm-2201	95	22	findings	finding	NOUN
ajlm-2201	95	23	.	.	PUNCT
ajlm-2201	96	1	we	we	PRON
ajlm-2201	96	2	found	find	VERB
ajlm-2201	96	3	that	that	SCONJ
ajlm-2201	96	4	most	most	ADJ
ajlm-2201	96	5	patients	patient	NOUN
ajlm-2201	96	6	who	who	PRON
ajlm-2201	96	7	underwent	undergo	VERB
ajlm-2201	96	8	mg	mg	NOUN
ajlm-2201	96	9	screening	screen	VERB
ajlm-2201	96	10	were	be	AUX
ajlm-2201	96	11	over	over	ADP
ajlm-2201	96	12	50	50	NUM
ajlm-2201	96	13	and	and	CCONJ
ajlm-2201	96	14	were	be	AUX
ajlm-2201	96	15	primarily	primarily	ADV
ajlm-2201	96	16	female	female	ADJ
ajlm-2201	96	17	.	.	PUNCT
ajlm-2201	97	1	most	most	ADJ
ajlm-2201	97	2	sflc	sflc	ADJ
ajlm-2201	97	3	requests	request	NOUN
ajlm-2201	97	4	came	come	VERB
ajlm-2201	97	5	from	from	ADP
ajlm-2201	97	6	tertiary	tertiary	ADJ
ajlm-2201	97	7	healthcare	healthcare	NOUN
ajlm-2201	97	8	institutions	institution	NOUN
ajlm-2201	97	9	.	.	PUNCT
ajlm-2201	98	1	the	the	DET
ajlm-2201	98	2	most	most	ADV
ajlm-2201	98	3	frequently	frequently	ADV
ajlm-2201	98	4	observed	observe	VERB
ajlm-2201	98	5	sflc	sflc	NOUN
ajlm-2201	98	6	pattern	pattern	NOUN
ajlm-2201	98	7	was	be	AUX
ajlm-2201	98	8	that	that	PRON
ajlm-2201	98	9	of	of	ADP
ajlm-2201	98	10	a	a	DET
ajlm-2201	98	11	raised	raise	VERB
ajlm-2201	98	12	κ	κ	NOUN
ajlm-2201	98	13	/	/	SYM
ajlm-2201	98	14	λ	λ	NOUN
ajlm-2201	98	15	ratio	ratio	NOUN
ajlm-2201	98	16	.	.	PUNCT
ajlm-2201	99	1	few	few	ADJ
ajlm-2201	99	2	patients	patient	NOUN
ajlm-2201	99	3	were	be	AUX
ajlm-2201	99	4	excluded	exclude	VERB
ajlm-2201	99	5	for	for	ADP
ajlm-2201	99	6	lack	lack	NOUN
ajlm-2201	99	7	of	of	ADP
ajlm-2201	99	8	a	a	DET
ajlm-2201	99	9	recent	recent	ADJ
ajlm-2201	99	10	spe	spe	NOUN
ajlm-2201	99	11	,	,	PUNCT
ajlm-2201	99	12	suggesting	suggest	VERB
ajlm-2201	99	13	that	that	SCONJ
ajlm-2201	99	14	most	most	ADJ
ajlm-2201	99	15	patients	patient	NOUN
ajlm-2201	99	16	were	be	AUX
ajlm-2201	99	17	screened	screen	VERB
ajlm-2201	99	18	with	with	ADP
ajlm-2201	99	19	both	both	CCONJ
ajlm-2201	99	20	spe	spe	NOUN
ajlm-2201	99	21	and	and	CCONJ
ajlm-2201	99	22	sflc	sflc	VERB
ajlm-2201	99	23	,	,	PUNCT
ajlm-2201	99	24	with	with	ADP
ajlm-2201	99	25	good	good	ADJ
ajlm-2201	99	26	adherence	adherence	NOUN
ajlm-2201	99	27	to	to	ADP
ajlm-2201	99	28	clinical	clinical	ADJ
ajlm-2201	99	29	guidelines	guideline	NOUN
ajlm-2201	99	30	.	.	PUNCT
ajlm-2201	100	1	in	in	ADP
ajlm-2201	100	2	the	the	DET
ajlm-2201	100	3	sub	sub	NOUN
ajlm-2201	100	4	-	-	NOUN
ajlm-2201	100	5	group	group	NOUN
ajlm-2201	100	6	analysis	analysis	NOUN
ajlm-2201	100	7	of	of	ADP
ajlm-2201	100	8	patients	patient	NOUN
ajlm-2201	100	9	with	with	ADP
ajlm-2201	100	10	abnormal	abnormal	ADJ
ajlm-2201	100	11	κ	κ	NOUN
ajlm-2201	100	12	/	/	SYM
ajlm-2201	100	13	λ	λ	NOUN
ajlm-2201	100	14	ratio	ratio	NOUN
ajlm-2201	100	15	,	,	PUNCT
ajlm-2201	100	16	over	over	ADP
ajlm-2201	100	17	half	half	NOUN
ajlm-2201	100	18	did	do	AUX
ajlm-2201	100	19	not	not	PART
ajlm-2201	100	20	have	have	VERB
ajlm-2201	100	21	a	a	DET
ajlm-2201	100	22	detectable	detectable	ADJ
ajlm-2201	100	23	m	m	NOUN
ajlm-2201	100	24	-	-	NOUN
ajlm-2201	100	25	protein	protein	NOUN
ajlm-2201	100	26	on	on	ADP
ajlm-2201	100	27	spe	spe	PROPN
ajlm-2201	100	28	.	.	PUNCT
ajlm-2201	101	1	a	a	DET
ajlm-2201	101	2	minority	minority	NOUN
ajlm-2201	101	3	of	of	ADP
ajlm-2201	101	4	patients	patient	NOUN
ajlm-2201	101	5	in	in	ADP
ajlm-2201	101	6	the	the	DET
ajlm-2201	101	7	sub	sub	NOUN
ajlm-2201	101	8	-	-	NOUN
ajlm-2201	101	9	group	group	NOUN
ajlm-2201	101	10	diagnosed	diagnose	VERB
ajlm-2201	101	11	with	with	ADP
ajlm-2201	101	12	mg	mg	PROPN
ajlm-2201	101	13	were	be	AUX
ajlm-2201	101	14	hiv	hiv	NOUN
ajlm-2201	101	15	-	-	PUNCT
ajlm-2201	101	16	positive	positive	ADJ
ajlm-2201	101	17	.	.	PUNCT
ajlm-2201	102	1	as	as	SCONJ
ajlm-2201	102	2	mgs	mgs	NOUN
ajlm-2201	102	3	are	be	AUX
ajlm-2201	102	4	more	more	ADV
ajlm-2201	102	5	frequently	frequently	ADV
ajlm-2201	102	6	suspected	suspect	VERB
ajlm-2201	102	7	and	and	CCONJ
ajlm-2201	102	8	diagnosed	diagnose	VERB
ajlm-2201	102	9	in	in	ADP
ajlm-2201	102	10	older	old	ADJ
ajlm-2201	102	11	populations	population	NOUN
ajlm-2201	102	12	,	,	PUNCT
ajlm-2201	102	13	our	our	PRON
ajlm-2201	102	14	finding	finding	NOUN
ajlm-2201	102	15	of	of	ADP
ajlm-2201	102	16	more	more	ADV
ajlm-2201	102	17	frequent	frequent	ADJ
ajlm-2201	102	18	screening	screening	NOUN
ajlm-2201	102	19	in	in	ADP
ajlm-2201	102	20	older	old	ADJ
ajlm-2201	102	21	populations	population	NOUN
ajlm-2201	102	22	is	be	AUX
ajlm-2201	102	23	expected.14	expected.14	NOUN
ajlm-2201	102	24	the	the	DET
ajlm-2201	102	25	gender	gender	NOUN
ajlm-2201	102	26	distribution	distribution	NOUN
ajlm-2201	102	27	in	in	ADP
ajlm-2201	102	28	our	our	PRON
ajlm-2201	102	29	study	study	NOUN
ajlm-2201	102	30	was	be	AUX
ajlm-2201	102	31	unexpected	unexpected	ADJ
ajlm-2201	102	32	as	as	SCONJ
ajlm-2201	102	33	higher	high	ADJ
ajlm-2201	102	34	incidences	incidence	NOUN
ajlm-2201	102	35	of	of	ADP
ajlm-2201	102	36	mg	mg	PROPN
ajlm-2201	102	37	have	have	AUX
ajlm-2201	102	38	been	be	AUX
ajlm-2201	102	39	reported	report	VERB
ajlm-2201	102	40	internationally	internationally	ADV
ajlm-2201	102	41	among	among	ADP
ajlm-2201	102	42	male	male	ADJ
ajlm-2201	102	43	patients.15	patients.15	PROPN
ajlm-2201	102	44	a	a	DET
ajlm-2201	102	45	previous	previous	ADJ
ajlm-2201	102	46	study	study	NOUN
ajlm-2201	102	47	performed	perform	VERB
ajlm-2201	102	48	at	at	ADP
ajlm-2201	102	49	a	a	DET
ajlm-2201	102	50	tertiary	tertiary	ADJ
ajlm-2201	102	51	hospital	hospital	NOUN
ajlm-2201	102	52	in	in	ADP
ajlm-2201	102	53	the	the	DET
ajlm-2201	102	54	western	western	ADJ
ajlm-2201	102	55	cape	cape	NOUN
ajlm-2201	102	56	included	include	VERB
ajlm-2201	102	57	100	100	NUM
ajlm-2201	102	58	myeloma	myeloma	NOUN
ajlm-2201	102	59	patients	patient	NOUN
ajlm-2201	102	60	diagnosed	diagnose	VERB
ajlm-2201	102	61	between	between	ADP
ajlm-2201	102	62	2008	2008	NUM
ajlm-2201	102	63	and	and	CCONJ
ajlm-2201	102	64	2015	2015	NUM
ajlm-2201	102	65	.	.	PUNCT
ajlm-2201	103	1	the	the	DET
ajlm-2201	103	2	authors	author	NOUN
ajlm-2201	103	3	found	find	VERB
ajlm-2201	103	4	a	a	DET
ajlm-2201	103	5	female	female	ADJ
ajlm-2201	103	6	predominance	predominance	NOUN
ajlm-2201	103	7	,	,	PUNCT
ajlm-2201	103	8	with	with	ADP
ajlm-2201	103	9	a	a	DET
ajlm-2201	103	10	female	female	NOUN
ajlm-2201	103	11	-	-	PUNCT
ajlm-2201	103	12	to	to	ADP
ajlm-2201	103	13	-	-	PUNCT
ajlm-2201	103	14	male	male	NOUN
ajlm-2201	103	15	ratio	ratio	NOUN
ajlm-2201	103	16	of	of	ADP
ajlm-2201	103	17	1.78:1	1.78:1	NUM
ajlm-2201	103	18	(	(	PUNCT
ajlm-2201	103	19	unpublished	unpublished	ADJ
ajlm-2201	103	20	data	datum	NOUN
ajlm-2201	103	21	)	)	PUNCT
ajlm-2201	103	22	.	.	PUNCT
ajlm-2201	104	1	an	an	DET
ajlm-2201	104	2	older	old	ADJ
ajlm-2201	104	3	study	study	NOUN
ajlm-2201	104	4	performed	perform	VERB
ajlm-2201	104	5	at	at	ADP
ajlm-2201	104	6	a	a	DET
ajlm-2201	104	7	tertiary	tertiary	ADJ
ajlm-2201	104	8	hospital	hospital	NOUN
ajlm-2201	104	9	in	in	ADP
ajlm-2201	104	10	gauteng	gauteng	PROPN
ajlm-2201	104	11	(	(	PUNCT
ajlm-2201	104	12	2004–2009	2004–2009	NUM
ajlm-2201	104	13	)	)	PUNCT
ajlm-2201	104	14	,	,	PUNCT
ajlm-2201	104	15	which	which	PRON
ajlm-2201	104	16	included	include	VERB
ajlm-2201	104	17	34	34	NUM
ajlm-2201	104	18	myeloma	myeloma	NOUN
ajlm-2201	104	19	patients	patient	NOUN
ajlm-2201	104	20	,	,	PUNCT
ajlm-2201	104	21	also	also	ADV
ajlm-2201	104	22	found	find	VERB
ajlm-2201	104	23	a	a	DET
ajlm-2201	104	24	female	female	ADJ
ajlm-2201	104	25	predominance	predominance	NOUN
ajlm-2201	104	26	(	(	PUNCT
ajlm-2201	104	27	2.4:1).16	2.4:1).16	NUM
ajlm-2201	104	28	a	a	DET
ajlm-2201	104	29	possible	possible	ADJ
ajlm-2201	104	30	reason	reason	NOUN
ajlm-2201	104	31	for	for	ADP
ajlm-2201	104	32	this	this	DET
ajlm-2201	104	33	discrepancy	discrepancy	NOUN
ajlm-2201	104	34	could	could	AUX
ajlm-2201	104	35	be	be	AUX
ajlm-2201	104	36	a	a	DET
ajlm-2201	104	37	difference	difference	NOUN
ajlm-2201	104	38	in	in	ADP
ajlm-2201	104	39	healthcare	healthcare	NOUN
ajlm-2201	104	40	-	-	PUNCT
ajlm-2201	104	41	seeking	seek	VERB
ajlm-2201	104	42	behaviour	behaviour	NOUN
ajlm-2201	104	43	among	among	ADP
ajlm-2201	104	44	genders	gender	NOUN
ajlm-2201	104	45	in	in	ADP
ajlm-2201	104	46	our	our	PRON
ajlm-2201	104	47	population	population	NOUN
ajlm-2201	104	48	.	.	PUNCT
ajlm-2201	105	1	national	national	PROPN
ajlm-2201	105	2	census	census	PROPN
ajlm-2201	105	3	data	datum	NOUN
ajlm-2201	105	4	from	from	ADP
ajlm-2201	105	5	2011	2011	NUM
ajlm-2201	105	6	obtained	obtain	VERB
ajlm-2201	105	7	by	by	ADP
ajlm-2201	105	8	statistics	statistic	NOUN
ajlm-2201	105	9	south	south	PROPN
ajlm-2201	105	10	africa	africa	PROPN
ajlm-2201	105	11	reported	report	VERB
ajlm-2201	105	12	that	that	SCONJ
ajlm-2201	105	13	24.4	24.4	NUM
ajlm-2201	105	14	%	%	NOUN
ajlm-2201	105	15	of	of	ADP
ajlm-2201	105	16	men	man	NOUN
ajlm-2201	105	17	(	(	PUNCT
ajlm-2201	105	18	compared	compare	VERB
ajlm-2201	105	19	to	to	ADP
ajlm-2201	105	20	21.1	21.1	NUM
ajlm-2201	105	21	%	%	NOUN
ajlm-2201	105	22	of	of	ADP
ajlm-2201	105	23	women	woman	NOUN
ajlm-2201	105	24	)	)	PUNCT
ajlm-2201	105	25	did	do	AUX
ajlm-2201	105	26	not	not	PART
ajlm-2201	105	27	consult	consult	VERB
ajlm-2201	105	28	a	a	DET
ajlm-2201	105	29	health	health	NOUN
ajlm-2201	105	30	worker	worker	NOUN
ajlm-2201	105	31	during	during	ADP
ajlm-2201	105	32	recent	recent	ADJ
ajlm-2201	105	33	episodes	episode	NOUN
ajlm-2201	105	34	of	of	ADP
ajlm-2201	105	35	illness	illness	NOUN
ajlm-2201	105	36	or	or	CCONJ
ajlm-2201	105	37	injury.17	injury.17	NOUN
ajlm-2201	105	38	this	this	DET
ajlm-2201	105	39	poor	poor	ADJ
ajlm-2201	105	40	healthcare	healthcare	NOUN
ajlm-2201	105	41	-	-	PUNCT
ajlm-2201	105	42	seeking	seek	VERB
ajlm-2201	105	43	behaviour	behaviour	NOUN
ajlm-2201	105	44	among	among	ADP
ajlm-2201	105	45	men	man	NOUN
ajlm-2201	105	46	could	could	AUX
ajlm-2201	105	47	also	also	ADV
ajlm-2201	105	48	explain	explain	VERB
ajlm-2201	105	49	why	why	SCONJ
ajlm-2201	105	50	more	more	ADJ
ajlm-2201	105	51	female	female	ADJ
ajlm-2201	105	52	patients	patient	NOUN
ajlm-2201	105	53	than	than	SCONJ
ajlm-2201	105	54	male	male	ADJ
ajlm-2201	105	55	patients	patient	NOUN
ajlm-2201	105	56	were	be	AUX
ajlm-2201	105	57	diagnosed	diagnose	VERB
ajlm-2201	105	58	with	with	ADP
ajlm-2201	105	59	mg	mg	PROPN
ajlm-2201	105	60	in	in	ADP
ajlm-2201	105	61	our	our	PRON
ajlm-2201	105	62	study	study	NOUN
ajlm-2201	105	63	cohort	cohort	NOUN
ajlm-2201	105	64	.	.	PUNCT
ajlm-2201	106	1	the	the	DET
ajlm-2201	106	2	low	low	ADJ
ajlm-2201	106	3	number	number	NOUN
ajlm-2201	106	4	of	of	ADP
ajlm-2201	106	5	sflc	sflc	VERB
ajlm-2201	106	6	requests	request	NOUN
ajlm-2201	106	7	from	from	ADP
ajlm-2201	106	8	primary	primary	ADJ
ajlm-2201	106	9	and	and	CCONJ
ajlm-2201	106	10	secondary	secondary	ADJ
ajlm-2201	106	11	healthcare	healthcare	NOUN
ajlm-2201	106	12	institutions	institution	NOUN
ajlm-2201	106	13	is	be	AUX
ajlm-2201	106	14	concerning	concern	VERB
ajlm-2201	106	15	as	as	ADV
ajlm-2201	106	16	many	many	ADJ
ajlm-2201	106	17	patients	patient	NOUN
ajlm-2201	106	18	could	could	AUX
ajlm-2201	106	19	present	present	VERB
ajlm-2201	106	20	to	to	ADP
ajlm-2201	106	21	their	their	PRON
ajlm-2201	106	22	local	local	ADJ
ajlm-2201	106	23	clinics	clinic	NOUN
ajlm-2201	106	24	for	for	ADP
ajlm-2201	106	25	non	non	ADJ
ajlm-2201	106	26	-	-	ADJ
ajlm-2201	106	27	specific	specific	ADJ
ajlm-2201	106	28	symptoms	symptom	NOUN
ajlm-2201	106	29	of	of	ADP
ajlm-2201	106	30	mm	mm	PROPN
ajlm-2201	106	31	,	,	PUNCT
ajlm-2201	106	32	such	such	ADJ
ajlm-2201	106	33	as	as	ADP
ajlm-2201	106	34	fatigue	fatigue	NOUN
ajlm-2201	106	35	or	or	CCONJ
ajlm-2201	106	36	back	back	NOUN
ajlm-2201	106	37	pain.14	pain.14	PROPN
ajlm-2201	106	38	a	a	DET
ajlm-2201	106	39	lack	lack	NOUN
ajlm-2201	106	40	of	of	ADP
ajlm-2201	106	41	awareness	awareness	NOUN
ajlm-2201	106	42	about	about	ADP
ajlm-2201	106	43	mg	mg	PROPN
ajlm-2201	106	44	among	among	ADP
ajlm-2201	106	45	health	health	NOUN
ajlm-2201	106	46	workers	worker	NOUN
ajlm-2201	106	47	at	at	ADP
ajlm-2201	106	48	the	the	DET
ajlm-2201	106	49	primary	primary	ADJ
ajlm-2201	106	50	care	care	NOUN
ajlm-2201	106	51	-	-	PUNCT
ajlm-2201	106	52	level	level	NOUN
ajlm-2201	106	53	facilities	facility	NOUN
ajlm-2201	106	54	may	may	AUX
ajlm-2201	106	55	explain	explain	VERB
ajlm-2201	106	56	the	the	DET
ajlm-2201	106	57	low	low	ADJ
ajlm-2201	106	58	screening	screening	NOUN
ajlm-2201	106	59	rate	rate	NOUN
ajlm-2201	106	60	.	.	PUNCT
ajlm-2201	107	1	alternatively	alternatively	ADV
ajlm-2201	107	2	,	,	PUNCT
ajlm-2201	107	3	these	these	DET
ajlm-2201	107	4	facilities	facility	NOUN
ajlm-2201	107	5	may	may	AUX
ajlm-2201	107	6	not	not	PART
ajlm-2201	107	7	have	have	VERB
ajlm-2201	107	8	the	the	DET
ajlm-2201	107	9	budget	budget	NOUN
ajlm-2201	107	10	to	to	PART
ajlm-2201	107	11	request	request	VERB
ajlm-2201	107	12	the	the	DET
ajlm-2201	107	13	relatively	relatively	ADV
ajlm-2201	107	14	expensive	expensive	ADJ
ajlm-2201	107	15	tests	test	NOUN
ajlm-2201	107	16	required	require	VERB
ajlm-2201	107	17	for	for	ADP
ajlm-2201	107	18	screening	screen	VERB
ajlm-2201	107	19	,	,	PUNCT
ajlm-2201	107	20	necessitating	necessitate	VERB
ajlm-2201	107	21	patient	patient	ADJ
ajlm-2201	107	22	referral	referral	NOUN
ajlm-2201	107	23	for	for	ADP
ajlm-2201	107	24	further	further	ADJ
ajlm-2201	107	25	investigation	investigation	NOUN
ajlm-2201	107	26	.	.	PUNCT
ajlm-2201	108	1	the	the	DET
ajlm-2201	108	2	relatively	relatively	ADV
ajlm-2201	108	3	few	few	ADJ
ajlm-2201	108	4	requests	request	NOUN
ajlm-2201	108	5	received	receive	VERB
ajlm-2201	108	6	from	from	ADP
ajlm-2201	108	7	primary	primary	ADJ
ajlm-2201	108	8	and	and	CCONJ
ajlm-2201	108	9	secondary	secondary	ADJ
ajlm-2201	108	10	healthcare	healthcare	NOUN
ajlm-2201	108	11	institutions	institution	NOUN
ajlm-2201	108	12	may	may	AUX
ajlm-2201	108	13	also	also	ADV
ajlm-2201	108	14	explain	explain	VERB
ajlm-2201	108	15	why	why	SCONJ
ajlm-2201	108	16	patients	patient	NOUN
ajlm-2201	108	17	in	in	ADP
ajlm-2201	108	18	our	our	PRON
ajlm-2201	108	19	setting	setting	NOUN
ajlm-2201	108	20	often	often	ADV
ajlm-2201	108	21	present	present	ADJ
ajlm-2201	108	22	late	late	ADV
ajlm-2201	108	23	and	and	CCONJ
ajlm-2201	108	24	with	with	ADP
ajlm-2201	108	25	overt	overt	ADJ
ajlm-2201	108	26	signs	sign	NOUN
ajlm-2201	108	27	of	of	ADP
ajlm-2201	108	28	end	end	NOUN
ajlm-2201	108	29	-	-	PUNCT
ajlm-2201	108	30	organ	organ	NOUN
ajlm-2201	108	31	damage	damage	NOUN
ajlm-2201	108	32	.	.	PUNCT
ajlm-2201	109	1	many	many	ADJ
ajlm-2201	109	2	patients	patient	NOUN
ajlm-2201	109	3	newly	newly	ADV
ajlm-2201	109	4	diagnosed	diagnose	VERB
ajlm-2201	109	5	with	with	ADP
ajlm-2201	109	6	mg	mg	PROPN
ajlm-2201	109	7	were	be	AUX
ajlm-2201	109	8	not	not	PART
ajlm-2201	109	9	thoroughly	thoroughly	ADV
ajlm-2201	109	10	investigated	investigate	VERB
ajlm-2201	109	11	as	as	SCONJ
ajlm-2201	109	12	they	they	PRON
ajlm-2201	109	13	did	do	AUX
ajlm-2201	109	14	not	not	PART
ajlm-2201	109	15	have	have	VERB
ajlm-2201	109	16	a	a	DET
ajlm-2201	109	17	bone	bone	NOUN
ajlm-2201	109	18	marrow	marrow	NOUN
ajlm-2201	109	19	biopsy	biopsy	NOUN
ajlm-2201	109	20	performed	perform	VERB
ajlm-2201	109	21	.	.	PUNCT
ajlm-2201	110	1	one	one	NUM
ajlm-2201	110	2	patient	patient	NOUN
ajlm-2201	110	3	did	do	AUX
ajlm-2201	110	4	not	not	PART
ajlm-2201	110	5	return	return	VERB
ajlm-2201	110	6	for	for	ADP
ajlm-2201	110	7	the	the	DET
ajlm-2201	110	8	scheduled	scheduled	ADJ
ajlm-2201	110	9	biopsy	biopsy	NOUN
ajlm-2201	110	10	,	,	PUNCT
ajlm-2201	110	11	and	and	CCONJ
ajlm-2201	110	12	one	one	NUM
ajlm-2201	110	13	had	have	AUX
ajlm-2201	110	14	demised	demise	VERB
ajlm-2201	110	15	before	before	SCONJ
ajlm-2201	110	16	the	the	DET
ajlm-2201	110	17	biopsy	biopsy	NOUN
ajlm-2201	110	18	could	could	AUX
ajlm-2201	110	19	be	be	AUX
ajlm-2201	110	20	performed	perform	VERB
ajlm-2201	110	21	.	.	PUNCT
ajlm-2201	111	1	it	it	PRON
ajlm-2201	111	2	is	be	AUX
ajlm-2201	111	3	unclear	unclear	ADJ
ajlm-2201	111	4	why	why	SCONJ
ajlm-2201	111	5	the	the	DET
ajlm-2201	111	6	rest	rest	NOUN
ajlm-2201	111	7	were	be	AUX
ajlm-2201	111	8	not	not	PART
ajlm-2201	111	9	investigated	investigate	VERB
ajlm-2201	111	10	further	far	ADV
ajlm-2201	111	11	,	,	PUNCT
ajlm-2201	111	12	although	although	SCONJ
ajlm-2201	111	13	possible	possible	ADJ
ajlm-2201	111	14	reasons	reason	NOUN
ajlm-2201	111	15	could	could	AUX
ajlm-2201	111	16	be	be	AUX
ajlm-2201	111	17	that	that	SCONJ
ajlm-2201	111	18	the	the	DET
ajlm-2201	111	19	patients	patient	NOUN
ajlm-2201	111	20	demised	demise	VERB
ajlm-2201	111	21	at	at	ADP
ajlm-2201	111	22	home	home	NOUN
ajlm-2201	111	23	,	,	PUNCT
ajlm-2201	111	24	clinicians	clinician	NOUN
ajlm-2201	111	25	did	do	AUX
ajlm-2201	111	26	not	not	PART
ajlm-2201	111	27	view	view	VERB
ajlm-2201	111	28	or	or	CCONJ
ajlm-2201	111	29	understand	understand	VERB
ajlm-2201	111	30	the	the	DET
ajlm-2201	111	31	implications	implication	NOUN
ajlm-2201	111	32	of	of	ADP
ajlm-2201	111	33	the	the	DET
ajlm-2201	111	34	screening	screening	NOUN
ajlm-2201	111	35	results	result	NOUN
ajlm-2201	111	36	,	,	PUNCT
ajlm-2201	111	37	or	or	CCONJ
ajlm-2201	111	38	the	the	DET
ajlm-2201	111	39	patients	patient	NOUN
ajlm-2201	111	40	did	do	AUX
ajlm-2201	111	41	not	not	PART
ajlm-2201	111	42	return	return	VERB
ajlm-2201	111	43	for	for	ADP
ajlm-2201	111	44	other	other	ADJ
ajlm-2201	111	45	reasons	reason	NOUN
ajlm-2201	111	46	(	(	PUNCT
ajlm-2201	111	47	lack	lack	NOUN
ajlm-2201	111	48	of	of	ADP
ajlm-2201	111	49	funds	fund	NOUN
ajlm-2201	111	50	to	to	PART
ajlm-2201	111	51	pay	pay	VERB
ajlm-2201	111	52	for	for	ADP
ajlm-2201	111	53	transport	transport	NOUN
ajlm-2201	111	54	or	or	CCONJ
ajlm-2201	111	55	misunderstanding	misunderstand	VERB
ajlm-2201	111	56	their	their	PRON
ajlm-2201	111	57	diagnosis	diagnosis	NOUN
ajlm-2201	111	58	)	)	PUNCT
ajlm-2201	111	59	.	.	PUNCT
ajlm-2201	112	1	additionally	additionally	ADV
ajlm-2201	112	2	,	,	PUNCT
ajlm-2201	112	3	clinicians	clinician	NOUN
ajlm-2201	112	4	may	may	AUX
ajlm-2201	112	5	have	have	AUX
ajlm-2201	112	6	made	make	VERB
ajlm-2201	112	7	a	a	DET
ajlm-2201	112	8	preliminary	preliminary	ADJ
ajlm-2201	112	9	diagnosis	diagnosis	NOUN
ajlm-2201	112	10	of	of	ADP
ajlm-2201	112	11	low	low	ADJ
ajlm-2201	112	12	-	-	PUNCT
ajlm-2201	112	13	risk	risk	NOUN
ajlm-2201	112	14	mgus	mgus	ADJ
ajlm-2201	112	15	in	in	ADP
ajlm-2201	112	16	certain	certain	ADJ
ajlm-2201	112	17	patients	patient	NOUN
ajlm-2201	112	18	,	,	PUNCT
ajlm-2201	112	19	thus	thus	ADV
ajlm-2201	112	20	deferring	defer	VERB
ajlm-2201	112	21	bone	bone	NOUN
ajlm-2201	112	22	marrow	marrow	NOUN
ajlm-2201	112	23	biopsy.18	biopsy.18	NOUN
ajlm-2201	112	24	in	in	ADP
ajlm-2201	112	25	an	an	DET
ajlm-2201	112	26	audit	audit	NOUN
ajlm-2201	112	27	of	of	ADP
ajlm-2201	112	28	ife	ife	PROPN
ajlm-2201	112	29	and	and	CCONJ
ajlm-2201	112	30	sflc	sflc	VERB
ajlm-2201	112	31	results	result	NOUN
ajlm-2201	112	32	between	between	ADP
ajlm-2201	112	33	january	january	PROPN
ajlm-2201	112	34	2018	2018	NUM
ajlm-2201	112	35	and	and	CCONJ
ajlm-2201	112	36	may	may	AUX
ajlm-2201	112	37	2019	2019	NUM
ajlm-2201	112	38	performed	perform	VERB
ajlm-2201	112	39	in	in	ADP
ajlm-2201	112	40	india	india	PROPN
ajlm-2201	112	41	,	,	PUNCT
ajlm-2201	112	42	authors	author	NOUN
ajlm-2201	112	43	also	also	ADV
ajlm-2201	112	44	noted	note	VERB
ajlm-2201	112	45	poor	poor	ADJ
ajlm-2201	112	46	follow	follow	NOUN
ajlm-2201	112	47	-	-	PUNCT
ajlm-2201	112	48	up	up	NOUN
ajlm-2201	112	49	of	of	ADP
ajlm-2201	112	50	patients	patient	NOUN
ajlm-2201	112	51	which	which	PRON
ajlm-2201	112	52	they	they	PRON
ajlm-2201	112	53	attributed	attribute	VERB
ajlm-2201	112	54	to	to	ADP
ajlm-2201	112	55	financial	financial	ADJ
ajlm-2201	112	56	constraints	constraint	NOUN
ajlm-2201	112	57	,	,	PUNCT
ajlm-2201	112	58	ignorance	ignorance	NOUN
ajlm-2201	112	59	or	or	CCONJ
ajlm-2201	112	60	patient	patient	NOUN
ajlm-2201	112	61	death.19	death.19	NOUN
ajlm-2201	112	62	an	an	DET
ajlm-2201	112	63	unexpected	unexpected	ADJ
ajlm-2201	112	64	finding	finding	NOUN
ajlm-2201	112	65	in	in	ADP
ajlm-2201	112	66	our	our	PRON
ajlm-2201	112	67	study	study	NOUN
ajlm-2201	112	68	was	be	AUX
ajlm-2201	112	69	the	the	DET
ajlm-2201	112	70	presence	presence	NOUN
ajlm-2201	112	71	of	of	ADP
ajlm-2201	112	72	a	a	DET
ajlm-2201	112	73	raised	raise	VERB
ajlm-2201	112	74	κ	κ	NOUN
ajlm-2201	112	75	/	/	SYM
ajlm-2201	112	76	λ	λ	NOUN
ajlm-2201	112	77	ratio	ratio	NOUN
ajlm-2201	112	78	and	and	CCONJ
ajlm-2201	112	79	λ	λ	NOUN
ajlm-2201	112	80	m	m	NOUN
ajlm-2201	112	81	-	-	NOUN
ajlm-2201	112	82	protein	protein	NOUN
ajlm-2201	112	83	on	on	ADP
ajlm-2201	112	84	spe	spe	PROPN
ajlm-2201	112	85	in	in	ADP
ajlm-2201	112	86	two	two	NUM
ajlm-2201	112	87	patients	patient	NOUN
ajlm-2201	112	88	.	.	PUNCT
ajlm-2201	113	1	with	with	ADP
ajlm-2201	113	2	a	a	DET
ajlm-2201	113	3	λ	λ	NOUN
ajlm-2201	113	4	m	m	NOUN
ajlm-2201	113	5	-	-	NOUN
ajlm-2201	113	6	protein	protein	NOUN
ajlm-2201	113	7	,	,	PUNCT
ajlm-2201	113	8	the	the	DET
ajlm-2201	113	9	ratio	ratio	NOUN
ajlm-2201	113	10	should	should	AUX
ajlm-2201	113	11	be	be	AUX
ajlm-2201	113	12	decreased.8	decreased.8	PROPN
ajlm-2201	113	13	patient	patient	ADJ
ajlm-2201	113	14	1	1	NUM
ajlm-2201	113	15	’s	’s	PART
ajlm-2201	113	16	serum	serum	NOUN
ajlm-2201	113	17	was	be	AUX
ajlm-2201	113	18	sent	send	VERB
ajlm-2201	113	19	to	to	ADP
ajlm-2201	113	20	another	another	DET
ajlm-2201	113	21	laboratory	laboratory	NOUN
ajlm-2201	113	22	for	for	ADP
ajlm-2201	113	23	repeat	repeat	NOUN
ajlm-2201	113	24	sflc	sflc	VERB
ajlm-2201	113	25	testing	testing	NOUN
ajlm-2201	113	26	,	,	PUNCT
ajlm-2201	113	27	and	and	CCONJ
ajlm-2201	113	28	a	a	DET
ajlm-2201	113	29	similar	similar	ADJ
ajlm-2201	113	30	pattern	pattern	NOUN
ajlm-2201	113	31	was	be	AUX
ajlm-2201	113	32	seen	see	VERB
ajlm-2201	113	33	,	,	PUNCT
ajlm-2201	113	34	confirming	confirm	VERB
ajlm-2201	113	35	the	the	DET
ajlm-2201	113	36	result	result	NOUN
ajlm-2201	113	37	.	.	PUNCT
ajlm-2201	114	1	patient	patient	ADJ
ajlm-2201	114	2	2	2	NUM
ajlm-2201	114	3	’s	’s	PART
ajlm-2201	114	4	serum	serum	NOUN
ajlm-2201	114	5	had	have	AUX
ajlm-2201	114	6	not	not	PART
ajlm-2201	114	7	been	be	AUX
ajlm-2201	114	8	referred	refer	VERB
ajlm-2201	114	9	for	for	ADP
ajlm-2201	114	10	confirmation	confirmation	NOUN
ajlm-2201	114	11	.	.	PUNCT
ajlm-2201	115	1	we	we	PRON
ajlm-2201	115	2	postulate	postulate	VERB
ajlm-2201	115	3	that	that	SCONJ
ajlm-2201	115	4	this	this	DET
ajlm-2201	115	5	discordance	discordance	NOUN
ajlm-2201	115	6	between	between	ADP
ajlm-2201	115	7	the	the	DET
ajlm-2201	115	8	sflc	sflc	ADJ
ajlm-2201	115	9	ratio	ratio	NOUN
ajlm-2201	115	10	and	and	CCONJ
ajlm-2201	115	11	spe	spe	PROPN
ajlm-2201	115	12	may	may	AUX
ajlm-2201	115	13	be	be	AUX
ajlm-2201	115	14	explained	explain	VERB
ajlm-2201	115	15	by	by	ADP
ajlm-2201	115	16	the	the	DET
ajlm-2201	115	17	tendency	tendency	NOUN
ajlm-2201	115	18	of	of	ADP
ajlm-2201	115	19	λ	λ	PROPN
ajlm-2201	115	20	flc	flc	PROPN
ajlm-2201	115	21	to	to	PART
ajlm-2201	115	22	form	form	VERB
ajlm-2201	115	23	dimers	dimer	NOUN
ajlm-2201	115	24	,	,	PUNCT
ajlm-2201	115	25	which	which	PRON
ajlm-2201	115	26	could	could	AUX
ajlm-2201	115	27	obscure	obscure	VERB
ajlm-2201	115	28	target	target	NOUN
ajlm-2201	115	29	epitopes	epitope	NOUN
ajlm-2201	115	30	necessary	necessary	ADJ
ajlm-2201	115	31	for	for	ADP
ajlm-2201	115	32	detection	detection	NOUN
ajlm-2201	115	33	by	by	ADP
ajlm-2201	115	34	the	the	DET
ajlm-2201	115	35	sflc	sflc	PROPN
ajlm-2201	115	36	assay	assay	NOUN
ajlm-2201	115	37	antibodies	antibodie	VERB
ajlm-2201	115	38	.	.	PUNCT
ajlm-2201	116	1	as	as	SCONJ
ajlm-2201	116	2	described	describe	VERB
ajlm-2201	116	3	in	in	ADP
ajlm-2201	116	4	a	a	DET
ajlm-2201	116	5	previous	previous	ADJ
ajlm-2201	116	6	study	study	NOUN
ajlm-2201	116	7	,	,	PUNCT
ajlm-2201	116	8	the	the	DET
ajlm-2201	116	9	sflc	sflc	NOUN
ajlm-2201	116	10	assay	assay	NOUN
ajlm-2201	116	11	had	have	VERB
ajlm-2201	116	12	a	a	DET
ajlm-2201	116	13	relatively	relatively	ADV
ajlm-2201	116	14	high	high	ADJ
ajlm-2201	116	15	false	false	ADJ
ajlm-2201	116	16	-	-	PUNCT
ajlm-2201	116	17	negative	negative	ADJ
ajlm-2201	116	18	rate	rate	NOUN
ajlm-2201	116	19	compared	compare	VERB
ajlm-2201	116	20	to	to	ADP
ajlm-2201	116	21	spe	spe	PROPN
ajlm-2201	116	22	and	and	CCONJ
ajlm-2201	116	23	ife	ife	PROPN
ajlm-2201	116	24	in	in	ADP
ajlm-2201	116	25	identifying	identify	VERB
ajlm-2201	116	26	patients	patient	NOUN
ajlm-2201	116	27	with	with	ADP
ajlm-2201	116	28	a	a	DET
ajlm-2201	116	29	λ	λ	PROPN
ajlm-2201	116	30	m	m	NOUN
ajlm-2201	116	31	-	-	PUNCT
ajlm-2201	116	32	protein.20	protein.20	NOUN
ajlm-2201	116	33	in	in	ADP
ajlm-2201	116	34	the	the	DET
ajlm-2201	116	35	presence	presence	NOUN
ajlm-2201	116	36	of	of	ADP
ajlm-2201	116	37	an	an	DET
ajlm-2201	116	38	inflammatory	inflammatory	ADJ
ajlm-2201	116	39	disease	disease	NOUN
ajlm-2201	116	40	process	process	NOUN
ajlm-2201	116	41	,	,	PUNCT
ajlm-2201	116	42	it	it	PRON
ajlm-2201	116	43	would	would	AUX
ajlm-2201	116	44	then	then	ADV
ajlm-2201	116	45	be	be	AUX
ajlm-2201	116	46	possible	possible	ADJ
ajlm-2201	116	47	to	to	PART
ajlm-2201	116	48	see	see	VERB
ajlm-2201	116	49	a	a	DET
ajlm-2201	116	50	mildly	mildly	ADV
ajlm-2201	116	51	increased	increase	VERB
ajlm-2201	116	52	ratio	ratio	NOUN
ajlm-2201	116	53	.	.	PUNCT
ajlm-2201	117	1	it	it	PRON
ajlm-2201	117	2	is	be	AUX
ajlm-2201	117	3	important	important	ADJ
ajlm-2201	117	4	to	to	PART
ajlm-2201	117	5	note	note	VERB
ajlm-2201	117	6	that	that	SCONJ
ajlm-2201	117	7	an	an	DET
ajlm-2201	117	8	abnormal	abnormal	ADJ
ajlm-2201	117	9	sflc	sflc	NOUN
ajlm-2201	117	10	ratio	ratio	NOUN
ajlm-2201	117	11	is	be	AUX
ajlm-2201	117	12	not	not	PART
ajlm-2201	117	13	entirely	entirely	ADV
ajlm-2201	117	14	specific	specific	ADJ
ajlm-2201	117	15	to	to	ADP
ajlm-2201	117	16	the	the	DET
ajlm-2201	117	17	presence	presence	NOUN
ajlm-2201	117	18	of	of	ADP
ajlm-2201	117	19	a	a	DET
ajlm-2201	117	20	mg	mg	NOUN
ajlm-2201	117	21	.	.	PUNCT
ajlm-2201	118	1	with	with	ADP
ajlm-2201	118	2	decreases	decrease	NOUN
ajlm-2201	118	3	in	in	ADP
ajlm-2201	118	4	renal	renal	ADJ
ajlm-2201	118	5	glomerular	glomerular	ADJ
ajlm-2201	118	6	filtration	filtration	NOUN
ajlm-2201	118	7	rate	rate	NOUN
ajlm-2201	118	8	,	,	PUNCT
ajlm-2201	118	9	there	there	PRON
ajlm-2201	118	10	is	be	VERB
ajlm-2201	118	11	a	a	DET
ajlm-2201	118	12	corresponding	corresponding	ADJ
ajlm-2201	118	13	decrease	decrease	NOUN
ajlm-2201	118	14	in	in	ADP
ajlm-2201	118	15	renal	renal	ADJ
ajlm-2201	118	16	clearance	clearance	NOUN
ajlm-2201	118	17	of	of	ADP
ajlm-2201	118	18	flc	flc	PROPN
ajlm-2201	118	19	,	,	PUNCT
ajlm-2201	118	20	leading	lead	VERB
ajlm-2201	118	21	to	to	ADP
ajlm-2201	118	22	a	a	DET
ajlm-2201	118	23	mild	mild	ADJ
ajlm-2201	118	24	increase	increase	NOUN
ajlm-2201	118	25	in	in	ADP
ajlm-2201	118	26	the	the	DET
ajlm-2201	118	27	sflc	sflc	ADJ
ajlm-2201	118	28	ratio	ratio	NOUN
ajlm-2201	118	29	in	in	ADP
ajlm-2201	118	30	the	the	DET
ajlm-2201	118	31	absence	absence	NOUN
ajlm-2201	118	32	of	of	ADP
ajlm-2201	118	33	mg.13	mg.13	NOUN
ajlm-2201	118	34	a	a	DET
ajlm-2201	118	35	large	large	ADJ
ajlm-2201	118	36	number	number	NOUN
ajlm-2201	118	37	of	of	ADP
ajlm-2201	118	38	patients	patient	NOUN
ajlm-2201	118	39	with	with	ADP
ajlm-2201	118	40	an	an	DET
ajlm-2201	118	41	abnormal	abnormal	ADJ
ajlm-2201	118	42	sflc	sflc	VERB
ajlm-2201	118	43	ratio	ratio	NOUN
ajlm-2201	118	44	and	and	CCONJ
ajlm-2201	118	45	no	no	DET
ajlm-2201	118	46	m	m	NOUN
ajlm-2201	118	47	-	-	NOUN
ajlm-2201	118	48	protein	protein	NOUN
ajlm-2201	118	49	on	on	ADP
ajlm-2201	118	50	spe	spe	NOUN
ajlm-2201	118	51	in	in	ADP
ajlm-2201	118	52	our	our	PRON
ajlm-2201	118	53	study	study	NOUN
ajlm-2201	118	54	cohort	cohort	NOUN
ajlm-2201	118	55	could	could	AUX
ajlm-2201	118	56	be	be	AUX
ajlm-2201	118	57	explained	explain	VERB
ajlm-2201	118	58	by	by	ADP
ajlm-2201	118	59	renal	renal	ADJ
ajlm-2201	118	60	impairment	impairment	NOUN
ajlm-2201	118	61	.	.	PUNCT
ajlm-2201	119	1	applying	apply	VERB
ajlm-2201	119	2	the	the	DET
ajlm-2201	119	3	proposed	propose	VERB
ajlm-2201	119	4	renal	renal	ADJ
ajlm-2201	119	5	reference	reference	NOUN
ajlm-2201	119	6	interval	interval	NOUN
ajlm-2201	119	7	would	would	AUX
ajlm-2201	119	8	then	then	ADV
ajlm-2201	119	9	allow	allow	VERB
ajlm-2201	119	10	them	they	PRON
ajlm-2201	119	11	to	to	PART
ajlm-2201	119	12	be	be	AUX
ajlm-2201	119	13	classified	classify	VERB
ajlm-2201	119	14	as	as	ADP
ajlm-2201	119	15	having	have	VERB
ajlm-2201	119	16	a	a	DET
ajlm-2201	119	17	normal	normal	ADJ
ajlm-2201	119	18	sflc	sflc	NOUN
ajlm-2201	119	19	ratio	ratio	NOUN
ajlm-2201	119	20	.	.	PUNCT
ajlm-2201	120	1	it	it	PRON
ajlm-2201	120	2	is	be	AUX
ajlm-2201	120	3	not	not	PART
ajlm-2201	120	4	uncommon	uncommon	ADJ
ajlm-2201	120	5	for	for	SCONJ
ajlm-2201	120	6	myeloma	myeloma	NOUN
ajlm-2201	120	7	patients	patient	NOUN
ajlm-2201	120	8	to	to	PART
ajlm-2201	120	9	present	present	VERB
ajlm-2201	120	10	with	with	ADP
ajlm-2201	120	11	renal	renal	ADJ
ajlm-2201	120	12	impairment	impairment	NOUN
ajlm-2201	120	13	;	;	PUNCT
ajlm-2201	120	14	one	one	NUM
ajlm-2201	120	15	patient	patient	NOUN
ajlm-2201	120	16	with	with	ADP
ajlm-2201	120	17	renal	renal	ADJ
ajlm-2201	120	18	failure	failure	NOUN
ajlm-2201	120	19	and	and	CCONJ
ajlm-2201	120	20	absent	absent	ADJ
ajlm-2201	120	21	m	m	NOUN
ajlm-2201	120	22	-	-	NOUN
ajlm-2201	120	23	protein	protein	NOUN
ajlm-2201	120	24	on	on	ADP
ajlm-2201	120	25	spe	spe	PROPN
ajlm-2201	120	26	was	be	AUX
ajlm-2201	120	27	determined	determine	VERB
ajlm-2201	120	28	to	to	PART
ajlm-2201	120	29	have	have	VERB
ajlm-2201	120	30	mm	mm	PROPN
ajlm-2201	120	31	on	on	ADP
ajlm-2201	120	32	bone	bone	NOUN
ajlm-2201	120	33	marrow	marrow	NOUN
ajlm-2201	120	34	biopsy	biopsy	NOUN
ajlm-2201	120	35	.	.	PUNCT
ajlm-2201	121	1	in	in	ADP
ajlm-2201	121	2	this	this	DET
ajlm-2201	121	3	case	case	NOUN
ajlm-2201	121	4	,	,	PUNCT
ajlm-2201	121	5	the	the	DET
ajlm-2201	121	6	ratio	ratio	NOUN
ajlm-2201	121	7	was	be	AUX
ajlm-2201	121	8	0.13	0.13	NUM
ajlm-2201	121	9	,	,	PUNCT
ajlm-2201	121	10	falling	fall	VERB
ajlm-2201	121	11	outside	outside	ADV
ajlm-2201	121	12	of	of	ADP
ajlm-2201	121	13	the	the	DET
ajlm-2201	121	14	renal	renal	ADJ
ajlm-2201	121	15	reference	reference	NOUN
ajlm-2201	121	16	interval	interval	NOUN
ajlm-2201	121	17	(	(	PUNCT
ajlm-2201	121	18	0.37–3.1).13	0.37–3.1).13	NUM
ajlm-2201	121	19	in	in	ADP
ajlm-2201	121	20	addition	addition	NOUN
ajlm-2201	121	21	to	to	ADP
ajlm-2201	121	22	renal	renal	ADJ
ajlm-2201	121	23	impairment	impairment	NOUN
ajlm-2201	121	24	,	,	PUNCT
ajlm-2201	121	25	inflammatory	inflammatory	ADJ
ajlm-2201	121	26	disorders	disorder	NOUN
ajlm-2201	121	27	such	such	ADJ
ajlm-2201	121	28	as	as	ADP
ajlm-2201	121	29	autoimmune	autoimmune	ADJ
ajlm-2201	121	30	diseases	disease	NOUN
ajlm-2201	121	31	have	have	AUX
ajlm-2201	121	32	been	be	AUX
ajlm-2201	121	33	identified	identify	VERB
ajlm-2201	121	34	as	as	ADP
ajlm-2201	121	35	causes	cause	NOUN
ajlm-2201	121	36	for	for	ADP
ajlm-2201	121	37	elevated	elevated	ADJ
ajlm-2201	121	38	sflc	sflc	NOUN
ajlm-2201	121	39	concentrations	concentration	NOUN
ajlm-2201	121	40	and	and	CCONJ
ajlm-2201	121	41	a	a	DET
ajlm-2201	121	42	normal	normal	ADJ
ajlm-2201	121	43	to	to	PART
ajlm-2201	121	44	mildly	mildly	ADV
ajlm-2201	121	45	raised	raise	VERB
ajlm-2201	121	46	κ	κ	NOUN
ajlm-2201	121	47	/	/	SYM
ajlm-2201	121	48	λ	λ	NOUN
ajlm-2201	121	49	ratio	ratio	NOUN
ajlm-2201	121	50	due	due	ADJ
ajlm-2201	121	51	to	to	ADP
ajlm-2201	121	52	polyclonal	polyclonal	ADJ
ajlm-2201	121	53	increases	increase	NOUN
ajlm-2201	121	54	in	in	ADP
ajlm-2201	121	55	light	light	ADJ
ajlm-2201	121	56	chain	chain	NOUN
ajlm-2201	121	57	production.21,22	production.21,22	NOUN
ajlm-2201	121	58	in	in	ADP
ajlm-2201	121	59	our	our	PRON
ajlm-2201	121	60	study	study	NOUN
ajlm-2201	121	61	,	,	PUNCT
ajlm-2201	121	62	many	many	ADJ
ajlm-2201	121	63	patients	patient	NOUN
ajlm-2201	121	64	with	with	ADP
ajlm-2201	121	65	normal	normal	ADJ
ajlm-2201	121	66	renal	renal	ADJ
ajlm-2201	121	67	function	function	NOUN
ajlm-2201	121	68	,	,	PUNCT
ajlm-2201	121	69	abnormal	abnormal	ADJ
ajlm-2201	121	70	sflc	sflc	VERB
ajlm-2201	121	71	ratio	ratio	NOUN
ajlm-2201	121	72	and	and	CCONJ
ajlm-2201	121	73	absent	absent	ADJ
ajlm-2201	121	74	m	m	NOUN
ajlm-2201	121	75	-	-	NOUN
ajlm-2201	121	76	protein	protein	NOUN
ajlm-2201	121	77	had	have	VERB
ajlm-2201	121	78	a	a	DET
ajlm-2201	121	79	polyclonal	polyclonal	ADJ
ajlm-2201	121	80	increase	increase	NOUN
ajlm-2201	121	81	in	in	ADP
ajlm-2201	121	82	gamma	gamma	PROPN
ajlm-2201	121	83	globulins	globulin	NOUN
ajlm-2201	121	84	on	on	ADP
ajlm-2201	121	85	spe	spe	NOUN
ajlm-2201	121	86	.	.	PUNCT
ajlm-2201	122	1	this	this	PRON
ajlm-2201	122	2	could	could	AUX
ajlm-2201	122	3	imply	imply	VERB
ajlm-2201	122	4	the	the	DET
ajlm-2201	122	5	presence	presence	NOUN
ajlm-2201	122	6	of	of	ADP
ajlm-2201	122	7	an	an	DET
ajlm-2201	122	8	inflammatory	inflammatory	ADJ
ajlm-2201	122	9	process	process	NOUN
ajlm-2201	122	10	.	.	PUNCT
ajlm-2201	123	1	most	most	ADJ
ajlm-2201	123	2	of	of	ADP
ajlm-2201	123	3	these	these	DET
ajlm-2201	123	4	requests	request	NOUN
ajlm-2201	123	5	were	be	AUX
ajlm-2201	123	6	from	from	ADP
ajlm-2201	123	7	sub	sub	NOUN
ajlm-2201	123	8	-	-	NOUN
ajlm-2201	123	9	specialities	speciality	NOUN
ajlm-2201	123	10	of	of	ADP
ajlm-2201	123	11	internal	internal	ADJ
ajlm-2201	123	12	medicine	medicine	NOUN
ajlm-2201	123	13	,	,	PUNCT
ajlm-2201	123	14	in	in	ADP
ajlm-2201	123	15	particular	particular	ADJ
ajlm-2201	123	16	from	from	ADP
ajlm-2201	123	17	pulmonology	pulmonology	NOUN
ajlm-2201	123	18	,	,	PUNCT
ajlm-2201	123	19	neurology	neurology	NOUN
ajlm-2201	123	20	and	and	CCONJ
ajlm-2201	123	21	rheumatology	rheumatology	NOUN
ajlm-2201	123	22	.	.	PUNCT
ajlm-2201	124	1	other	other	ADJ
ajlm-2201	124	2	studies	study	NOUN
ajlm-2201	124	3	have	have	AUX
ajlm-2201	124	4	reported	report	VERB
ajlm-2201	124	5	on	on	ADP
ajlm-2201	124	6	the	the	DET
ajlm-2201	124	7	finding	finding	NOUN
ajlm-2201	124	8	of	of	ADP
ajlm-2201	124	9	a	a	DET
ajlm-2201	124	10	mildly	mildly	ADV
ajlm-2201	124	11	raised	raise	VERB
ajlm-2201	124	12	κ	κ	NOUN
ajlm-2201	124	13	/	/	SYM
ajlm-2201	124	14	λ	λ	NOUN
ajlm-2201	124	15	ratio	ratio	NOUN
ajlm-2201	124	16	with	with	ADP
ajlm-2201	124	17	inflammatory	inflammatory	ADJ
ajlm-2201	124	18	disorders	disorder	NOUN
ajlm-2201	124	19	,	,	PUNCT
ajlm-2201	124	20	and	and	CCONJ
ajlm-2201	124	21	alternative	alternative	ADJ
ajlm-2201	124	22	reference	reference	NOUN
ajlm-2201	124	23	intervals	interval	NOUN
ajlm-2201	124	24	with	with	ADP
ajlm-2201	124	25	higher	high	ADJ
ajlm-2201	124	26	upper	upper	ADJ
ajlm-2201	124	27	limits	limit	NOUN
ajlm-2201	124	28	have	have	AUX
ajlm-2201	124	29	been	be	AUX
ajlm-2201	124	30	suggested	suggest	VERB
ajlm-2201	124	31	to	to	PART
ajlm-2201	124	32	reduce	reduce	VERB
ajlm-2201	124	33	the	the	DET
ajlm-2201	124	34	rates	rate	NOUN
ajlm-2201	124	35	of	of	ADP
ajlm-2201	124	36	false	false	ADJ
ajlm-2201	124	37	positive	positive	ADJ
ajlm-2201	124	38	ratios	ratio	NOUN
ajlm-2201	124	39	while	while	SCONJ
ajlm-2201	124	40	maintaining	maintain	VERB
ajlm-2201	124	41	diagnostic	diagnostic	ADJ
ajlm-2201	124	42	sensitivity	sensitivity	NOUN
ajlm-2201	124	43	.	.	PUNCT
ajlm-2201	125	1	hill	hill	PROPN
ajlm-2201	125	2	et	et	PROPN
ajlm-2201	125	3	al	al	PROPN
ajlm-2201	125	4	.	.	PROPN
ajlm-2201	125	5	(	(	PUNCT
ajlm-2201	125	6	2006	2006	NUM
ajlm-2201	125	7	)	)	PUNCT
ajlm-2201	125	8	showed	show	VERB
ajlm-2201	125	9	that	that	SCONJ
ajlm-2201	125	10	the	the	DET
ajlm-2201	125	11	positive	positive	ADJ
ajlm-2201	125	12	predictive	predictive	ADJ
ajlm-2201	125	13	value	value	NOUN
ajlm-2201	125	14	for	for	ADP
ajlm-2201	125	15	an	an	DET
ajlm-2201	125	16	increased	increase	VERB
ajlm-2201	125	17	ratio	ratio	NOUN
ajlm-2201	125	18	improved	improve	VERB
ajlm-2201	125	19	from	from	ADP
ajlm-2201	125	20	34	34	NUM
ajlm-2201	125	21	%	%	NOUN
ajlm-2201	125	22	to	to	PART
ajlm-2201	125	23	58	58	NUM
ajlm-2201	125	24	%	%	NOUN
ajlm-2201	125	25	when	when	SCONJ
ajlm-2201	125	26	a	a	DET
ajlm-2201	125	27	cut	cut	NOUN
ajlm-2201	125	28	-	-	PUNCT
ajlm-2201	125	29	off	off	NOUN
ajlm-2201	125	30	of	of	ADP
ajlm-2201	125	31	>	>	X
ajlm-2201	125	32	3.0	3.0	NUM
ajlm-2201	125	33	was	be	AUX
ajlm-2201	125	34	used	use	VERB
ajlm-2201	125	35	,	,	PUNCT
ajlm-2201	125	36	and	and	CCONJ
ajlm-2201	125	37	further	further	ADJ
ajlm-2201	125	38	improvement	improvement	NOUN
ajlm-2201	125	39	to	to	ADP
ajlm-2201	125	40	78	78	NUM
ajlm-2201	125	41	%	%	NOUN
ajlm-2201	125	42	when	when	SCONJ
ajlm-2201	125	43	a	a	DET
ajlm-2201	125	44	cut	cut	NOUN
ajlm-2201	125	45	-	-	PUNCT
ajlm-2201	125	46	off	off	NOUN
ajlm-2201	125	47	of	of	ADP
ajlm-2201	125	48	>	>	X
ajlm-2201	125	49	5.0	5.0	NUM
ajlm-2201	125	50	was	be	AUX
ajlm-2201	125	51	applied.23	applied.23	NOUN
ajlm-2201	125	52	similarly	similarly	ADV
ajlm-2201	125	53	,	,	PUNCT
ajlm-2201	125	54	sandfeld	sandfeld	NOUN
ajlm-2201	125	55	-	-	PUNCT
ajlm-2201	125	56	paulsen	paulsen	PROPN
ajlm-2201	125	57	et	et	PROPN
ajlm-2201	125	58	al	al	PROPN
ajlm-2201	125	59	.	.	PROPN
ajlm-2201	125	60	(	(	PUNCT
ajlm-2201	125	61	2022	2022	NUM
ajlm-2201	125	62	)	)	PUNCT
ajlm-2201	125	63	found	find	VERB
ajlm-2201	125	64	that	that	SCONJ
ajlm-2201	125	65	increasing	increase	VERB
ajlm-2201	125	66	the	the	DET
ajlm-2201	125	67	ratio	ratio	NOUN
ajlm-2201	125	68	cut	cut	NOUN
ajlm-2201	125	69	-	-	PUNCT
ajlm-2201	125	70	off	off	NOUN
ajlm-2201	125	71	to	to	ADP
ajlm-2201	125	72	4.32	4.32	NUM
ajlm-2201	125	73	allowed	allow	VERB
ajlm-2201	125	74	a	a	DET
ajlm-2201	125	75	reduction	reduction	NOUN
ajlm-2201	125	76	in	in	ADP
ajlm-2201	125	77	false	false	ADJ
ajlm-2201	125	78	positive	positive	ADJ
ajlm-2201	125	79	results	result	NOUN
ajlm-2201	125	80	from	from	ADP
ajlm-2201	125	81	19	19	NUM
ajlm-2201	125	82	%	%	NOUN
ajlm-2201	125	83	to	to	ADP
ajlm-2201	125	84	6%.24	6%.24	PRON
ajlm-2201	125	85	as	as	SCONJ
ajlm-2201	125	86	noted	note	VERB
ajlm-2201	125	87	in	in	ADP
ajlm-2201	125	88	previous	previous	ADJ
ajlm-2201	125	89	guidelines	guideline	NOUN
ajlm-2201	125	90	,	,	PUNCT
ajlm-2201	125	91	sflcs	sflcs	NOUN
ajlm-2201	125	92	are	be	AUX
ajlm-2201	125	93	especially	especially	ADV
ajlm-2201	125	94	useful	useful	ADJ
ajlm-2201	125	95	in	in	ADP
ajlm-2201	125	96	identifying	identify	VERB
ajlm-2201	125	97	and	and	CCONJ
ajlm-2201	125	98	monitoring	monitor	VERB
ajlm-2201	125	99	light	light	NOUN
ajlm-2201	125	100	-	-	PUNCT
ajlm-2201	125	101	chain	chain	NOUN
ajlm-2201	125	102	mm	mm	NOUN
ajlm-2201	125	103	and	and	CCONJ
ajlm-2201	125	104	light	light	NOUN
ajlm-2201	125	105	-	-	PUNCT
ajlm-2201	125	106	chain	chain	NOUN
ajlm-2201	125	107	amyloidosis.3,10	amyloidosis.3,10	NOUN
ajlm-2201	125	108	in	in	ADP
ajlm-2201	125	109	the	the	DET
ajlm-2201	125	110	current	current	ADJ
ajlm-2201	125	111	study	study	NOUN
ajlm-2201	125	112	,	,	PUNCT
ajlm-2201	125	113	four	four	NUM
ajlm-2201	125	114	patients	patient	NOUN
ajlm-2201	125	115	with	with	ADP
ajlm-2201	125	116	negative	negative	ADJ
ajlm-2201	125	117	spe	spe	NOUN
ajlm-2201	125	118	and	and	CCONJ
ajlm-2201	125	119	abnormal	abnormal	ADJ
ajlm-2201	125	120	ratios	ratio	NOUN
ajlm-2201	125	121	had	have	VERB
ajlm-2201	125	122	the	the	DET
ajlm-2201	125	123	diagnoses	diagnosis	NOUN
ajlm-2201	125	124	of	of	ADP
ajlm-2201	125	125	light	light	NOUN
ajlm-2201	125	126	-	-	PUNCT
ajlm-2201	125	127	chain	chain	NOUN
ajlm-2201	125	128	mm	mm	NOUN
ajlm-2201	125	129	and	and	CCONJ
ajlm-2201	125	130	solitary	solitary	ADJ
ajlm-2201	125	131	plasmacytoma	plasmacytoma	NOUN
ajlm-2201	125	132	.	.	PUNCT
ajlm-2201	126	1	this	this	DET
ajlm-2201	126	2	finding	finding	NOUN
ajlm-2201	126	3	demonstrates	demonstrate	VERB
ajlm-2201	126	4	the	the	DET
ajlm-2201	126	5	utility	utility	NOUN
ajlm-2201	126	6	of	of	ADP
ajlm-2201	126	7	requesting	request	VERB
ajlm-2201	126	8	both	both	CCONJ
ajlm-2201	126	9	spe	spe	PROPN
ajlm-2201	126	10	and	and	CCONJ
ajlm-2201	126	11	sflc	sflc	VERB
ajlm-2201	126	12	in	in	ADP
ajlm-2201	126	13	the	the	DET
ajlm-2201	126	14	initial	initial	ADJ
ajlm-2201	126	15	screening	screening	NOUN
ajlm-2201	126	16	of	of	ADP
ajlm-2201	126	17	patients	patient	NOUN
ajlm-2201	126	18	.	.	PUNCT
ajlm-2201	127	1	studies	study	NOUN
ajlm-2201	127	2	have	have	AUX
ajlm-2201	127	3	shown	show	VERB
ajlm-2201	127	4	that	that	SCONJ
ajlm-2201	127	5	this	this	DET
ajlm-2201	127	6	combination	combination	NOUN
ajlm-2201	127	7	of	of	ADP
ajlm-2201	127	8	tests	test	NOUN
ajlm-2201	127	9	allows	allow	VERB
ajlm-2201	127	10	identification	identification	NOUN
ajlm-2201	127	11	of	of	ADP
ajlm-2201	127	12	virtually	virtually	ADV
ajlm-2201	127	13	all	all	PRON
ajlm-2201	127	14	cases	case	NOUN
ajlm-2201	127	15	of	of	ADP
ajlm-2201	127	16	mg,25,26	mg,25,26	NOUN
ajlm-2201	127	17	although	although	SCONJ
ajlm-2201	127	18	upe	upe	ADJ
ajlm-2201	127	19	and	and	CCONJ
ajlm-2201	127	20	uife	uife	NOUN
ajlm-2201	127	21	is	be	AUX
ajlm-2201	127	22	still	still	ADV
ajlm-2201	127	23	recommended	recommend	VERB
ajlm-2201	127	24	when	when	SCONJ
ajlm-2201	127	25	screening	screen	VERB
ajlm-2201	127	26	for	for	ADP
ajlm-2201	127	27	light	light	ADJ
ajlm-2201	127	28	-	-	PUNCT
ajlm-2201	127	29	chain	chain	NOUN
ajlm-2201	127	30	amyloidosis.10	amyloidosis.10	NOUN
ajlm-2201	127	31	the	the	DET
ajlm-2201	127	32	current	current	ADJ
ajlm-2201	127	33	study	study	NOUN
ajlm-2201	127	34	focused	focus	VERB
ajlm-2201	127	35	on	on	ADP
ajlm-2201	127	36	new	new	ADJ
ajlm-2201	127	37	patients	patient	NOUN
ajlm-2201	127	38	not	not	PART
ajlm-2201	127	39	previously	previously	ADV
ajlm-2201	127	40	identified	identify	VERB
ajlm-2201	127	41	with	with	ADP
ajlm-2201	127	42	a	a	DET
ajlm-2201	127	43	mg	mg	NOUN
ajlm-2201	127	44	as	as	SCONJ
ajlm-2201	127	45	there	there	PRON
ajlm-2201	127	46	is	be	VERB
ajlm-2201	127	47	ongoing	ongoing	ADJ
ajlm-2201	127	48	discussion	discussion	NOUN
ajlm-2201	127	49	regarding	regard	VERB
ajlm-2201	127	50	the	the	DET
ajlm-2201	127	51	ideal	ideal	ADJ
ajlm-2201	127	52	mg	mg	PROPN
ajlm-2201	127	53	screening	screen	VERB
ajlm-2201	127	54	test	test	NOUN
ajlm-2201	127	55	combination	combination	NOUN
ajlm-2201	127	56	:	:	PUNCT
ajlm-2201	127	57	spe	spe	PROPN
ajlm-2201	127	58	/	/	SYM
ajlm-2201	127	59	ife	ife	PROPN
ajlm-2201	127	60	and	and	CCONJ
ajlm-2201	127	61	sflc	sflc	PROPN
ajlm-2201	127	62	or	or	CCONJ
ajlm-2201	127	63	spe	spe	PROPN
ajlm-2201	127	64	/	/	SYM
ajlm-2201	127	65	ife	ife	PROPN
ajlm-2201	127	66	and	and	CCONJ
ajlm-2201	127	67	upe	upe	ADJ
ajlm-2201	127	68	/	/	SYM
ajlm-2201	127	69	uife.1,27	uife.1,27	PROPN
ajlm-2201	127	70	in	in	ADP
ajlm-2201	127	71	a	a	DET
ajlm-2201	127	72	recently	recently	ADV
ajlm-2201	127	73	published	publish	VERB
ajlm-2201	127	74	clinical	clinical	ADJ
ajlm-2201	127	75	update	update	NOUN
ajlm-2201	127	76	article	article	NOUN
ajlm-2201	127	77	,	,	PUNCT
ajlm-2201	127	78	rajkumar	rajkumar	PROPN
ajlm-2201	127	79	recommended	recommend	VERB
ajlm-2201	127	80	that	that	SCONJ
ajlm-2201	127	81	the	the	DET
ajlm-2201	127	82	initial	initial	ADJ
ajlm-2201	127	83	investigation	investigation	NOUN
ajlm-2201	127	84	for	for	ADP
ajlm-2201	127	85	a	a	DET
ajlm-2201	127	86	patient	patient	NOUN
ajlm-2201	127	87	suspected	suspect	VERB
ajlm-2201	127	88	of	of	ADP
ajlm-2201	127	89	having	have	VERB
ajlm-2201	127	90	mm	mm	PROPN
ajlm-2201	127	91	should	should	AUX
ajlm-2201	127	92	include	include	VERB
ajlm-2201	127	93	spe	spe	NOUN
ajlm-2201	127	94	,	,	PUNCT
ajlm-2201	127	95	serum	serum	PROPN
ajlm-2201	127	96	ife	ife	PROPN
ajlm-2201	127	97	and	and	CCONJ
ajlm-2201	127	98	sflc.1	sflc.1	PROPN
ajlm-2201	127	99	this	this	PRON
ajlm-2201	127	100	is	be	AUX
ajlm-2201	127	101	based	base	VERB
ajlm-2201	127	102	on	on	ADP
ajlm-2201	127	103	a	a	DET
ajlm-2201	127	104	study	study	NOUN
ajlm-2201	127	105	by	by	ADP
ajlm-2201	127	106	katzmann	katzmann	PROPN
ajlm-2201	127	107	et	et	PROPN
ajlm-2201	127	108	al	al	PROPN
ajlm-2201	127	109	.	.	PROPN
ajlm-2201	127	110	,	,	PUNCT
ajlm-2201	127	111	who	who	PRON
ajlm-2201	127	112	identified	identify	VERB
ajlm-2201	127	113	428	428	NUM
ajlm-2201	127	114	patients	patient	NOUN
ajlm-2201	127	115	with	with	ADP
ajlm-2201	127	116	positive	positive	ADJ
ajlm-2201	127	117	m	m	NOUN
ajlm-2201	127	118	-	-	NOUN
ajlm-2201	127	119	protein	protein	NOUN
ajlm-2201	127	120	on	on	ADP
ajlm-2201	127	121	urine	urine	NOUN
ajlm-2201	127	122	ife	ife	NOUN
ajlm-2201	127	123	and	and	CCONJ
ajlm-2201	127	124	determined	determine	VERB
ajlm-2201	127	125	the	the	DET
ajlm-2201	127	126	diagnostic	diagnostic	ADJ
ajlm-2201	127	127	sensitivity	sensitivity	NOUN
ajlm-2201	127	128	of	of	ADP
ajlm-2201	127	129	different	different	ADJ
ajlm-2201	127	130	screening	screening	NOUN
ajlm-2201	127	131	strategies	strategy	NOUN
ajlm-2201	127	132	.	.	PUNCT
ajlm-2201	128	1	they	they	PRON
ajlm-2201	128	2	determined	determine	VERB
ajlm-2201	128	3	that	that	SCONJ
ajlm-2201	128	4	spe	spe	VERB
ajlm-2201	128	5	with	with	ADP
ajlm-2201	128	6	ife	ife	PROPN
ajlm-2201	128	7	alone	alone	ADV
ajlm-2201	128	8	would	would	AUX
ajlm-2201	128	9	have	have	AUX
ajlm-2201	128	10	missed	miss	VERB
ajlm-2201	128	11	6.5	6.5	NUM
ajlm-2201	128	12	%	%	NOUN
ajlm-2201	128	13	of	of	ADP
ajlm-2201	128	14	patients	patient	NOUN
ajlm-2201	128	15	(	(	PUNCT
ajlm-2201	128	16	primarily	primarily	ADV
ajlm-2201	128	17	light	light	ADJ
ajlm-2201	128	18	chain	chain	NOUN
ajlm-2201	128	19	amyloidosis	amyloidosis	NOUN
ajlm-2201	128	20	)	)	PUNCT
ajlm-2201	128	21	,	,	PUNCT
ajlm-2201	128	22	while	while	SCONJ
ajlm-2201	128	23	sflc	sflc	VERB
ajlm-2201	128	24	alone	alone	ADV
ajlm-2201	128	25	would	would	AUX
ajlm-2201	128	26	have	have	AUX
ajlm-2201	128	27	missed	miss	VERB
ajlm-2201	128	28	14	14	NUM
ajlm-2201	128	29	%	%	NOUN
ajlm-2201	128	30	of	of	ADP
ajlm-2201	128	31	patients	patient	NOUN
ajlm-2201	128	32	.	.	PUNCT
ajlm-2201	129	1	the	the	DET
ajlm-2201	129	2	combination	combination	NOUN
ajlm-2201	129	3	of	of	ADP
ajlm-2201	129	4	spe	spe	NOUN
ajlm-2201	129	5	,	,	PUNCT
ajlm-2201	129	6	ife	ife	PROPN
ajlm-2201	129	7	and	and	CCONJ
ajlm-2201	129	8	sflc	sflc	NOUN
ajlm-2201	129	9	identified	identify	VERB
ajlm-2201	129	10	99.5	99.5	NUM
ajlm-2201	129	11	%	%	NOUN
ajlm-2201	129	12	of	of	ADP
ajlm-2201	129	13	patients	patient	NOUN
ajlm-2201	129	14	.	.	PUNCT
ajlm-2201	130	1	the	the	DET
ajlm-2201	130	2	two	two	NUM
ajlm-2201	130	3	cases	case	NOUN
ajlm-2201	130	4	missed	miss	VERB
ajlm-2201	130	5	by	by	ADP
ajlm-2201	130	6	this	this	DET
ajlm-2201	130	7	combination	combination	NOUN
ajlm-2201	130	8	were	be	AUX
ajlm-2201	130	9	diagnosed	diagnose	VERB
ajlm-2201	130	10	with	with	ADP
ajlm-2201	130	11	mgus	mgus	ADJ
ajlm-2201	130	12	and	and	CCONJ
ajlm-2201	130	13	did	do	AUX
ajlm-2201	130	14	not	not	PART
ajlm-2201	130	15	require	require	VERB
ajlm-2201	130	16	medical	medical	ADJ
ajlm-2201	130	17	intervention.25	intervention.25	NOUN
ajlm-2201	130	18	in	in	ADP
ajlm-2201	130	19	practice	practice	NOUN
ajlm-2201	130	20	,	,	PUNCT
ajlm-2201	130	21	collecting	collect	VERB
ajlm-2201	130	22	a	a	DET
ajlm-2201	130	23	single	single	ADJ
ajlm-2201	130	24	serum	serum	NOUN
ajlm-2201	130	25	specimen	speciman	NOUN
ajlm-2201	130	26	rather	rather	ADV
ajlm-2201	130	27	than	than	ADP
ajlm-2201	130	28	collecting	collect	VERB
ajlm-2201	130	29	both	both	DET
ajlm-2201	130	30	serum	serum	NOUN
ajlm-2201	130	31	and	and	CCONJ
ajlm-2201	130	32	urine	urine	NOUN
ajlm-2201	130	33	from	from	ADP
ajlm-2201	130	34	patients	patient	NOUN
ajlm-2201	130	35	for	for	ADP
ajlm-2201	130	36	screening	screen	VERB
ajlm-2201	130	37	purposes	purpose	NOUN
ajlm-2201	130	38	is	be	AUX
ajlm-2201	130	39	also	also	ADV
ajlm-2201	130	40	more	more	ADV
ajlm-2201	130	41	convenient	convenient	ADJ
ajlm-2201	130	42	.	.	PUNCT
ajlm-2201	131	1	in	in	ADP
ajlm-2201	131	2	a	a	DET
ajlm-2201	131	3	review	review	NOUN
ajlm-2201	131	4	article	article	NOUN
ajlm-2201	131	5	,	,	PUNCT
ajlm-2201	131	6	singh	singh	PROPN
ajlm-2201	131	7	described	describe	VERB
ajlm-2201	131	8	spe	spe	NOUN
ajlm-2201	131	9	and	and	CCONJ
ajlm-2201	131	10	upe	upe	ADJ
ajlm-2201	131	11	with	with	ADP
ajlm-2201	131	12	ife	ife	PROPN
ajlm-2201	131	13	as	as	ADP
ajlm-2201	131	14	the	the	DET
ajlm-2201	131	15	gold	gold	NOUN
ajlm-2201	131	16	standard	standard	NOUN
ajlm-2201	131	17	for	for	ADP
ajlm-2201	131	18	diagnosing	diagnose	VERB
ajlm-2201	131	19	mg.27	mg.27	PROPN
ajlm-2201	131	20	when	when	SCONJ
ajlm-2201	131	21	a	a	DET
ajlm-2201	131	22	m	m	NOUN
ajlm-2201	131	23	-	-	ADJ
ajlm-2201	131	24	protein	protein	NOUN
ajlm-2201	131	25	is	be	AUX
ajlm-2201	131	26	identified	identify	VERB
ajlm-2201	131	27	on	on	ADP
ajlm-2201	131	28	upe	upe	PROPN
ajlm-2201	131	29	,	,	PUNCT
ajlm-2201	131	30	it	it	PRON
ajlm-2201	131	31	is	be	AUX
ajlm-2201	131	32	diagnostic	diagnostic	ADJ
ajlm-2201	131	33	of	of	ADP
ajlm-2201	131	34	mg	mg	PROPN
ajlm-2201	131	35	,	,	PUNCT
ajlm-2201	131	36	while	while	SCONJ
ajlm-2201	131	37	an	an	DET
ajlm-2201	131	38	abnormal	abnormal	ADJ
ajlm-2201	131	39	sflc	sflc	NOUN
ajlm-2201	131	40	ratio	ratio	NOUN
ajlm-2201	131	41	is	be	AUX
ajlm-2201	131	42	not	not	PART
ajlm-2201	131	43	.	.	PUNCT
ajlm-2201	132	1	therefore	therefore	ADV
ajlm-2201	132	2	,	,	PUNCT
ajlm-2201	132	3	the	the	DET
ajlm-2201	132	4	test	test	NOUN
ajlm-2201	132	5	combination	combination	NOUN
ajlm-2201	132	6	of	of	ADP
ajlm-2201	132	7	spe	spe	PROPN
ajlm-2201	132	8	/	/	SYM
ajlm-2201	132	9	ife	ife	PROPN
ajlm-2201	132	10	and	and	CCONJ
ajlm-2201	132	11	upe	upe	PROPN
ajlm-2201	132	12	/	/	SYM
ajlm-2201	132	13	uife	uife	NOUN
ajlm-2201	132	14	does	do	AUX
ajlm-2201	132	15	not	not	PART
ajlm-2201	132	16	produce	produce	VERB
ajlm-2201	132	17	false	false	ADJ
ajlm-2201	132	18	positive	positive	ADJ
ajlm-2201	132	19	results	result	NOUN
ajlm-2201	132	20	as	as	ADP
ajlm-2201	132	21	with	with	ADP
ajlm-2201	132	22	sflc	sflc	NOUN
ajlm-2201	132	23	testing.27	testing.27	VERB
ajlm-2201	132	24	false	false	ADJ
ajlm-2201	132	25	positive	positive	ADJ
ajlm-2201	132	26	results	result	NOUN
ajlm-2201	132	27	may	may	AUX
ajlm-2201	132	28	lead	lead	VERB
ajlm-2201	132	29	to	to	ADP
ajlm-2201	132	30	unnecessary	unnecessary	ADJ
ajlm-2201	132	31	further	further	ADJ
ajlm-2201	132	32	investigation	investigation	NOUN
ajlm-2201	132	33	and	and	CCONJ
ajlm-2201	132	34	patient	patient	ADJ
ajlm-2201	132	35	anxiety.28	anxiety.28	NOUN
ajlm-2201	132	36	while	while	SCONJ
ajlm-2201	132	37	the	the	DET
ajlm-2201	132	38	above	above	ADJ
ajlm-2201	132	39	is	be	AUX
ajlm-2201	132	40	true	true	ADJ
ajlm-2201	132	41	,	,	PUNCT
ajlm-2201	132	42	it	it	PRON
ajlm-2201	132	43	is	be	AUX
ajlm-2201	132	44	crucial	crucial	ADJ
ajlm-2201	132	45	to	to	PART
ajlm-2201	132	46	consider	consider	VERB
ajlm-2201	132	47	that	that	DET
ajlm-2201	132	48	upe	upe	NOUN
ajlm-2201	132	49	is	be	AUX
ajlm-2201	132	50	typically	typically	ADV
ajlm-2201	132	51	a	a	DET
ajlm-2201	132	52	semi	semi	ADJ
ajlm-2201	132	53	-	-	ADJ
ajlm-2201	132	54	automated	automated	ADJ
ajlm-2201	132	55	method	method	NOUN
ajlm-2201	132	56	and	and	CCONJ
ajlm-2201	132	57	,	,	PUNCT
ajlm-2201	132	58	therefore	therefore	ADV
ajlm-2201	132	59	,	,	PUNCT
ajlm-2201	132	60	more	more	ADJ
ajlm-2201	132	61	labour	labour	NOUN
ajlm-2201	132	62	-	-	PUNCT
ajlm-2201	132	63	intensive	intensive	ADJ
ajlm-2201	132	64	than	than	ADP
ajlm-2201	132	65	fully	fully	ADV
ajlm-2201	132	66	automated	automate	VERB
ajlm-2201	132	67	sflc	sflc	ADJ
ajlm-2201	132	68	analysis	analysis	NOUN
ajlm-2201	132	69	.	.	PUNCT
ajlm-2201	133	1	automation	automation	NOUN
ajlm-2201	133	2	allows	allow	VERB
ajlm-2201	133	3	higher	high	ADJ
ajlm-2201	133	4	throughput	throughput	NOUN
ajlm-2201	133	5	and	and	CCONJ
ajlm-2201	133	6	shorter	short	ADJ
ajlm-2201	133	7	turnaround	turnaround	NOUN
ajlm-2201	133	8	time	time	NOUN
ajlm-2201	133	9	for	for	ADP
ajlm-2201	133	10	sflc	sflc	ADJ
ajlm-2201	133	11	testing	testing	NOUN
ajlm-2201	133	12	.	.	PUNCT
ajlm-2201	134	1	urine	urine	NOUN
ajlm-2201	134	2	protein	protein	NOUN
ajlm-2201	134	3	electrophoresis	electrophoresis	NOUN
ajlm-2201	134	4	and	and	CCONJ
ajlm-2201	134	5	uife	uife	NOUN
ajlm-2201	134	6	also	also	ADV
ajlm-2201	134	7	require	require	VERB
ajlm-2201	134	8	visual	visual	ADJ
ajlm-2201	134	9	inspection	inspection	NOUN
ajlm-2201	134	10	and	and	CCONJ
ajlm-2201	134	11	manual	manual	ADJ
ajlm-2201	134	12	interpretation	interpretation	NOUN
ajlm-2201	134	13	,	,	PUNCT
ajlm-2201	134	14	leaving	leave	VERB
ajlm-2201	134	15	room	room	NOUN
ajlm-2201	134	16	for	for	ADP
ajlm-2201	134	17	human	human	ADJ
ajlm-2201	134	18	error	error	NOUN
ajlm-2201	134	19	.	.	PUNCT
ajlm-2201	135	1	limitations	limitation	NOUN
ajlm-2201	135	2	a	a	DET
ajlm-2201	135	3	limitation	limitation	NOUN
ajlm-2201	135	4	of	of	ADP
ajlm-2201	135	5	our	our	PRON
ajlm-2201	135	6	study	study	NOUN
ajlm-2201	135	7	is	be	AUX
ajlm-2201	135	8	the	the	DET
ajlm-2201	135	9	small	small	ADJ
ajlm-2201	135	10	number	number	NOUN
ajlm-2201	135	11	of	of	ADP
ajlm-2201	135	12	patients	patient	NOUN
ajlm-2201	135	13	included	include	VERB
ajlm-2201	135	14	in	in	ADP
ajlm-2201	135	15	the	the	DET
ajlm-2201	135	16	comparison	comparison	NOUN
ajlm-2201	135	17	of	of	ADP
ajlm-2201	135	18	κ	κ	PROPN
ajlm-2201	135	19	/	/	SYM
ajlm-2201	135	20	λ	λ	NOUN
ajlm-2201	135	21	ratio	ratio	NOUN
ajlm-2201	135	22	with	with	ADP
ajlm-2201	135	23	spe	spe	NOUN
ajlm-2201	135	24	.	.	PUNCT
ajlm-2201	136	1	samples	sample	NOUN
ajlm-2201	136	2	for	for	ADP
ajlm-2201	136	3	sflc	sflc	ADJ
ajlm-2201	136	4	analysis	analysis	NOUN
ajlm-2201	136	5	are	be	AUX
ajlm-2201	136	6	received	receive	VERB
ajlm-2201	136	7	from	from	ADP
ajlm-2201	136	8	multiple	multiple	ADJ
ajlm-2201	136	9	sites	site	NOUN
ajlm-2201	136	10	around	around	ADP
ajlm-2201	136	11	the	the	DET
ajlm-2201	136	12	country	country	NOUN
ajlm-2201	136	13	;	;	PUNCT
ajlm-2201	136	14	however	however	ADV
ajlm-2201	136	15	,	,	PUNCT
ajlm-2201	136	16	only	only	ADV
ajlm-2201	136	17	a	a	DET
ajlm-2201	136	18	limited	limited	ADJ
ajlm-2201	136	19	number	number	NOUN
ajlm-2201	136	20	of	of	ADP
ajlm-2201	136	21	these	these	DET
ajlm-2201	136	22	sites	site	NOUN
ajlm-2201	136	23	use	use	VERB
ajlm-2201	136	24	electronic	electronic	ADJ
ajlm-2201	136	25	medical	medical	ADJ
ajlm-2201	136	26	record	record	NOUN
ajlm-2201	136	27	-	-	PUNCT
ajlm-2201	136	28	keeping	keeping	NOUN
ajlm-2201	136	29	.	.	PUNCT
ajlm-2201	137	1	it	it	PRON
ajlm-2201	137	2	was	be	AUX
ajlm-2201	137	3	not	not	PART
ajlm-2201	137	4	feasible	feasible	ADJ
ajlm-2201	137	5	to	to	PART
ajlm-2201	137	6	trace	trace	VERB
ajlm-2201	137	7	the	the	DET
ajlm-2201	137	8	physical	physical	ADJ
ajlm-2201	137	9	medical	medical	ADJ
ajlm-2201	137	10	records	record	NOUN
ajlm-2201	137	11	of	of	ADP
ajlm-2201	137	12	these	these	DET
ajlm-2201	137	13	patients	patient	NOUN
ajlm-2201	137	14	,	,	PUNCT
ajlm-2201	137	15	and	and	CCONJ
ajlm-2201	137	16	we	we	PRON
ajlm-2201	137	17	were	be	AUX
ajlm-2201	137	18	,	,	PUNCT
ajlm-2201	137	19	therefore	therefore	ADV
ajlm-2201	137	20	,	,	PUNCT
ajlm-2201	137	21	limited	limit	VERB
ajlm-2201	137	22	to	to	ADP
ajlm-2201	137	23	patients	patient	NOUN
ajlm-2201	137	24	assessed	assess	VERB
ajlm-2201	137	25	at	at	ADP
ajlm-2201	137	26	our	our	PRON
ajlm-2201	137	27	centre	centre	NOUN
ajlm-2201	137	28	.	.	PUNCT
ajlm-2201	138	1	a	a	DET
ajlm-2201	138	2	further	further	ADJ
ajlm-2201	138	3	limitation	limitation	NOUN
ajlm-2201	138	4	is	be	AUX
ajlm-2201	138	5	that	that	SCONJ
ajlm-2201	138	6	we	we	PRON
ajlm-2201	138	7	did	do	AUX
ajlm-2201	138	8	not	not	PART
ajlm-2201	138	9	determine	determine	VERB
ajlm-2201	138	10	the	the	DET
ajlm-2201	138	11	diagnostic	diagnostic	ADJ
ajlm-2201	138	12	sensitivity	sensitivity	NOUN
ajlm-2201	138	13	and	and	CCONJ
ajlm-2201	138	14	specificity	specificity	NOUN
ajlm-2201	138	15	of	of	ADP
ajlm-2201	138	16	the	the	DET
ajlm-2201	138	17	available	available	ADJ
ajlm-2201	138	18	screening	screening	NOUN
ajlm-2201	138	19	strategies	strategy	NOUN
ajlm-2201	138	20	due	due	ADJ
ajlm-2201	138	21	to	to	ADP
ajlm-2201	138	22	the	the	DET
ajlm-2201	138	23	small	small	ADJ
ajlm-2201	138	24	numbers	number	NOUN
ajlm-2201	138	25	of	of	ADP
ajlm-2201	138	26	patients	patient	NOUN
ajlm-2201	138	27	with	with	ADP
ajlm-2201	138	28	biopsy	biopsy	NOUN
ajlm-2201	138	29	-	-	PUNCT
ajlm-2201	138	30	confirmed	confirm	VERB
ajlm-2201	138	31	mm	mm	PROPN
ajlm-2201	138	32	included	include	VERB
ajlm-2201	138	33	in	in	ADP
ajlm-2201	138	34	the	the	DET
ajlm-2201	138	35	study	study	NOUN
ajlm-2201	138	36	.	.	PUNCT
ajlm-2201	139	1	due	due	ADP
ajlm-2201	139	2	to	to	ADP
ajlm-2201	139	3	the	the	DET
ajlm-2201	139	4	study	study	NOUN
ajlm-2201	139	5	’s	’s	PART
ajlm-2201	139	6	retrospective	retrospective	ADJ
ajlm-2201	139	7	nature	nature	NOUN
ajlm-2201	139	8	,	,	PUNCT
ajlm-2201	139	9	we	we	PRON
ajlm-2201	139	10	did	do	AUX
ajlm-2201	139	11	not	not	PART
ajlm-2201	139	12	look	look	VERB
ajlm-2201	139	13	at	at	ADP
ajlm-2201	139	14	other	other	ADJ
ajlm-2201	139	15	markers	marker	NOUN
ajlm-2201	139	16	of	of	ADP
ajlm-2201	139	17	inflammation	inflammation	NOUN
ajlm-2201	139	18	,	,	PUNCT
ajlm-2201	139	19	which	which	PRON
ajlm-2201	139	20	may	may	AUX
ajlm-2201	139	21	be	be	AUX
ajlm-2201	139	22	helpful	helpful	ADJ
ajlm-2201	139	23	in	in	ADP
ajlm-2201	139	24	patients	patient	NOUN
ajlm-2201	139	25	with	with	ADP
ajlm-2201	139	26	a	a	DET
ajlm-2201	139	27	mildly	mildly	ADV
ajlm-2201	139	28	increased	increase	VERB
ajlm-2201	139	29	κ	κ	NOUN
ajlm-2201	139	30	/	/	SYM
ajlm-2201	139	31	λ	λ	NOUN
ajlm-2201	139	32	ratio	ratio	NOUN
ajlm-2201	139	33	and	and	CCONJ
ajlm-2201	139	34	absent	absent	ADJ
ajlm-2201	139	35	m	m	NOUN
ajlm-2201	139	36	-	-	NOUN
ajlm-2201	139	37	protein	protein	NOUN
ajlm-2201	139	38	on	on	ADP
ajlm-2201	139	39	spe	spe	NOUN
ajlm-2201	139	40	.	.	PUNCT
ajlm-2201	140	1	conclusion	conclusion	NOUN
ajlm-2201	140	2	this	this	DET
ajlm-2201	140	3	study	study	NOUN
ajlm-2201	140	4	is	be	AUX
ajlm-2201	140	5	one	one	NUM
ajlm-2201	140	6	of	of	ADP
ajlm-2201	140	7	the	the	DET
ajlm-2201	140	8	first	first	ADJ
ajlm-2201	140	9	to	to	PART
ajlm-2201	140	10	report	report	VERB
ajlm-2201	140	11	on	on	ADP
ajlm-2201	140	12	sflc	sflc	ADJ
ajlm-2201	140	13	findings	finding	NOUN
ajlm-2201	140	14	in	in	ADP
ajlm-2201	140	15	an	an	DET
ajlm-2201	140	16	african	african	ADJ
ajlm-2201	140	17	context	context	NOUN
ajlm-2201	140	18	.	.	PUNCT
ajlm-2201	141	1	it	it	PRON
ajlm-2201	141	2	highlights	highlight	VERB
ajlm-2201	141	3	challenges	challenge	NOUN
ajlm-2201	141	4	unique	unique	ADJ
ajlm-2201	141	5	to	to	ADP
ajlm-2201	141	6	a	a	DET
ajlm-2201	141	7	lowerto	lowerto	ADJ
ajlm-2201	141	8	middle	middle	ADJ
ajlm-2201	141	9	-	-	PUNCT
ajlm-2201	141	10	income	income	NOUN
ajlm-2201	141	11	setting	setting	NOUN
ajlm-2201	141	12	,	,	PUNCT
ajlm-2201	141	13	such	such	ADJ
ajlm-2201	141	14	as	as	ADP
ajlm-2201	141	15	the	the	DET
ajlm-2201	141	16	high	high	ADJ
ajlm-2201	141	17	rates	rate	NOUN
ajlm-2201	141	18	of	of	ADP
ajlm-2201	141	19	patients	patient	NOUN
ajlm-2201	141	20	lost	lose	VERB
ajlm-2201	141	21	to	to	PART
ajlm-2201	141	22	follow	follow	VERB
ajlm-2201	141	23	-	-	PUNCT
ajlm-2201	141	24	up	up	NOUN
ajlm-2201	141	25	or	or	CCONJ
ajlm-2201	141	26	incomplete	incomplete	ADJ
ajlm-2201	141	27	investigation	investigation	NOUN
ajlm-2201	141	28	and	and	CCONJ
ajlm-2201	141	29	low	low	ADJ
ajlm-2201	141	30	volumes	volume	NOUN
ajlm-2201	141	31	of	of	ADP
ajlm-2201	141	32	tests	test	NOUN
ajlm-2201	141	33	received	receive	VERB
ajlm-2201	141	34	from	from	ADP
ajlm-2201	141	35	primary	primary	ADJ
ajlm-2201	141	36	and	and	CCONJ
ajlm-2201	141	37	secondary	secondary	ADJ
ajlm-2201	141	38	care	care	NOUN
ajlm-2201	141	39	levels	level	NOUN
ajlm-2201	141	40	.	.	PUNCT
ajlm-2201	142	1	the	the	DET
ajlm-2201	142	2	authors	author	NOUN
ajlm-2201	142	3	have	have	AUX
ajlm-2201	142	4	also	also	ADV
ajlm-2201	142	5	demonstrated	demonstrate	VERB
ajlm-2201	142	6	some	some	PRON
ajlm-2201	142	7	of	of	ADP
ajlm-2201	142	8	the	the	DET
ajlm-2201	142	9	strengths	strength	NOUN
ajlm-2201	142	10	and	and	CCONJ
ajlm-2201	142	11	limitations	limitation	NOUN
ajlm-2201	142	12	of	of	ADP
ajlm-2201	142	13	sflc	sflc	NOUN
ajlm-2201	142	14	and	and	CCONJ
ajlm-2201	142	15	spe	spe	ADJ
ajlm-2201	142	16	methods	method	NOUN
ajlm-2201	142	17	in	in	ADP
ajlm-2201	142	18	screening	screen	VERB
ajlm-2201	142	19	patients	patient	NOUN
ajlm-2201	142	20	for	for	ADP
ajlm-2201	142	21	mg	mg	PROPN
ajlm-2201	142	22	.	.	PUNCT
ajlm-2201	143	1	the	the	DET
ajlm-2201	143	2	findings	finding	NOUN
ajlm-2201	143	3	showed	show	VERB
ajlm-2201	143	4	that	that	SCONJ
ajlm-2201	143	5	many	many	ADJ
ajlm-2201	143	6	sflc	sflc	ADJ
ajlm-2201	143	7	results	result	NOUN
ajlm-2201	143	8	were	be	AUX
ajlm-2201	143	9	in	in	ADP
ajlm-2201	143	10	keeping	keep	VERB
ajlm-2201	143	11	with	with	ADP
ajlm-2201	143	12	an	an	DET
ajlm-2201	143	13	inflammatory	inflammatory	ADJ
ajlm-2201	143	14	pattern	pattern	NOUN
ajlm-2201	143	15	,	,	PUNCT
ajlm-2201	143	16	and	and	CCONJ
ajlm-2201	143	17	hence	hence	ADV
ajlm-2201	143	18	,	,	PUNCT
ajlm-2201	143	19	in	in	ADP
ajlm-2201	143	20	patients	patient	NOUN
ajlm-2201	143	21	suspected	suspect	VERB
ajlm-2201	143	22	to	to	PART
ajlm-2201	143	23	have	have	VERB
ajlm-2201	143	24	mg	mg	PROPN
ajlm-2201	143	25	,	,	PUNCT
ajlm-2201	143	26	sflc	sflc	VERB
ajlm-2201	143	27	requests	request	NOUN
ajlm-2201	143	28	should	should	AUX
ajlm-2201	143	29	be	be	AUX
ajlm-2201	143	30	based	base	VERB
ajlm-2201	143	31	on	on	ADP
ajlm-2201	143	32	a	a	DET
ajlm-2201	143	33	high	high	ADJ
ajlm-2201	143	34	index	index	NOUN
ajlm-2201	143	35	of	of	ADP
ajlm-2201	143	36	clinical	clinical	ADJ
ajlm-2201	143	37	suspicion	suspicion	NOUN
ajlm-2201	143	38	and	and	CCONJ
ajlm-2201	143	39	performed	perform	VERB
ajlm-2201	143	40	with	with	ADP
ajlm-2201	143	41	spe	spe	PROPN
ajlm-2201	143	42	.	.	PUNCT
ajlm-2201	144	1	as	as	ADP
ajlm-2201	144	2	per	per	ADP
ajlm-2201	144	3	the	the	DET
ajlm-2201	144	4	literature	literature	NOUN
ajlm-2201	144	5	,	,	PUNCT
ajlm-2201	144	6	the	the	DET
ajlm-2201	144	7	most	most	ADV
ajlm-2201	144	8	critical	critical	ADJ
ajlm-2201	144	9	finding	finding	NOUN
ajlm-2201	144	10	is	be	AUX
ajlm-2201	144	11	that	that	SCONJ
ajlm-2201	144	12	neither	neither	CCONJ
ajlm-2201	144	13	sflc	sflc	VERB
ajlm-2201	144	14	nor	nor	CCONJ
ajlm-2201	144	15	spe	spe	PROPN
ajlm-2201	144	16	should	should	AUX
ajlm-2201	144	17	be	be	AUX
ajlm-2201	144	18	performed	perform	VERB
ajlm-2201	144	19	in	in	ADP
ajlm-2201	144	20	isolation	isolation	NOUN
ajlm-2201	144	21	to	to	PART
ajlm-2201	144	22	ensure	ensure	VERB
ajlm-2201	144	23	no	no	DET
ajlm-2201	144	24	patient	patient	NOUN
ajlm-2201	144	25	is	be	AUX
ajlm-2201	144	26	missed	miss	VERB
ajlm-2201	144	27	.	.	PUNCT
ajlm-2201	145	1	acknowledgements	acknowledgement	NOUN
ajlm-2201	145	2	the	the	DET
ajlm-2201	145	3	authors	author	NOUN
ajlm-2201	145	4	would	would	AUX
ajlm-2201	145	5	like	like	VERB
ajlm-2201	145	6	to	to	PART
ajlm-2201	145	7	acknowledge	acknowledge	VERB
ajlm-2201	145	8	prof	prof	PROPN
ajlm-2201	145	9	.	.	PUNCT
ajlm-2201	146	1	tonya	tonya	PROPN
ajlm-2201	146	2	esterhuizen	esterhuizen	PROPN
ajlm-2201	146	3	from	from	ADP
ajlm-2201	146	4	the	the	DET
ajlm-2201	146	5	biostatistics	biostatistic	NOUN
ajlm-2201	146	6	unit	unit	NOUN
ajlm-2201	146	7	,	,	PUNCT
ajlm-2201	146	8	division	division	NOUN
ajlm-2201	146	9	of	of	ADP
ajlm-2201	146	10	epidemiology	epidemiology	NOUN
ajlm-2201	146	11	and	and	CCONJ
ajlm-2201	146	12	biostatistics	biostatistic	NOUN
ajlm-2201	146	13	,	,	PUNCT
ajlm-2201	146	14	for	for	ADP
ajlm-2201	146	15	assistance	assistance	NOUN
ajlm-2201	146	16	with	with	ADP
ajlm-2201	146	17	data	datum	NOUN
ajlm-2201	146	18	organisation	organisation	NOUN
ajlm-2201	146	19	and	and	CCONJ
ajlm-2201	146	20	analysis	analysis	NOUN
ajlm-2201	146	21	through	through	ADP
ajlm-2201	146	22	the	the	DET
ajlm-2201	146	23	support	support	NOUN
ajlm-2201	146	24	from	from	ADP
ajlm-2201	146	25	the	the	DET
ajlm-2201	146	26	stellenbosch	stellenbosch	PROPN
ajlm-2201	146	27	university	university	PROPN
ajlm-2201	146	28	faculty	faculty	NOUN
ajlm-2201	146	29	of	of	ADP
ajlm-2201	146	30	medicine	medicine	NOUN
ajlm-2201	146	31	and	and	CCONJ
ajlm-2201	146	32	health	health	PROPN
ajlm-2201	146	33	sciences	sciences	PROPN
ajlm-2201	146	34	dean	dean	PROPN
ajlm-2201	146	35	’s	’s	PART
ajlm-2201	146	36	fund	fund	NOUN
ajlm-2201	146	37	.	.	PUNCT
ajlm-2201	147	1	competing	compete	VERB
ajlm-2201	147	2	interests	interest	NOUN
ajlm-2201	147	3	the	the	DET
ajlm-2201	147	4	authors	author	NOUN
ajlm-2201	147	5	declare	declare	VERB
ajlm-2201	147	6	that	that	SCONJ
ajlm-2201	147	7	they	they	PRON
ajlm-2201	147	8	have	have	VERB
ajlm-2201	147	9	no	no	DET
ajlm-2201	147	10	financial	financial	ADJ
ajlm-2201	147	11	or	or	CCONJ
ajlm-2201	147	12	personal	personal	ADJ
ajlm-2201	147	13	relationships	relationship	NOUN
ajlm-2201	147	14	that	that	PRON
ajlm-2201	147	15	may	may	AUX
ajlm-2201	147	16	have	have	AUX
ajlm-2201	147	17	inappropriately	inappropriately	ADV
ajlm-2201	147	18	influenced	influence	VERB
ajlm-2201	147	19	them	they	PRON
ajlm-2201	147	20	in	in	ADP
ajlm-2201	147	21	writing	write	VERB
ajlm-2201	147	22	this	this	DET
ajlm-2201	147	23	article	article	NOUN
ajlm-2201	147	24	.	.	PUNCT
ajlm-2201	148	1	authors	author	NOUN
ajlm-2201	148	2	’	’	PART
ajlm-2201	148	3	contributions	contribution	NOUN
ajlm-2201	148	4	r.b.b	r.b.b	NOUN
ajlm-2201	148	5	.	.	PUNCT
ajlm-2201	148	6	was	be	AUX
ajlm-2201	148	7	responsible	responsible	ADJ
ajlm-2201	148	8	for	for	ADP
ajlm-2201	148	9	study	study	NOUN
ajlm-2201	148	10	design	design	NOUN
ajlm-2201	148	11	,	,	PUNCT
ajlm-2201	148	12	data	datum	NOUN
ajlm-2201	148	13	collection	collection	NOUN
ajlm-2201	148	14	and	and	CCONJ
ajlm-2201	148	15	curation	curation	NOUN
ajlm-2201	148	16	,	,	PUNCT
ajlm-2201	148	17	data	datum	NOUN
ajlm-2201	148	18	analysis	analysis	NOUN
ajlm-2201	148	19	,	,	PUNCT
ajlm-2201	148	20	data	data	NOUN
ajlm-2201	148	21	visualisation	visualisation	NOUN
ajlm-2201	148	22	,	,	PUNCT
ajlm-2201	148	23	original	original	ADJ
ajlm-2201	148	24	draft	draft	NOUN
ajlm-2201	148	25	and	and	CCONJ
ajlm-2201	148	26	review	review	NOUN
ajlm-2201	148	27	of	of	ADP
ajlm-2201	148	28	the	the	DET
ajlm-2201	148	29	article	article	NOUN
ajlm-2201	148	30	.	.	PUNCT
ajlm-2201	149	1	f.b.f	f.b.f	PROPN
ajlm-2201	149	2	.	.	PROPN
ajlm-2201	149	3	contributed	contribute	VERB
ajlm-2201	149	4	to	to	PART
ajlm-2201	149	5	study	study	VERB
ajlm-2201	149	6	design	design	NOUN
ajlm-2201	149	7	,	,	PUNCT
ajlm-2201	149	8	data	datum	NOUN
ajlm-2201	149	9	analysis	analysis	NOUN
ajlm-2201	149	10	,	,	PUNCT
ajlm-2201	149	11	original	original	ADJ
ajlm-2201	149	12	draft	draft	NOUN
ajlm-2201	149	13	and	and	CCONJ
ajlm-2201	149	14	review	review	NOUN
ajlm-2201	149	15	of	of	ADP
ajlm-2201	149	16	the	the	DET
ajlm-2201	149	17	article	article	NOUN
ajlm-2201	149	18	.	.	PUNCT
ajlm-2201	150	1	a.e.z	a.e.z	PROPN
ajlm-2201	150	2	.	.	PROPN
ajlm-2201	150	3	,	,	PUNCT
ajlm-2201	150	4	a	a	PROPN
ajlm-2201	150	5	-	-	PUNCT
ajlm-2201	150	6	a.k	a.k	NOUN
ajlm-2201	150	7	.	.	PROPN
ajlm-2201	150	8	and	and	CCONJ
ajlm-2201	150	9	t.p.j	t.p.j	PROPN
ajlm-2201	150	10	.	.	PROPN
ajlm-2201	150	11	contributed	contribute	VERB
ajlm-2201	150	12	to	to	ADP
ajlm-2201	150	13	conceptualisation	conceptualisation	NOUN
ajlm-2201	150	14	,	,	PUNCT
ajlm-2201	150	15	study	study	NOUN
ajlm-2201	150	16	design	design	NOUN
ajlm-2201	150	17	,	,	PUNCT
ajlm-2201	150	18	original	original	ADJ
ajlm-2201	150	19	draft	draft	NOUN
ajlm-2201	150	20	and	and	CCONJ
ajlm-2201	150	21	review	review	NOUN
ajlm-2201	150	22	of	of	ADP
ajlm-2201	150	23	the	the	DET
ajlm-2201	150	24	article	article	NOUN
ajlm-2201	150	25	.	.	PUNCT
ajlm-2201	151	1	sources	source	NOUN
ajlm-2201	151	2	of	of	ADP
ajlm-2201	151	3	support	support	NOUN
ajlm-2201	151	4	this	this	DET
ajlm-2201	151	5	research	research	NOUN
ajlm-2201	151	6	received	receive	VERB
ajlm-2201	151	7	no	no	DET
ajlm-2201	151	8	specific	specific	ADJ
ajlm-2201	151	9	grant	grant	NOUN
ajlm-2201	151	10	from	from	ADP
ajlm-2201	151	11	any	any	DET
ajlm-2201	151	12	funding	funding	NOUN
ajlm-2201	151	13	agency	agency	NOUN
ajlm-2201	151	14	in	in	ADP
ajlm-2201	151	15	the	the	DET
ajlm-2201	151	16	public	public	ADJ
ajlm-2201	151	17	,	,	PUNCT
ajlm-2201	151	18	commercial	commercial	ADJ
ajlm-2201	151	19	,	,	PUNCT
ajlm-2201	151	20	or	or	CCONJ
ajlm-2201	151	21	not	not	PART
ajlm-2201	151	22	-	-	PUNCT
ajlm-2201	151	23	for	for	ADP
ajlm-2201	151	24	-	-	PUNCT
ajlm-2201	151	25	profit	profit	NOUN
ajlm-2201	151	26	sectors	sector	NOUN
ajlm-2201	151	27	.	.	PUNCT
ajlm-2201	152	1	data	datum	NOUN
ajlm-2201	152	2	availability	availability	NOUN
ajlm-2201	152	3	data	datum	NOUN
ajlm-2201	152	4	are	be	AUX
ajlm-2201	152	5	not	not	PART
ajlm-2201	152	6	publicly	publicly	ADV
ajlm-2201	152	7	available	available	ADJ
ajlm-2201	152	8	but	but	CCONJ
ajlm-2201	152	9	may	may	AUX
ajlm-2201	152	10	be	be	AUX
ajlm-2201	152	11	requested	request	VERB
ajlm-2201	152	12	from	from	ADP
ajlm-2201	152	13	the	the	DET
ajlm-2201	152	14	corresponding	corresponding	ADJ
ajlm-2201	152	15	author	author	NOUN
ajlm-2201	152	16	,	,	PUNCT
ajlm-2201	152	17	t.p.j	t.p.j	NOUN
ajlm-2201	152	18	.	.	PUNCT
ajlm-2201	152	19	,	,	PUNCT
ajlm-2201	152	20	upon	upon	SCONJ
ajlm-2201	152	21	reasonable	reasonable	ADJ
ajlm-2201	152	22	request	request	NOUN
ajlm-2201	152	23	and	and	CCONJ
ajlm-2201	152	24	after	after	ADP
ajlm-2201	152	25	consultation	consultation	NOUN
ajlm-2201	152	26	with	with	ADP
ajlm-2201	152	27	the	the	DET
ajlm-2201	152	28	health	health	NOUN
ajlm-2201	152	29	research	research	PROPN
ajlm-2201	152	30	ethics	ethic	NOUN
ajlm-2201	152	31	committee	committee	PROPN
ajlm-2201	152	32	of	of	ADP
ajlm-2201	152	33	stellenbosch	stellenbosch	PROPN
ajlm-2201	152	34	university	university	PROPN
ajlm-2201	152	35	.	.	PUNCT
ajlm-2201	153	1	disclaimer	disclaimer	VERB
ajlm-2201	153	2	the	the	DET
ajlm-2201	153	3	views	view	NOUN
ajlm-2201	153	4	and	and	CCONJ
ajlm-2201	153	5	opinions	opinion	NOUN
ajlm-2201	153	6	expressed	express	VERB
ajlm-2201	153	7	in	in	ADP
ajlm-2201	153	8	this	this	DET
ajlm-2201	153	9	article	article	NOUN
ajlm-2201	153	10	are	be	AUX
ajlm-2201	153	11	those	those	PRON
ajlm-2201	153	12	of	of	ADP
ajlm-2201	153	13	the	the	DET
ajlm-2201	153	14	authors	author	NOUN
ajlm-2201	153	15	and	and	CCONJ
ajlm-2201	153	16	do	do	AUX
ajlm-2201	153	17	not	not	PART
ajlm-2201	153	18	necessarily	necessarily	ADV
ajlm-2201	153	19	reflect	reflect	VERB
ajlm-2201	153	20	the	the	DET
ajlm-2201	153	21	official	official	ADJ
ajlm-2201	153	22	policy	policy	NOUN
ajlm-2201	153	23	or	or	CCONJ
ajlm-2201	153	24	position	position	NOUN
ajlm-2201	153	25	of	of	ADP
ajlm-2201	153	26	any	any	DET
ajlm-2201	153	27	affiliated	affiliated	ADJ
ajlm-2201	153	28	agency	agency	NOUN
ajlm-2201	153	29	of	of	ADP
ajlm-2201	153	30	the	the	DET
ajlm-2201	153	31	authors	author	NOUN
ajlm-2201	153	32	.	.	PUNCT
ajlm-2201	154	1	references	reference	NOUN
ajlm-2201	154	2	rajkumar	rajkumar	PROPN
ajlm-2201	154	3	sv	sv	PROPN
ajlm-2201	154	4	.	.	PUNCT
ajlm-2201	154	5	multiple	multiple	ADJ
ajlm-2201	154	6	myeloma	myeloma	NOUN
ajlm-2201	154	7	:	:	PUNCT
ajlm-2201	154	8	2022	2022	NUM
ajlm-2201	154	9	update	update	NOUN
ajlm-2201	154	10	on	on	ADP
ajlm-2201	154	11	diagnosis	diagnosis	NOUN
ajlm-2201	154	12	,	,	PUNCT
ajlm-2201	154	13	risk	risk	NOUN
ajlm-2201	154	14	stratification	stratification	NOUN
ajlm-2201	154	15	,	,	PUNCT
ajlm-2201	154	16	and	and	CCONJ
ajlm-2201	154	17	management	management	NOUN
ajlm-2201	154	18	.	.	PUNCT
ajlm-2201	154	19	am	be	AUX
ajlm-2201	154	20	j	j	PROPN
ajlm-2201	154	21	hematol	hematol	NOUN
ajlm-2201	154	22	.	.	PUNCT
ajlm-2201	155	1	2022;97(8):1086–1107	2022;97(8):1086–1107	NOUN
ajlm-2201	155	2	.	.	PUNCT
ajlm-2201	156	1	https://doi.org/10.1002/ajh.26590	https://doi.org/10.1002/ajh.26590	PROPN
ajlm-2201	156	2	jenner	jenner	PROPN
ajlm-2201	156	3	e.	e.	PROPN
ajlm-2201	156	4	serum	serum	PROPN
ajlm-2201	156	5	free	free	ADJ
ajlm-2201	156	6	light	light	ADJ
ajlm-2201	156	7	chains	chain	NOUN
ajlm-2201	156	8	in	in	ADP
ajlm-2201	156	9	clinical	clinical	ADJ
ajlm-2201	156	10	laboratory	laboratory	NOUN
ajlm-2201	156	11	diagnostics	diagnostic	NOUN
ajlm-2201	156	12	.	.	PUNCT
ajlm-2201	157	1	clin	clin	PROPN
ajlm-2201	157	2	chim	chim	PROPN
ajlm-2201	157	3	acta	acta	PROPN
ajlm-2201	157	4	.	.	PUNCT
ajlm-2201	158	1	2014;427:15–20	2014;427:15–20	NUM
ajlm-2201	158	2	.	.	PUNCT
ajlm-2201	158	3	https://doi.org/10.1016/j.cca.2013.08.018	https://doi.org/10.1016/j.cca.2013.08.018	PROPN
ajlm-2201	158	4	tate	tate	PROPN
ajlm-2201	158	5	j.	j.	PROPN
ajlm-2201	158	6	the	the	DET
ajlm-2201	158	7	paraprotein	paraprotein	PROPN
ajlm-2201	158	8	–	–	PUNCT
ajlm-2201	158	9	an	an	DET
ajlm-2201	158	10	enduring	enduring	ADJ
ajlm-2201	158	11	biomarker	biomarker	NOUN
ajlm-2201	158	12	.	.	PUNCT
ajlm-2201	159	1	clin	clin	PROPN
ajlm-2201	159	2	biochem	biochem	PROPN
ajlm-2201	159	3	rev	rev	VERB
ajlm-2201	159	4	.	.	PROPN
ajlm-2201	160	1	2019;40(1):5–23	2019;40(1):5–23	NUM
ajlm-2201	160	2	.	.	PROPN
ajlm-2201	161	1	2019	2019	NUM
ajlm-2201	161	2	cancer	cancer	NOUN
ajlm-2201	161	3	association	association	NOUN
ajlm-2201	161	4	of	of	ADP
ajlm-2201	161	5	south	south	PROPN
ajlm-2201	161	6	africa	africa	PROPN
ajlm-2201	161	7	(	(	PUNCT
ajlm-2201	161	8	cansa	cansa	PROPN
ajlm-2201	161	9	)	)	PUNCT
ajlm-2201	161	10	cancer	cancer	NOUN
ajlm-2201	161	11	registry	registry	NOUN
ajlm-2201	162	1	[	[	X
ajlm-2201	162	2	homepage	homepage	NOUN
ajlm-2201	162	3	on	on	ADP
ajlm-2201	162	4	the	the	DET
ajlm-2201	162	5	internet	internet	NOUN
ajlm-2201	162	6	]	]	PUNCT
ajlm-2201	162	7	.	.	PUNCT
ajlm-2201	163	1	[	[	X
ajlm-2201	163	2	cited	cite	VERB
ajlm-2201	163	3	2022	2022	NUM
ajlm-2201	163	4	oct	oct	NOUN
ajlm-2201	163	5	11	11	NUM
ajlm-2201	163	6	]	]	PUNCT
ajlm-2201	163	7	.	.	PUNCT
ajlm-2201	164	1	available	available	ADJ
ajlm-2201	164	2	from	from	ADP
ajlm-2201	164	3	:	:	PUNCT
ajlm-2201	164	4	https://cansa.org.za/files/2022/03/ncr_path_2019_full_report_8dec2021.pdf	https://cansa.org.za/files/2022/03/ncr_path_2019_full_report_8dec2021.pdf	PROPN
ajlm-2201	164	5	bradwell	bradwell	PROPN
ajlm-2201	164	6	ar	ar	PROPN
ajlm-2201	164	7	,	,	PUNCT
ajlm-2201	164	8	carr	carr	PROPN
ajlm-2201	164	9	-	-	PUNCT
ajlm-2201	164	10	smith	smith	PROPN
ajlm-2201	164	11	hd	hd	PROPN
ajlm-2201	164	12	,	,	PUNCT
ajlm-2201	164	13	mead	mead	NOUN
ajlm-2201	164	14	gp	gp	NOUN
ajlm-2201	164	15	,	,	PUNCT
ajlm-2201	164	16	et	et	PROPN
ajlm-2201	164	17	al	al	PROPN
ajlm-2201	164	18	.	.	PUNCT
ajlm-2201	165	1	highly	highly	ADV
ajlm-2201	165	2	sensitive	sensitive	ADJ
ajlm-2201	165	3	,	,	PUNCT
ajlm-2201	165	4	automated	automate	VERB
ajlm-2201	165	5	immunoassay	immunoassay	NOUN
ajlm-2201	165	6	for	for	ADP
ajlm-2201	165	7	immunoglobulin	immunoglobulin	NOUN
ajlm-2201	165	8	free	free	ADJ
ajlm-2201	165	9	light	light	ADJ
ajlm-2201	165	10	chains	chain	NOUN
ajlm-2201	165	11	in	in	ADP
ajlm-2201	165	12	serum	serum	NOUN
ajlm-2201	165	13	and	and	CCONJ
ajlm-2201	165	14	urine	urine	NOUN
ajlm-2201	165	15	.	.	PUNCT
ajlm-2201	166	1	clin	clin	PROPN
ajlm-2201	166	2	chem	chem	PROPN
ajlm-2201	166	3	.	.	PUNCT
ajlm-2201	167	1	2001;47(4):673–680	2001;47(4):673–680	X
ajlm-2201	167	2	.	.	X
ajlm-2201	167	3	https://doi.org/10.1093/clinchem/47.4.673	https://doi.org/10.1093/clinchem/47.4.673	PROPN
ajlm-2201	167	4	drayson	drayson	PROPN
ajlm-2201	167	5	m	m	PROPN
ajlm-2201	167	6	,	,	PUNCT
ajlm-2201	167	7	tang	tang	PROPN
ajlm-2201	167	8	lx	lx	NOUN
ajlm-2201	167	9	,	,	PUNCT
ajlm-2201	167	10	drew	draw	VERB
ajlm-2201	167	11	r	r	NOUN
ajlm-2201	167	12	,	,	PUNCT
ajlm-2201	167	13	et	et	PROPN
ajlm-2201	167	14	al	al	PROPN
ajlm-2201	167	15	.	.	PROPN
ajlm-2201	167	16	serum	serum	PROPN
ajlm-2201	167	17	free	free	ADJ
ajlm-2201	167	18	light	light	ADJ
ajlm-2201	167	19	-	-	PUNCT
ajlm-2201	167	20	chain	chain	NOUN
ajlm-2201	167	21	measurements	measurement	NOUN
ajlm-2201	167	22	for	for	ADP
ajlm-2201	167	23	identifying	identify	VERB
ajlm-2201	167	24	and	and	CCONJ
ajlm-2201	167	25	monitoring	monitor	VERB
ajlm-2201	167	26	patients	patient	NOUN
ajlm-2201	167	27	with	with	ADP
ajlm-2201	167	28	non	non	ADJ
ajlm-2201	167	29	-	-	ADJ
ajlm-2201	167	30	secretory	secretory	ADJ
ajlm-2201	167	31	multiple	multiple	ADJ
ajlm-2201	167	32	myeloma	myeloma	NOUN
ajlm-2201	167	33	.	.	PUNCT
ajlm-2201	168	1	blood	blood	NOUN
ajlm-2201	168	2	.	.	PUNCT
ajlm-2201	169	1	2001;97(9):2900–2902	2001;97(9):2900–2902	PROPN
ajlm-2201	169	2	.	.	PUNCT
ajlm-2201	170	1	https://doi.org/10.1182/blood.v97.9.2900	https://doi.org/10.1182/blood.v97.9.2900	PROPN
ajlm-2201	170	2	reddy	reddy	PROPN
ajlm-2201	170	3	a	a	PROPN
ajlm-2201	170	4	,	,	PUNCT
ajlm-2201	170	5	rapiti	rapiti	PROPN
ajlm-2201	170	6	n	n	CCONJ
ajlm-2201	170	7	,	,	PUNCT
ajlm-2201	170	8	gounden	gounden	ADJ
ajlm-2201	170	9	v.	v.	ADP
ajlm-2201	170	10	comparison	comparison	NOUN
ajlm-2201	170	11	of	of	ADP
ajlm-2201	170	12	24	24	NUM
ajlm-2201	170	13	-	-	PUNCT
ajlm-2201	170	14	hour	hour	NOUN
ajlm-2201	170	15	versus	versus	ADP
ajlm-2201	170	16	random	random	ADJ
ajlm-2201	170	17	urine	urine	NOUN
ajlm-2201	170	18	samples	sample	NOUN
ajlm-2201	170	19	for	for	ADP
ajlm-2201	170	20	determination	determination	NOUN
ajlm-2201	170	21	and	and	CCONJ
ajlm-2201	170	22	quantification	quantification	NOUN
ajlm-2201	170	23	of	of	ADP
ajlm-2201	170	24	bence	bence	NOUN
ajlm-2201	170	25	jones	jones	NOUN
ajlm-2201	170	26	protein	protein	NOUN
ajlm-2201	170	27	in	in	ADP
ajlm-2201	170	28	a	a	DET
ajlm-2201	170	29	south	south	ADJ
ajlm-2201	170	30	african	african	ADJ
ajlm-2201	170	31	population	population	NOUN
ajlm-2201	170	32	.	.	PUNCT
ajlm-2201	171	1	afr	afr	PROPN
ajlm-2201	171	2	j	j	PROPN
ajlm-2201	171	3	lab	lab	PROPN
ajlm-2201	171	4	med	med	PROPN
ajlm-2201	171	5	.	.	PUNCT
ajlm-2201	172	1	2021;10(1):a1228	2021;10(1):a1228	NUM
ajlm-2201	172	2	.	.	PROPN
ajlm-2201	172	3	https://doi.org/10.4102/ajlm.v10i1.1228	https://doi.org/10.4102/ajlm.v10i1.1228	PROPN
ajlm-2201	172	4	katzmann	katzmann	PROPN
ajlm-2201	172	5	ja	ja	PROPN
ajlm-2201	172	6	,	,	PUNCT
ajlm-2201	172	7	clark	clark	PROPN
ajlm-2201	172	8	rj	rj	PROPN
ajlm-2201	172	9	,	,	PUNCT
ajlm-2201	172	10	abraham	abraham	PROPN
ajlm-2201	172	11	rs	rs	PROPN
ajlm-2201	172	12	,	,	PUNCT
ajlm-2201	172	13	et	et	PROPN
ajlm-2201	172	14	al	al	PROPN
ajlm-2201	172	15	.	.	PROPN
ajlm-2201	172	16	serum	serum	PROPN
ajlm-2201	172	17	reference	reference	NOUN
ajlm-2201	172	18	intervals	interval	NOUN
ajlm-2201	172	19	and	and	CCONJ
ajlm-2201	172	20	diagnostic	diagnostic	ADJ
ajlm-2201	172	21	ranges	range	NOUN
ajlm-2201	172	22	for	for	ADP
ajlm-2201	172	23	free	free	ADJ
ajlm-2201	172	24	kappa	kappa	ADJ
ajlm-2201	172	25	and	and	CCONJ
ajlm-2201	172	26	free	free	ADJ
ajlm-2201	172	27	lambda	lambda	NOUN
ajlm-2201	172	28	immunoglobulin	immunoglobulin	NOUN
ajlm-2201	172	29	light	light	NOUN
ajlm-2201	172	30	chains	chain	NOUN
ajlm-2201	172	31	:	:	PUNCT
ajlm-2201	172	32	relative	relative	ADJ
ajlm-2201	172	33	sensitivity	sensitivity	NOUN
ajlm-2201	172	34	for	for	ADP
ajlm-2201	172	35	detection	detection	NOUN
ajlm-2201	172	36	of	of	ADP
ajlm-2201	172	37	monoclonal	monoclonal	NOUN
ajlm-2201	172	38	light	light	NOUN
ajlm-2201	172	39	chains	chain	NOUN
ajlm-2201	172	40	.	.	PUNCT
ajlm-2201	173	1	clin	clin	PROPN
ajlm-2201	173	2	chem	chem	PROPN
ajlm-2201	173	3	.	.	PUNCT
ajlm-2201	174	1	2002;48(9):1437–1444	2002;48(9):1437–1444	NUM
ajlm-2201	174	2	.	.	PUNCT
ajlm-2201	175	1	https://doi.org/10.1093/clinchem/48.9.1437	https://doi.org/10.1093/clinchem/48.9.1437	PROPN
ajlm-2201	175	2	dimopoulos	dimopoulos	PROPN
ajlm-2201	175	3	m	m	PROPN
ajlm-2201	175	4	,	,	PUNCT
ajlm-2201	175	5	kyle	kyle	PROPN
ajlm-2201	175	6	r	r	PROPN
ajlm-2201	175	7	,	,	PUNCT
ajlm-2201	175	8	fermand	fermand	NOUN
ajlm-2201	175	9	jp	jp	NOUN
ajlm-2201	175	10	,	,	PUNCT
ajlm-2201	175	11	et	et	PROPN
ajlm-2201	175	12	al	al	PROPN
ajlm-2201	175	13	.	.	PUNCT
ajlm-2201	176	1	consensus	consensus	NOUN
ajlm-2201	176	2	recommendations	recommendation	NOUN
ajlm-2201	176	3	for	for	ADP
ajlm-2201	176	4	standard	standard	ADJ
ajlm-2201	176	5	investigative	investigative	ADJ
ajlm-2201	176	6	workup	workup	NOUN
ajlm-2201	176	7	:	:	PUNCT
ajlm-2201	176	8	report	report	NOUN
ajlm-2201	176	9	of	of	ADP
ajlm-2201	176	10	the	the	DET
ajlm-2201	176	11	international	international	ADJ
ajlm-2201	176	12	myeloma	myeloma	PROPN
ajlm-2201	176	13	workshop	workshop	NOUN
ajlm-2201	176	14	consensus	consensus	NOUN
ajlm-2201	176	15	panel	panel	NOUN
ajlm-2201	176	16	3	3	NUM
ajlm-2201	176	17	.	.	PUNCT
ajlm-2201	176	18	blood	blood	NOUN
ajlm-2201	176	19	.	.	PUNCT
ajlm-2201	177	1	2011;117(18):4701–4705	2011;117(18):4701–4705	NUM
ajlm-2201	177	2	.	.	PUNCT
ajlm-2201	178	1	https://doi.org/10.1182/blood-2010-10-299529	https://doi.org/10.1182/blood-2010-10-299529	ADP
ajlm-2201	178	2	dispenzieri	dispenzieri	ADV
ajlm-2201	178	3	a	a	PRON
ajlm-2201	178	4	,	,	PUNCT
ajlm-2201	178	5	kyle	kyle	PROPN
ajlm-2201	178	6	r	r	PROPN
ajlm-2201	178	7	,	,	PUNCT
ajlm-2201	178	8	merlini	merlini	PROPN
ajlm-2201	178	9	g	g	PROPN
ajlm-2201	178	10	,	,	PUNCT
ajlm-2201	178	11	et	et	PROPN
ajlm-2201	178	12	al	al	PROPN
ajlm-2201	178	13	.	.	PUNCT
ajlm-2201	179	1	international	international	ADJ
ajlm-2201	179	2	myeloma	myeloma	PROPN
ajlm-2201	179	3	working	working	PROPN
ajlm-2201	179	4	group	group	NOUN
ajlm-2201	179	5	guidelines	guideline	NOUN
ajlm-2201	179	6	for	for	ADP
ajlm-2201	179	7	serum	serum	NOUN
ajlm-2201	179	8	-	-	PUNCT
ajlm-2201	179	9	free	free	ADJ
ajlm-2201	179	10	light	light	NOUN
ajlm-2201	179	11	chain	chain	NOUN
ajlm-2201	179	12	analysis	analysis	NOUN
ajlm-2201	179	13	in	in	ADP
ajlm-2201	179	14	multiple	multiple	ADJ
ajlm-2201	179	15	myeloma	myeloma	NOUN
ajlm-2201	179	16	and	and	CCONJ
ajlm-2201	179	17	related	related	ADJ
ajlm-2201	179	18	disorders	disorder	NOUN
ajlm-2201	179	19	.	.	PUNCT
ajlm-2201	180	1	leukemia	leukemia	NOUN
ajlm-2201	180	2	.	.	PUNCT
ajlm-2201	181	1	2009;23(2):215–224	2009;23(2):215–224	X
ajlm-2201	181	2	.	.	PUNCT
ajlm-2201	182	1	https://doi.org/10.1038/leu.2008.307	https://doi.org/10.1038/leu.2008.307	NOUN
ajlm-2201	182	2	fazel	fazel	NOUN
ajlm-2201	182	3	f	f	X
ajlm-2201	182	4	,	,	PUNCT
ajlm-2201	182	5	bassa	bassa	PROPN
ajlm-2201	182	6	f.	f.	PROPN
ajlm-2201	182	7	an	an	DET
ajlm-2201	182	8	approach	approach	NOUN
ajlm-2201	182	9	to	to	ADP
ajlm-2201	182	10	the	the	DET
ajlm-2201	182	11	diagnosis	diagnosis	NOUN
ajlm-2201	182	12	and	and	CCONJ
ajlm-2201	182	13	management	management	NOUN
ajlm-2201	182	14	of	of	ADP
ajlm-2201	182	15	multiple	multiple	ADJ
ajlm-2201	182	16	myeloma	myeloma	NOUN
ajlm-2201	182	17	.	.	PUNCT
ajlm-2201	183	1	samj	samj	PROPN
ajlm-2201	183	2	.	.	PUNCT
ajlm-2201	184	1	2019;109(10):723–727	2019;109(10):723–727	NOUN
ajlm-2201	184	2	.	.	PUNCT
ajlm-2201	185	1	https://doi.org/10.7196/samj.2019.v109i10.14376	https://doi.org/10.7196/samj.2019.v109i10.14376	PROPN
ajlm-2201	185	2	zemlin	zemlin	PROPN
ajlm-2201	185	3	ae	ae	PROPN
ajlm-2201	185	4	,	,	PUNCT
ajlm-2201	185	5	rensburg	rensburg	PROPN
ajlm-2201	185	6	ma	ma	PROPN
ajlm-2201	185	7	,	,	PUNCT
ajlm-2201	185	8	ipp	ipp	PROPN
ajlm-2201	185	9	h	h	NOUN
ajlm-2201	185	10	,	,	PUNCT
ajlm-2201	185	11	et	et	PROPN
ajlm-2201	185	12	al	al	PROPN
ajlm-2201	185	13	.	.	PUNCT
ajlm-2201	185	14	verification	verification	NOUN
ajlm-2201	185	15	of	of	ADP
ajlm-2201	185	16	serum	serum	NOUN
ajlm-2201	185	17	reference	reference	NOUN
ajlm-2201	185	18	intervals	interval	NOUN
ajlm-2201	185	19	for	for	ADP
ajlm-2201	185	20	free	free	ADJ
ajlm-2201	185	21	light	light	ADJ
ajlm-2201	185	22	chains	chain	NOUN
ajlm-2201	185	23	in	in	ADP
ajlm-2201	185	24	a	a	DET
ajlm-2201	185	25	local	local	ADJ
ajlm-2201	185	26	south	south	ADJ
ajlm-2201	185	27	african	african	ADJ
ajlm-2201	185	28	population	population	NOUN
ajlm-2201	185	29	.	.	PUNCT
ajlm-2201	186	1	j	j	PROPN
ajlm-2201	186	2	clin	clin	PROPN
ajlm-2201	186	3	pathol	pathol	PROPN
ajlm-2201	186	4	.	.	PUNCT
ajlm-2201	187	1	2013;66(11):992–995	2013;66(11):992–995	NUM
ajlm-2201	187	2	.	.	PUNCT
ajlm-2201	188	1	https://doi.org/10.1136/jclinpath-2013-201511	https://doi.org/10.1136/jclinpath-2013-201511	PROPN
ajlm-2201	188	2	hutchison	hutchison	PROPN
ajlm-2201	188	3	ca	ca	PROPN
ajlm-2201	188	4	,	,	PUNCT
ajlm-2201	188	5	plant	plant	NOUN
ajlm-2201	188	6	t	t	PROPN
ajlm-2201	188	7	,	,	PUNCT
ajlm-2201	188	8	drayson	drayson	PROPN
ajlm-2201	188	9	m	m	PROPN
ajlm-2201	188	10	,	,	PUNCT
ajlm-2201	188	11	et	et	PROPN
ajlm-2201	188	12	al	al	PROPN
ajlm-2201	188	13	.	.	PROPN
ajlm-2201	188	14	serum	serum	PROPN
ajlm-2201	188	15	free	free	ADJ
ajlm-2201	188	16	light	light	NOUN
ajlm-2201	188	17	chain	chain	NOUN
ajlm-2201	188	18	measurement	measurement	NOUN
ajlm-2201	188	19	aids	aid	VERB
ajlm-2201	188	20	the	the	DET
ajlm-2201	188	21	diagnosis	diagnosis	NOUN
ajlm-2201	188	22	of	of	ADP
ajlm-2201	188	23	myeloma	myeloma	NOUN
ajlm-2201	188	24	in	in	ADP
ajlm-2201	188	25	patients	patient	NOUN
ajlm-2201	188	26	with	with	ADP
ajlm-2201	188	27	severe	severe	ADJ
ajlm-2201	188	28	renal	renal	ADJ
ajlm-2201	188	29	failure	failure	NOUN
ajlm-2201	188	30	.	.	PUNCT
ajlm-2201	189	1	bmc	bmc	ADJ
ajlm-2201	189	2	nephrol	nephrol	PROPN
ajlm-2201	189	3	.	.	PUNCT
ajlm-2201	190	1	2008;9:11	2008;9:11	PROPN
ajlm-2201	190	2	.	.	PUNCT
ajlm-2201	191	1	https://doi.org/10.1186/1471-2369-9-11	https://doi.org/10.1186/1471-2369-9-11	PROPN
ajlm-2201	192	1	van	van	PROPN
ajlm-2201	192	2	de	de	PROPN
ajlm-2201	192	3	donk	donk	PROPN
ajlm-2201	192	4	nwcj	nwcj	NOUN
ajlm-2201	192	5	,	,	PUNCT
ajlm-2201	192	6	pawlyn	pawlyn	ADJ
ajlm-2201	192	7	c	c	NOUN
ajlm-2201	192	8	,	,	PUNCT
ajlm-2201	192	9	yong	yong	PROPN
ajlm-2201	192	10	kl	kl	PROPN
ajlm-2201	192	11	.	.	PROPN
ajlm-2201	192	12	multiple	multiple	ADJ
ajlm-2201	192	13	myeloma	myeloma	PROPN
ajlm-2201	192	14	.	.	PUNCT
ajlm-2201	193	1	lancet	lancet	VERB
ajlm-2201	193	2	.	.	PUNCT
ajlm-2201	194	1	2021;397(10272):410–427	2021;397(10272):410–427	X
ajlm-2201	194	2	.	.	PUNCT
ajlm-2201	195	1	https://doi.org/10.1016/s0140-6736(21)00135-5	https://doi.org/10.1016/s0140-6736(21)00135-5	PROPN
ajlm-2201	195	2	bird	bird	PROPN
ajlm-2201	195	3	s	s	PROPN
ajlm-2201	195	4	,	,	PUNCT
ajlm-2201	195	5	cairns	cairns	PROPN
ajlm-2201	195	6	d	d	PROPN
ajlm-2201	195	7	,	,	PUNCT
ajlm-2201	195	8	menzies	menzies	PROPN
ajlm-2201	195	9	t	t	PROPN
ajlm-2201	195	10	,	,	PUNCT
ajlm-2201	195	11	et	et	PROPN
ajlm-2201	195	12	al	al	PROPN
ajlm-2201	195	13	.	.	PROPN
ajlm-2201	196	1	sex	sex	NOUN
ajlm-2201	196	2	differences	difference	NOUN
ajlm-2201	196	3	in	in	ADP
ajlm-2201	196	4	multiple	multiple	ADJ
ajlm-2201	196	5	myeloma	myeloma	NOUN
ajlm-2201	196	6	biology	biology	NOUN
ajlm-2201	196	7	but	but	CCONJ
ajlm-2201	196	8	not	not	PART
ajlm-2201	196	9	clinical	clinical	ADJ
ajlm-2201	196	10	outcomes	outcome	NOUN
ajlm-2201	196	11	:	:	PUNCT
ajlm-2201	196	12	results	result	NOUN
ajlm-2201	196	13	from	from	ADP
ajlm-2201	196	14	3894	3894	NUM
ajlm-2201	196	15	patients	patient	NOUN
ajlm-2201	196	16	in	in	ADP
ajlm-2201	196	17	the	the	DET
ajlm-2201	196	18	myeloma	myeloma	NOUN
ajlm-2201	196	19	xi	xi	ADP
ajlm-2201	196	20	trial	trial	NOUN
ajlm-2201	196	21	.	.	PUNCT
ajlm-2201	197	1	clin	clin	PROPN
ajlm-2201	197	2	lymphoma	lymphoma	PROPN
ajlm-2201	197	3	myeloma	myeloma	PROPN
ajlm-2201	197	4	leuk	leuk	NOUN
ajlm-2201	197	5	.	.	PUNCT
ajlm-2201	198	1	2021;21(10):667–675	2021;21(10):667–675	X
ajlm-2201	198	2	.	.	PUNCT
ajlm-2201	198	3	https://doi.org/10.1016/j.clml.2021.04.013	https://doi.org/10.1016/j.clml.2021.04.013	PROPN
ajlm-2201	198	4	rankapole	rankapole	PROPN
ajlm-2201	198	5	rk	rk	NOUN
ajlm-2201	198	6	,	,	PUNCT
ajlm-2201	198	7	sedumedi	sedumedi	PROPN
ajlm-2201	198	8	b	b	PROPN
ajlm-2201	198	9	,	,	PUNCT
ajlm-2201	198	10	torres	torre	VERB
ajlm-2201	198	11	z.	z.	PROPN
ajlm-2201	199	1	the	the	DET
ajlm-2201	199	2	occurrence	occurrence	NOUN
ajlm-2201	199	3	of	of	ADP
ajlm-2201	199	4	multiple	multiple	ADJ
ajlm-2201	199	5	myeloma	myeloma	NOUN
ajlm-2201	199	6	at	at	ADP
ajlm-2201	199	7	dr	dr	PROPN
ajlm-2201	199	8	george	george	PROPN
ajlm-2201	199	9	mukhari	mukhari	PROPN
ajlm-2201	199	10	hospital	hospital	PROPN
ajlm-2201	199	11	,	,	PUNCT
ajlm-2201	199	12	gauteng	gauteng	PROPN
ajlm-2201	199	13	:	:	PUNCT
ajlm-2201	199	14	a	a	DET
ajlm-2201	199	15	retrospective	retrospective	ADJ
ajlm-2201	199	16	review	review	NOUN
ajlm-2201	199	17	(	(	PUNCT
ajlm-2201	199	18	2004–2009	2004–2009	NUM
ajlm-2201	199	19	)	)	PUNCT
ajlm-2201	199	20	[	[	X
ajlm-2201	199	21	homepage	homepage	NOUN
ajlm-2201	199	22	on	on	ADP
ajlm-2201	199	23	the	the	DET
ajlm-2201	199	24	internet	internet	NOUN
ajlm-2201	199	25	]	]	PUNCT
ajlm-2201	199	26	.	.	PUNCT
ajlm-2201	200	1	[	[	X
ajlm-2201	200	2	cited	cite	VERB
ajlm-2201	200	3	2023	2023	NUM
ajlm-2201	200	4	aug	aug	NOUN
ajlm-2201	200	5	22	22	NUM
ajlm-2201	200	6	]	]	PUNCT
ajlm-2201	200	7	.	.	PUNCT
ajlm-2201	201	1	available	available	ADJ
ajlm-2201	201	2	from	from	ADP
ajlm-2201	201	3	:	:	PUNCT
ajlm-2201	201	4	http://ulspace.ul.ac.za/bitstream/handle/10386/667/dissertation%20pdf%20may%205th.pdf?sequence=1&isallowed=y	http://ulspace.ul.ac.za/bitstream/handle/10386/667/dissertation%20pdf%20may%205th.pdf?sequence=1&isallowed=y	NOUN
ajlm-2201	201	5	stats	stat	NOUN
ajlm-2201	201	6	sa	sa	PROPN
ajlm-2201	201	7	library	library	PROPN
ajlm-2201	201	8	cataloguing	cataloguing	NOUN
ajlm-2201	201	9	–	–	PUNCT
ajlm-2201	201	10	in	in	ADP
ajlm-2201	201	11	–	–	PUNCT
ajlm-2201	201	12	publication	publication	NOUN
ajlm-2201	201	13	(	(	PUNCT
ajlm-2201	201	14	cip	cip	NOUN
ajlm-2201	201	15	)	)	PUNCT
ajlm-2201	201	16	data	datum	NOUN
ajlm-2201	201	17	.	.	PUNCT
ajlm-2201	202	1	use	use	NOUN
ajlm-2201	202	2	of	of	ADP
ajlm-2201	202	3	health	health	NOUN
ajlm-2201	202	4	facilities	facility	NOUN
ajlm-2201	202	5	and	and	CCONJ
ajlm-2201	202	6	levels	level	NOUN
ajlm-2201	202	7	of	of	ADP
ajlm-2201	202	8	selected	select	VERB
ajlm-2201	202	9	health	health	NOUN
ajlm-2201	202	10	conditions	condition	NOUN
ajlm-2201	202	11	in	in	ADP
ajlm-2201	202	12	south	south	PROPN
ajlm-2201	202	13	africa	africa	PROPN
ajlm-2201	202	14	:	:	PUNCT
ajlm-2201	202	15	findings	finding	NOUN
ajlm-2201	202	16	from	from	ADP
ajlm-2201	202	17	the	the	DET
ajlm-2201	202	18	general	general	ADJ
ajlm-2201	202	19	household	household	NOUN
ajlm-2201	202	20	survey	survey	NOUN
ajlm-2201	202	21	,	,	PUNCT
ajlm-2201	202	22	2011	2011	NUM
ajlm-2201	202	23	statistics	statistic	NOUN
ajlm-2201	202	24	south	south	PROPN
ajlm-2201	202	25	africa	africa	PROPN
ajlm-2201	203	1	[	[	X
ajlm-2201	203	2	homepage	homepage	NOUN
ajlm-2201	203	3	on	on	ADP
ajlm-2201	203	4	the	the	DET
ajlm-2201	203	5	internet	internet	NOUN
ajlm-2201	203	6	]	]	PUNCT
ajlm-2201	203	7	.	.	PUNCT
ajlm-2201	204	1	pretoria	pretoria	PROPN
ajlm-2201	204	2	:	:	PUNCT
ajlm-2201	204	3	statistics	statistics	PROPN
ajlm-2201	204	4	south	south	PROPN
ajlm-2201	204	5	africa	africa	PROPN
ajlm-2201	204	6	;	;	PUNCT
ajlm-2201	204	7	2013	2013	NUM
ajlm-2201	204	8	[	[	X
ajlm-2201	204	9	cited	cite	VERB
ajlm-2201	204	10	2022	2022	NUM
ajlm-2201	204	11	oct	oct	NOUN
ajlm-2201	204	12	13	13	NUM
ajlm-2201	204	13	]	]	PUNCT
ajlm-2201	204	14	.	.	PUNCT
ajlm-2201	205	1	available	available	ADJ
ajlm-2201	205	2	from	from	ADP
ajlm-2201	205	3	:	:	PUNCT
ajlm-2201	205	4	http://www.statssa.gov.za/publications/report-03-00-05/report-03-00-052011.pdf	http://www.statssa.gov.za/publications/report-03-00-05/report-03-00-052011.pdf	NOUN
ajlm-2201	205	5	go	go	VERB
ajlm-2201	205	6	rs	rs	ADJ
ajlm-2201	205	7	,	,	PUNCT
ajlm-2201	205	8	rajkumar	rajkumar	PROPN
ajlm-2201	205	9	sv	sv	PROPN
ajlm-2201	205	10	.	.	PUNCT
ajlm-2201	206	1	how	how	SCONJ
ajlm-2201	206	2	i	i	PRON
ajlm-2201	206	3	manage	manage	VERB
ajlm-2201	206	4	monoclonal	monoclonal	NOUN
ajlm-2201	206	5	gammopathy	gammopathy	ADJ
ajlm-2201	206	6	of	of	ADP
ajlm-2201	206	7	undetermined	undetermined	ADJ
ajlm-2201	206	8	significance	significance	NOUN
ajlm-2201	206	9	.	.	PUNCT
ajlm-2201	207	1	blood	blood	NOUN
ajlm-2201	207	2	.	.	PUNCT
ajlm-2201	208	1	2018;131(2):163–173	2018;131(2):163–173	NUM
ajlm-2201	208	2	.	.	PROPN
ajlm-2201	208	3	https://doi.org/10.1182/blood-2017-09-807560	https://doi.org/10.1182/blood-2017-09-807560	PROPN
ajlm-2201	208	4	paul	paul	PROPN
ajlm-2201	208	5	c	c	PROPN
ajlm-2201	208	6	,	,	PUNCT
ajlm-2201	208	7	chakraborty	chakraborty	PROPN
ajlm-2201	208	8	s	s	PROPN
ajlm-2201	208	9	,	,	PUNCT
ajlm-2201	208	10	sugumar	sugumar	PROPN
ajlm-2201	208	11	s	s	PROPN
ajlm-2201	208	12	,	,	PUNCT
ajlm-2201	208	13	et	et	PROPN
ajlm-2201	208	14	al	al	PROPN
ajlm-2201	208	15	.	.	PROPN
ajlm-2201	208	16	audit	audit	NOUN
ajlm-2201	208	17	of	of	ADP
ajlm-2201	208	18	the	the	DET
ajlm-2201	208	19	prevalence	prevalence	NOUN
ajlm-2201	208	20	of	of	ADP
ajlm-2201	208	21	noncorrelation	noncorrelation	NOUN
ajlm-2201	208	22	of	of	ADP
ajlm-2201	208	23	immunofixation	immunofixation	NOUN
ajlm-2201	208	24	with	with	ADP
ajlm-2201	208	25	protein	protein	NOUN
ajlm-2201	208	26	electrophoresis	electrophoresis	NOUN
ajlm-2201	208	27	and	and	CCONJ
ajlm-2201	208	28	serum	serum	NOUN
ajlm-2201	208	29	free	free	ADJ
ajlm-2201	208	30	light	light	NOUN
ajlm-2201	208	31	chain	chain	NOUN
ajlm-2201	208	32	assays	assay	NOUN
ajlm-2201	208	33	in	in	ADP
ajlm-2201	208	34	multiple	multiple	ADJ
ajlm-2201	208	35	myeloma	myeloma	NOUN
ajlm-2201	208	36	in	in	ADP
ajlm-2201	208	37	a	a	DET
ajlm-2201	208	38	tertiary	tertiary	ADJ
ajlm-2201	208	39	cancer	cancer	NOUN
ajlm-2201	208	40	care	care	NOUN
ajlm-2201	208	41	center	center	NOUN
ajlm-2201	208	42	.	.	PUNCT
ajlm-2201	209	1	indian	indian	PROPN
ajlm-2201	209	2	j	j	PROPN
ajlm-2201	209	3	clin	clin	PROPN
ajlm-2201	209	4	biochem	biochem	PROPN
ajlm-2201	209	5	.	.	PUNCT
ajlm-2201	210	1	2021;36(3):353–359	2021;36(3):353–359	PROPN
ajlm-2201	210	2	.	.	PUNCT
ajlm-2201	211	1	https://doi.org/10.1007/s12291-020-00924-3	https://doi.org/10.1007/s12291-020-00924-3	PROPN
ajlm-2201	211	2	singh	singh	PROPN
ajlm-2201	211	3	g.	g.	PROPN
ajlm-2201	211	4	serum	serum	PROPN
ajlm-2201	211	5	free	free	ADJ
ajlm-2201	211	6	light	light	NOUN
ajlm-2201	211	7	chain	chain	NOUN
ajlm-2201	211	8	assay	assay	NOUN
ajlm-2201	211	9	and	and	CCONJ
ajlm-2201	211	10	κ	κ	NOUN
ajlm-2201	211	11	/	/	SYM
ajlm-2201	211	12	λ	λ	NOUN
ajlm-2201	211	13	ratio	ratio	NOUN
ajlm-2201	211	14	:	:	PUNCT
ajlm-2201	211	15	performance	performance	NOUN
ajlm-2201	211	16	in	in	ADP
ajlm-2201	211	17	patients	patient	NOUN
ajlm-2201	211	18	with	with	ADP
ajlm-2201	211	19	monoclonal	monoclonal	NOUN
ajlm-2201	211	20	gammopathyhigh	gammopathyhigh	ADJ
ajlm-2201	211	21	false	false	ADJ
ajlm-2201	211	22	negative	negative	ADJ
ajlm-2201	211	23	rate	rate	NOUN
ajlm-2201	211	24	for	for	ADP
ajlm-2201	211	25	κ	κ	NOUN
ajlm-2201	211	26	/	/	SYM
ajlm-2201	211	27	λ	λ	NOUN
ajlm-2201	211	28	ratio	ratio	NOUN
ajlm-2201	211	29	.	.	PUNCT
ajlm-2201	212	1	j	j	PROPN
ajlm-2201	212	2	clin	clin	PROPN
ajlm-2201	212	3	med	med	PROPN
ajlm-2201	212	4	res	re	NOUN
ajlm-2201	212	5	.	.	PUNCT
ajlm-2201	213	1	2017;9(1):46–57	2017;9(1):46–57	NUM
ajlm-2201	213	2	.	.	PUNCT
ajlm-2201	214	1	https://doi.org/10.14740/jocmr2802w	https://doi.org/10.14740/jocmr2802w	ADJ
ajlm-2201	214	2	draborg	draborg	ADJ
ajlm-2201	214	3	ah	ah	INTJ
ajlm-2201	214	4	,	,	PUNCT
ajlm-2201	214	5	lydolph	lydolph	PROPN
ajlm-2201	214	6	mc	mc	PROPN
ajlm-2201	214	7	,	,	PUNCT
ajlm-2201	214	8	westergaard	westergaard	PROPN
ajlm-2201	214	9	m	m	PROPN
ajlm-2201	214	10	,	,	PUNCT
ajlm-2201	214	11	et	et	PROPN
ajlm-2201	214	12	al	al	PROPN
ajlm-2201	214	13	.	.	PROPN
ajlm-2201	214	14	elevated	elevated	ADJ
ajlm-2201	214	15	concentrations	concentration	NOUN
ajlm-2201	214	16	of	of	ADP
ajlm-2201	214	17	serum	serum	NOUN
ajlm-2201	214	18	immunoglobulin	immunoglobulin	NOUN
ajlm-2201	214	19	free	free	ADJ
ajlm-2201	214	20	light	light	ADJ
ajlm-2201	214	21	chains	chain	NOUN
ajlm-2201	214	22	in	in	ADP
ajlm-2201	214	23	systemic	systemic	ADJ
ajlm-2201	214	24	lupus	lupus	ADJ
ajlm-2201	214	25	erythematosus	erythematosus	PROPN
ajlm-2201	214	26	patients	patient	NOUN
ajlm-2201	214	27	in	in	ADP
ajlm-2201	214	28	relation	relation	NOUN
ajlm-2201	214	29	to	to	ADP
ajlm-2201	214	30	disease	disease	NOUN
ajlm-2201	214	31	activity	activity	NOUN
ajlm-2201	214	32	,	,	PUNCT
ajlm-2201	214	33	inflammatory	inflammatory	ADJ
ajlm-2201	214	34	status	status	NOUN
ajlm-2201	214	35	,	,	PUNCT
ajlm-2201	214	36	b	b	NOUN
ajlm-2201	214	37	cell	cell	NOUN
ajlm-2201	214	38	activity	activity	NOUN
ajlm-2201	214	39	and	and	CCONJ
ajlm-2201	214	40	epstein	epstein	PROPN
ajlm-2201	214	41	-	-	PUNCT
ajlm-2201	214	42	barr	barr	PROPN
ajlm-2201	214	43	virus	virus	PROPN
ajlm-2201	214	44	antibodies	antibodie	VERB
ajlm-2201	214	45	.	.	PUNCT
ajlm-2201	215	1	plos	plos	PROPN
ajlm-2201	215	2	one	one	NUM
ajlm-2201	215	3	.	.	PUNCT
ajlm-2201	216	1	2015;10(9):e0138753	2015;10(9):e0138753	X
ajlm-2201	216	2	.	.	PUNCT
ajlm-2201	216	3	https://doi.org/10.1371/journal.pone.0138753	https://doi.org/10.1371/journal.pone.0138753	PROPN
ajlm-2201	216	4	.	.	PUNCT
ajlm-2201	217	1	erratum	erratum	PROPN
ajlm-2201	217	2	in	in	ADP
ajlm-2201	217	3	:	:	PUNCT
ajlm-2201	217	4	plos	plos	PROPN
ajlm-2201	217	5	one	one	NUM
ajlm-2201	217	6	.	.	PUNCT
ajlm-2201	218	1	2016;11(1):e0148151	2016;11(1):e0148151	NUM
ajlm-2201	218	2	.	.	PUNCT
ajlm-2201	219	1	napodano	napodano	PROPN
ajlm-2201	219	2	c	c	PROPN
ajlm-2201	219	3	,	,	PUNCT
ajlm-2201	219	4	pocino	pocino	PROPN
ajlm-2201	219	5	k	k	PROPN
ajlm-2201	219	6	,	,	PUNCT
ajlm-2201	219	7	rigante	rigante	PROPN
ajlm-2201	219	8	d	d	PROPN
ajlm-2201	219	9	,	,	PUNCT
ajlm-2201	219	10	et	et	PROPN
ajlm-2201	219	11	al	al	PROPN
ajlm-2201	219	12	.	.	PUNCT
ajlm-2201	219	13	free	free	ADJ
ajlm-2201	219	14	light	light	ADJ
ajlm-2201	219	15	chains	chain	NOUN
ajlm-2201	219	16	and	and	CCONJ
ajlm-2201	219	17	autoimmunity	autoimmunity	NOUN
ajlm-2201	219	18	.	.	PUNCT
ajlm-2201	220	1	autoimmun	autoimmun	PROPN
ajlm-2201	220	2	rev	rev	PROPN
ajlm-2201	220	3	.	.	PROPN
ajlm-2201	220	4	2019;18(5):484–492	2019;18(5):484–492	NUM
ajlm-2201	220	5	.	.	PUNCT
ajlm-2201	221	1	https://doi.org/10.1016/j.autrev.2019.03.003	https://doi.org/10.1016/j.autrev.2019.03.003	PROPN
ajlm-2201	221	2	hill	hill	PROPN
ajlm-2201	221	3	pg	pg	PROPN
ajlm-2201	221	4	,	,	PUNCT
ajlm-2201	221	5	forsyth	forsyth	PROPN
ajlm-2201	221	6	jm	jm	PROPN
ajlm-2201	221	7	,	,	PUNCT
ajlm-2201	221	8	rai	rai	PROPN
ajlm-2201	221	9	b	b	X
ajlm-2201	221	10	,	,	PUNCT
ajlm-2201	221	11	et	et	PROPN
ajlm-2201	221	12	al	al	PROPN
ajlm-2201	221	13	.	.	PROPN
ajlm-2201	221	14	serum	serum	PROPN
ajlm-2201	221	15	free	free	ADJ
ajlm-2201	221	16	light	light	ADJ
ajlm-2201	221	17	chains	chain	NOUN
ajlm-2201	221	18	:	:	PUNCT
ajlm-2201	221	19	an	an	DET
ajlm-2201	221	20	alternative	alternative	NOUN
ajlm-2201	221	21	to	to	ADP
ajlm-2201	221	22	the	the	DET
ajlm-2201	221	23	urine	urine	NOUN
ajlm-2201	221	24	bence	bence	NOUN
ajlm-2201	221	25	jones	jones	NOUN
ajlm-2201	221	26	proteins	protein	NOUN
ajlm-2201	221	27	screening	screen	VERB
ajlm-2201	221	28	test	test	NOUN
ajlm-2201	221	29	for	for	ADP
ajlm-2201	221	30	monoclonal	monoclonal	NOUN
ajlm-2201	221	31	gammopathies	gammopathy	NOUN
ajlm-2201	221	32	.	.	PUNCT
ajlm-2201	222	1	clin	clin	PROPN
ajlm-2201	222	2	chem	chem	NOUN
ajlm-2201	222	3	.	.	PUNCT
ajlm-2201	223	1	2006;52(9):1743–1748	2006;52(9):1743–1748	NOUN
ajlm-2201	223	2	.	.	PUNCT
ajlm-2201	224	1	https://doi.org/10.1373/clinchem.2006.069104	https://doi.org/10.1373/clinchem.2006.069104	PROPN
ajlm-2201	224	2	sandfeld	sandfeld	PROPN
ajlm-2201	224	3	-	-	PUNCT
ajlm-2201	224	4	paulsen	paulsen	PROPN
ajlm-2201	224	5	b	b	PROPN
ajlm-2201	224	6	,	,	PUNCT
ajlm-2201	224	7	aggerholm	aggerholm	NOUN
ajlm-2201	224	8	-	-	PUNCT
ajlm-2201	224	9	pedersen	pedersen	PROPN
ajlm-2201	224	10	n	n	CCONJ
ajlm-2201	224	11	,	,	PUNCT
ajlm-2201	224	12	samson	samson	PROPN
ajlm-2201	224	13	mh	mh	PROPN
ajlm-2201	224	14	,	,	PUNCT
ajlm-2201	224	15	et	et	PROPN
ajlm-2201	224	16	al	al	PROPN
ajlm-2201	224	17	.	.	PUNCT
ajlm-2201	225	1	a	a	DET
ajlm-2201	225	2	cohort	cohort	NOUN
ajlm-2201	225	3	study	study	NOUN
ajlm-2201	225	4	of	of	ADP
ajlm-2201	225	5	free	free	ADJ
ajlm-2201	225	6	light	light	NOUN
ajlm-2201	225	7	chain	chain	NOUN
ajlm-2201	225	8	ratio	ratio	NOUN
ajlm-2201	225	9	in	in	ADP
ajlm-2201	225	10	combination	combination	NOUN
ajlm-2201	225	11	with	with	ADP
ajlm-2201	225	12	serum	serum	NOUN
ajlm-2201	225	13	protein	protein	NOUN
ajlm-2201	225	14	electrophoresis	electrophoresis	NOUN
ajlm-2201	225	15	as	as	ADP
ajlm-2201	225	16	a	a	DET
ajlm-2201	225	17	first	first	ADJ
ajlm-2201	225	18	-	-	PUNCT
ajlm-2201	225	19	line	line	NOUN
ajlm-2201	225	20	test	test	NOUN
ajlm-2201	225	21	in	in	ADP
ajlm-2201	225	22	general	general	ADJ
ajlm-2201	225	23	practice	practice	NOUN
ajlm-2201	225	24	.	.	PUNCT
ajlm-2201	226	1	cancers	cancer	NOUN
ajlm-2201	226	2	(	(	PUNCT
ajlm-2201	226	3	basel	basel	PROPN
ajlm-2201	226	4	)	)	PUNCT
ajlm-2201	226	5	.	.	PUNCT
ajlm-2201	227	1	2022;14(12):2930	2022;14(12):2930	NUM
ajlm-2201	227	2	.	.	X
ajlm-2201	227	3	https://doi.org/10.3390/cancers14122930	https://doi.org/10.3390/cancers14122930	PROPN
ajlm-2201	227	4	katzmann	katzmann	PROPN
ajlm-2201	227	5	ja	ja	PROPN
ajlm-2201	227	6	,	,	PUNCT
ajlm-2201	227	7	dispenzieri	dispenzieri	ADJ
ajlm-2201	227	8	a	a	PRON
ajlm-2201	227	9	,	,	PUNCT
ajlm-2201	227	10	kyle	kyle	PROPN
ajlm-2201	227	11	ra	ra	PROPN
ajlm-2201	227	12	,	,	PUNCT
ajlm-2201	227	13	et	et	PROPN
ajlm-2201	227	14	al	al	PROPN
ajlm-2201	227	15	.	.	PUNCT
ajlm-2201	227	16	elimination	elimination	NOUN
ajlm-2201	227	17	of	of	ADP
ajlm-2201	227	18	the	the	DET
ajlm-2201	227	19	need	need	NOUN
ajlm-2201	227	20	for	for	ADP
ajlm-2201	227	21	urine	urine	NOUN
ajlm-2201	227	22	studies	study	NOUN
ajlm-2201	227	23	in	in	ADP
ajlm-2201	227	24	the	the	DET
ajlm-2201	227	25	screening	screening	NOUN
ajlm-2201	227	26	algorithm	algorithm	NOUN
ajlm-2201	227	27	for	for	ADP
ajlm-2201	227	28	monoclonal	monoclonal	NOUN
ajlm-2201	227	29	gammopathies	gammopathy	NOUN
ajlm-2201	227	30	by	by	ADP
ajlm-2201	227	31	using	use	VERB
ajlm-2201	227	32	serum	serum	NOUN
ajlm-2201	227	33	immunofixation	immunofixation	NOUN
ajlm-2201	227	34	and	and	CCONJ
ajlm-2201	227	35	free	free	ADJ
ajlm-2201	227	36	light	light	NOUN
ajlm-2201	227	37	chain	chain	NOUN
ajlm-2201	227	38	assays	assay	NOUN
ajlm-2201	227	39	.	.	PUNCT
ajlm-2201	228	1	mayo	mayo	PROPN
ajlm-2201	228	2	clin	clin	PROPN
ajlm-2201	228	3	proc	proc	PROPN
ajlm-2201	228	4	.	.	PUNCT
ajlm-2201	229	1	2006;81(12):1575–1578	2006;81(12):1575–1578	NUM
ajlm-2201	229	2	.	.	PUNCT
ajlm-2201	230	1	https://doi.org/10.4065/81.12.1575	https://doi.org/10.4065/81.12.1575	PROPN
ajlm-2201	230	2	mctaggart	mctaggart	PROPN
ajlm-2201	230	3	m	m	PROPN
ajlm-2201	230	4	,	,	PUNCT
ajlm-2201	230	5	lindsay	lindsay	PROPN
ajlm-2201	230	6	j	j	PROPN
ajlm-2201	230	7	,	,	PUNCT
ajlm-2201	230	8	kearney	kearney	PROPN
ajlm-2201	230	9	m.	m.	PROPN
ajlm-2201	230	10	replacing	replace	VERB
ajlm-2201	230	11	urine	urine	NOUN
ajlm-2201	230	12	protein	protein	NOUN
ajlm-2201	230	13	electrophoresis	electrophoresis	NOUN
ajlm-2201	230	14	with	with	ADP
ajlm-2201	230	15	serum	serum	NOUN
ajlm-2201	230	16	free	free	ADJ
ajlm-2201	230	17	light	light	ADJ
ajlm-2201	230	18	chain	chain	NOUN
ajlm-2201	230	19	analysis	analysis	NOUN
ajlm-2201	230	20	as	as	ADP
ajlm-2201	230	21	a	a	DET
ajlm-2201	230	22	first	first	ADJ
ajlm-2201	230	23	-	-	PUNCT
ajlm-2201	230	24	line	line	NOUN
ajlm-2201	230	25	test	test	NOUN
ajlm-2201	230	26	for	for	ADP
ajlm-2201	230	27	detecting	detect	VERB
ajlm-2201	230	28	plasma	plasma	NOUN
ajlm-2201	230	29	cell	cell	NOUN
ajlm-2201	230	30	disorders	disorder	NOUN
ajlm-2201	230	31	offers	offer	VERB
ajlm-2201	230	32	increased	increase	VERB
ajlm-2201	230	33	diagnostic	diagnostic	ADJ
ajlm-2201	230	34	accuracy	accuracy	NOUN
ajlm-2201	230	35	and	and	CCONJ
ajlm-2201	230	36	potential	potential	ADJ
ajlm-2201	230	37	health	health	NOUN
ajlm-2201	230	38	benefit	benefit	NOUN
ajlm-2201	230	39	to	to	ADP
ajlm-2201	230	40	patients	patient	NOUN
ajlm-2201	230	41	.	.	PUNCT
ajlm-2201	231	1	am	be	AUX
ajlm-2201	231	2	j	j	PROPN
ajlm-2201	231	3	clin	clin	PROPN
ajlm-2201	231	4	pathol	pathol	NOUN
ajlm-2201	231	5	.	.	PUNCT
ajlm-2201	232	1	2013;140(6):890–897	2013;140(6):890–897	NUM
ajlm-2201	232	2	.	.	PUNCT
ajlm-2201	233	1	https://doi.org/10.1309/ajcp25ihylewcahj	https://doi.org/10.1309/ajcp25ihylewcahj	PROPN
ajlm-2201	233	2	singh	singh	PROPN
ajlm-2201	233	3	g.	g.	PROPN
ajlm-2201	233	4	serum	serum	PROPN
ajlm-2201	233	5	and	and	CCONJ
ajlm-2201	233	6	urine	urine	NOUN
ajlm-2201	233	7	protein	protein	NOUN
ajlm-2201	233	8	electrophoresis	electrophoresis	NOUN
ajlm-2201	233	9	and	and	CCONJ
ajlm-2201	233	10	serum	serum	NOUN
ajlm-2201	233	11	-	-	PUNCT
ajlm-2201	233	12	free	free	ADJ
ajlm-2201	233	13	light	light	NOUN
ajlm-2201	233	14	chain	chain	NOUN
ajlm-2201	233	15	assays	assay	NOUN
ajlm-2201	233	16	in	in	ADP
ajlm-2201	233	17	the	the	DET
ajlm-2201	233	18	diagnosis	diagnosis	NOUN
ajlm-2201	233	19	and	and	CCONJ
ajlm-2201	233	20	monitoring	monitoring	NOUN
ajlm-2201	233	21	of	of	ADP
ajlm-2201	233	22	monoclonal	monoclonal	NOUN
ajlm-2201	233	23	gammopathies	gammopathy	NOUN
ajlm-2201	233	24	.	.	PUNCT
ajlm-2201	234	1	j	j	PROPN
ajlm-2201	234	2	appl	appl	PROPN
ajlm-2201	234	3	lab	lab	PROPN
ajlm-2201	234	4	med	med	PROPN
ajlm-2201	234	5	.	.	PUNCT
ajlm-2201	235	1	2020;5(6):1358–1371	2020;5(6):1358–1371	X
ajlm-2201	235	2	.	.	PUNCT
ajlm-2201	236	1	https://doi.org/10.1093/jalm/jfaa153	https://doi.org/10.1093/jalm/jfaa153	VERB
ajlm-2201	236	2	singh	singh	PROPN
ajlm-2201	236	3	g.	g.	PROPN
ajlm-2201	236	4	serum	serum	PROPN
ajlm-2201	236	5	free	free	ADJ
ajlm-2201	236	6	light	light	NOUN
ajlm-2201	236	7	chain	chain	NOUN
ajlm-2201	236	8	assay	assay	NOUN
ajlm-2201	236	9	and	and	CCONJ
ajlm-2201	236	10	κ	κ	NOUN
ajlm-2201	236	11	/	/	SYM
ajlm-2201	236	12	λ	λ	NOUN
ajlm-2201	236	13	ratio	ratio	NOUN
ajlm-2201	236	14	performance	performance	NOUN
ajlm-2201	236	15	in	in	ADP
ajlm-2201	236	16	patients	patient	NOUN
ajlm-2201	236	17	without	without	ADP
ajlm-2201	236	18	monoclonal	monoclonal	NOUN
ajlm-2201	236	19	gammopathies	gammopathy	NOUN
ajlm-2201	236	20	:	:	PUNCT
ajlm-2201	236	21	high	high	ADJ
ajlm-2201	236	22	false	false	ADJ
ajlm-2201	236	23	-	-	PUNCT
ajlm-2201	236	24	positive	positive	ADJ
ajlm-2201	236	25	rate	rate	NOUN
ajlm-2201	236	26	.	.	PUNCT
ajlm-2201	237	1	am	be	AUX
ajlm-2201	237	2	j	j	PROPN
ajlm-2201	237	3	clin	clin	PROPN
ajlm-2201	237	4	pathol	pathol	NOUN
ajlm-2201	237	5	.	.	PUNCT
ajlm-2201	238	1	2016;146(2):207–214	2016;146(2):207–214	X
ajlm-2201	238	2	.	.	PUNCT
ajlm-2201	238	3	https://doi.org/10.1093/ajcp/aqw099	https://doi.org/10.1093/ajcp/aqw099	NOUN